Strategies to improve retention in randomised trials. by Brueton, VC et al.
Strategies to improve retention in randomised trials (Review)
Brueton VC, Tierney J, Stenning S, Harding S, Meredith S, Nazareth I, Rait G
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2013, Issue 12
http://www.thecochranelibrary.com
Strategies to improve retention in randomised trials (Review)
Copyright © 2013 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
15DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
27CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
88DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Addition of incentive vs none: main analysis, Outcome 1 Retention. . . . . . . . 93
Analysis 2.1. Comparison 2 Addition of incentive: sensitivity analysis: quasi-randomised trials removed, Outcome 1
Retention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
Analysis 3.1. Comparison 3 Addition of incentive: separating research arms of non-factorial trials (three-/four-arm trials),
Outcome 1 Retention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
Analysis 4.1. Comparison 4 Addition of telephone follow-up vs incentive, Outcome 1 Retention. . . . . . . . 97
Analysis 5.1. Comparison 5 Addition of monetary incentive to both study arms, Outcome 1 Retention. . . . . . 98
Analysis 6.1. Comparison 6 Addition of monetary incentive vs offer of incentive, Outcome 1 Retention. . . . . . 99
Analysis 7.1. Comparison 7 Enhanced letter versus standard letter: main analysis, Outcome 1 Retention. . . . . 99
Analysis 8.1. Comparison 8 Communication strategies letter: total design method, Outcome 1 Retention. . . . . 100
Analysis 9.1. Comparison 9 Communication strategies post: main analysis, Outcome 1 Retention. . . . . . . . 101
Analysis 10.1. Comparison 10 Communication strategies: additional reminder vs usual follow-up: main analysis, Outcome
1 Retention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
Analysis 11.1. Comparison 11 Communication strategies additional reminder to trial site vs usual reminder (ICC 0.054),
Outcome 1 Retention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Analysis 12.1. Comparison 12 Communication strategies: questionnaire administered early vs late, Outcome 1
Retention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Analysis 13.1. Comparison 13 Communication strategies: type of reminder: main analysis, Outcome 1 Retention. . 104
Analysis 14.1. Comparison 14 Questionnaire strategies: new vs standard questionnaire: main analysis, Outcome 1
Retention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
Analysis 15.1. Comparison 15 Questionnaire strategies: new vs standard questionnaire: sensitivity analysis quasi-randomised
trial McColl, Outcome 1 Retention. . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Analysis 16.1. Comparison 16 Behavioural strategies: main analysis, Outcome 1 Retention. . . . . . . . . . 107
Analysis 17.1. Comparison 17 Case management, Outcome 1 Retention. . . . . . . . . . . . . . . . 107
Analysis 18.1. Comparison 18 Methodology strategies, Outcome 1 Retention. . . . . . . . . . . . . . . 108
108ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
113APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
125CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
125DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
126SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
126DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
126INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iStrategies to improve retention in randomised trials (Review)
Copyright © 2013 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
[Methodology Review]
Strategies to improve retention in randomised trials
Valerie C Brueton1, Jayne Tierney2, Sally Stenning3 , Seeromanie Harding4 , Sarah Meredith3, Irwin Nazareth5, Greta Rait5
1Meta-analysis Group, MRC Clinical Trials Unit, London, UK. 2Meta-analysis Group, MRC Clinical Trials Unit at UCL, London,
UK. 3MRC Clinical Trials Unit, London, UK. 4Social and Public Health Sciences Unit, Medical Research Council, Glasgow, UK.
5Research Department of Primary Care and Population Health, University College London, London, UK
Contact address: Valerie C Brueton, Meta-analysis Group, MRC Clinical Trials Unit, 125 Kingsway, London, WC2B 6NH, UK.
vcb@ctu.mrc.ac.uk.
Editorial group: Cochrane Methodology Review Group.
Publication status and date: New, published in Issue 12, 2013.
Review content assessed as up-to-date: 13 June 2013.
Citation: Brueton VC, Tierney J, Stenning S, Harding S,Meredith S,Nazareth I, Rait G. Strategies to improve retention in randomised
trials. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: MR000032. DOI: 10.1002/14651858.MR000032.pub2.
Copyright © 2013 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf
of The Cochrane Collaboration. This is an open access article under the terms of the Creative Commons Attribution Licence, which
permits use, distribution and reproduction in any medium, provided the original work is properly cited.
A B S T R A C T
Background
Loss to follow-up from randomised trials can introduce bias and reduce study power, affecting the generalisability, validity and reliability
of results. Many strategies are used to reduce loss to follow-up and improve retention but few have been formally evaluated.
Objectives
To quantify the effect of strategies to improve retention on the proportion of participants retained in randomised trials and to investigate
if the effect varied by trial strategy and trial setting.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, PreMEDLINE, EMBASE, PsycINFO,
DARE, CINAHL, Campbell Collaboration’s Social, Psychological, Educational and Criminological Trials Register, and ERIC. We
handsearched conference proceedings and publication reference lists for eligible retention trials. We also surveyed all UK Clinical Trials
Units to identify further studies.
Selection criteria
We included eligible retention trials of randomised or quasi-randomised evaluations of strategies to increase retention that were
embedded in ’host’ randomised trials from all disease areas and healthcare settings. We excluded studies aiming to increase treatment
compliance.
Data collection and analysis
We contacted authors to supplement or confirm data that we had extracted. For retention trials, we recorded data on the method
of randomisation, type of strategy evaluated, comparator, primary outcome, planned sample size, numbers randomised and numbers
retained.Weused risk ratios (RR) to evaluate the effectiveness of the addition of strategies to improve retention.We assessed heterogeneity
between trials using the Chi2 and I2 statistics. For main trials that hosted retention trials, we extracted data on disease area, intervention,
population, healthcare setting, sequence generation and allocation concealment.
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Main results
We identified 38 eligible retention trials. Included trials evaluated six broad types of strategies to improve retention.Thesewere incentives,
communication strategies, new questionnaire format, participant case management, behavioural and methodological interventions.
For 34 of the included trials, retention was response to postal and electronic questionnaires with or without medical test kits. For four
trials, retention was the number of participants remaining in the trial. Included trials were conducted across a spectrum of disease areas,
countries, healthcare and community settings. Strategies that improved trial retention were addition of monetary incentives compared
with no incentive for return of trial-related postal questionnaires (RR 1.18; 95% CI 1.09 to 1.28, P value < 0.0001), addition of an
offer of monetary incentive compared with no offer for return of electronic questionnaires (RR 1.25; 95% CI 1.14 to 1.38, P value <
0.00001) and an offer of a GBP20 voucher compared with GBP10 for return of postal questionnaires and biomedical test kits (RR
1.12; 95% CI 1.04 to 1.22, P value < 0.005). The evidence that shorter questionnaires are better than longer questionnaires was unclear
(RR 1.04; 95% CI 1.00 to 1.08, P value = 0.07) and the evidence for questionnaires relevant to the disease/condition was also unclear
(RR 1.07; 95% CI 1.01 to 1.14). Although each was based on the results of a single trial, recorded delivery of questionnaires seemed to
be more effective than telephone reminders (RR 2.08; 95% CI 1.11 to 3.87, P value = 0.02) and a ’package’ of postal communication
strategies with reminder letters appeared to be better than standard procedures (RR 1.43; 95% CI 1.22 to 1.67, P value < 0.0001). An
open trial design also appeared more effective than a blind trial design for return of questionnaires in one fracture prevention trial (RR
1.37; 95% CI 1.16 to 1.63, P value = 0.0003).
There was no good evidence that the addition of a non-monetary incentive, an offer of a non-monetary incentive, ’enhanced’ letters,
letters delivered by priority post, additional reminders, or questionnaire question order either increased or decreased trial questionnaire
response/retention. There was also no evidence that a telephone survey was either more or less effective than a monetary incentive and
a questionnaire. As our analyses are based on single trials, the effect on questionnaire response of using offers of charity donations,
sending reminders to trial sites and when a questionnaire is sent, may need further evaluation. Case management and behavioural
strategies used for trial retention may also warrant further evaluation.
Authors’ conclusions
Most of the retention trials that we identified evaluated questionnaire response. There were few evaluations of ways to improve partic-
ipants returning to trial sites for trial follow-up. Monetary incentives and offers of monetary incentives increased postal and electronic
questionnaire response. Some other strategies evaluated in single trials looked promising but need further evaluation. Application of
the findings of this review would depend on trial setting, population, disease area, data collection and follow-up procedures.
P L A I N L A N G U A G E S U M M A R Y
Methods that might help to keep people in randomised trials
Background
Most trials follow people up to collect data through personal contact after they have been recruited. Some trials get data from other
sources, such as routine collected data or disease registers. There are many ways to collect data from people in trials, and these include
using letters, the internet, telephone calls, text messaging, face-to-face meetings or the return of medical test kits. Most trials have
missing data, for example, because people are too busy to reply, are unable to attend a clinic, havemoved or no longer want to participate.
Sometimes data has not been recorded at study sites, or are not sent to the trial co-ordinating centre. Researchers call this ’loss to follow-
up’, ’drop out’ or ’attrition’ and it can affect the trial’s results. For example, if the people with the most or least severe symptoms do not
return questionnaires or attend a follow-up visit, this will bias the findings of the trial. Many methods are used by researchers to keep
people in trials. These encourage people to send back data by questionnaire, return to a clinic or hospital for trial-related tests, or be
seen by a health or community care worker.
Study characteristics
This review identified methods that encouraged people to stay in trials. We searched scientific databases for randomised studies (where
people are allocated to one of two or more possible treatments in a random manner) or quasi-randomised studies (where allocation is
not really random, e.g. based on date of birth, order in which they attended clinic) that compared methods of increasing retention in
trials. We included trials of participants from any age, gender, ethnic, cultural, language and geographic groups.
Key results
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The methods that appeared to work were offering or giving a small amount of money for return of a completed questionnaire and
enclosing a small amount of money with a questionnaire with the promise of a further small amount of money for return of a filled
in questionnaire. The effect of other ways to keep people in trials is still not clear and more research is needed to see if these really do
work. Such methods are shorter questionnaires, sending questionnaires by recorded delivery, using a trial design where people know
which treatment they will receive, sending specially designed letters with a reply self addressed stamped envelope followed by a number
of reminders, offering a donation to charity or entry into a prize draw, sending a reminder to the study site about participants to follow-
up, sending questionnaires close to the time the patient was last followed-up, managing peoples’ follow-up, conducting follow-up by
telephone and changing the order of questionnaire questions.
Quality of evidence
The methods that we identified were tested in trials run in many different disease areas and settings and, in some cases, were tested in
only one trial. Therefore, more studies are needed to help decide whether our findings could be used in other research fields.
B A C K G R O U N D
Description of the problem or issue
Randomised trials are the gold standard for evaluating the effec-
tiveness and efficacy of interventions. Non-response or loss to fol-
low-up within study groups in randomised trials can compromise
study findings by reducing the power of a study to detect a true
difference between the control and the intervention group. Dif-
ferential loss to follow-up may lead to bias through exaggerated
effects in favour of one of the groups. This can affect the general-
isability and internal validity of the trial and the results (Fewtrell
2008; Schulz 2002).
Missing data from loss to follow-up can be dealt with statistically
by various methods including, for example, imputing values based
on valid assumptions about the missing data to give a conserva-
tive estimate of the treatment effect. However, the risk of bias still
remains when trials do not collect adequate data to give accurate
estimates (Hollis 1999). Schulz and colleagues suggested that less
than 5% loss to follow-up may lead to minimum bias, while 20%
loss to follow-up can threaten trial validity, although the pattern
of loss to follow-up by treatment may also be an important fac-
tor (Schulz 2002). Loss to follow-up from randomised trials can
sometimes go unreported and using different, but plausible, as-
sumptions about outcomes for participants lost to follow-up can
change the results of randomised trials.
A number of trials have retrospectively examined the predictors
of loss to follow-up in different disease areas (Arnow 2007; Snow
2007; Villarruel 2006). In a trial for the treatment of chronicmajor
depression, Arnow examined the predictors of time to, and reason
for, dropout of participants (Arnow 2007). Ethnic minorities and
participants with comorbid anxiety were more likely to drop out.
In a randomised trial of a human immunodeficiency virus (HIV)
prevention intervention for Latino youths, English speakers were
more likely to attend follow-up (Villarruel 2006). Snow examined
the predictors of clinic attendance and dropout at the 11-year
follow-up of the Lung Health study (Snow 2007). Age, gender,
number of cigarettes smoked per day, marital status and whether
participant’s children smoked were predictors of clinic attendance.
These analyses showed that attendance for follow-up can be trial
and disease specific. An awareness of these factors can help trialists
decide which strategies to adopt to improve retention in their
randomised trial.
Description of the methods being investigated
Strategies to improve trial retention include those designed to gen-
erate maximum data return or compliance to follow-up proce-
dures. These can include frequency and timing of follow-up visits
(follow-up shortly after randomisation versus long-term follow-
up), nature of the outcome to be measured (survey based self re-
ported outcomes versus morbidity or mortality reporting), target
of the intervention (participants versus providers versus trial sites),
and type of intervention (incentives versus communication strate-
gies versus participant case management).
How these methods might work
These retention strategies are designed to motivate participants
(Leathem 2009), or the trial site to continue participating in a trial
once they have been recruited and randomised. Some strategies
are designed to encourage participants to identify with the trial
and to promote a sense of value and belonging, for example, using
trial identity cards. Other strategies are designed to keep partic-
ipants engaged in the trial, for example, by sending participant
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newsletters. To encourage a proactive approach to trial retention,
strategies can be designed to target participants directly through
letters, emails, telephone calls or to target them via the clinicians
involved in participant follow-up, for example, through regular
communication with trial sites. Strategies have been specifically
developed to promote retention in areas of research where it is
particularly challenging, such as mental health (Furimsky 2008;
Loue 2008), weight loss ( Couper 2007; Goldberg 2005), rare
diseases (McKinstry 2007), substance abuse (El Khorazaty 2007),
research involving minority ethnic groups (Eakin 2007; Loftin
2005; Villacorta 2007), and vulnerable groups such as older peo-
ple (Burns 2008) or people with HIV (Anastasi 2005).
Why it is important to do this review
As drop-out or incomplete data causes problems in the conduct,
analysis and interpretation of randomised trials, it is important
to identify retention strategies that minimise this loss as far as
possible.
Davis and colleagues conducted a review of community-based tri-
als published from 1990 to 1999 and described retention strate-
gies and retention outcomes for this area (Davis 2002). Robinson
and colleagues conducted a systematic review of strategies for re-
taining study participants (Robinson 2007). While both reviews
identified studies providing data on retention rates from primary
studies and strategies used to promote retention, these were not
evaluated quantitatively in either review.
A systematic review of strategies to retain participants in popu-
lation-based cohort studies found that providing incentives was
consistently associated with retention in these studies and that re-
sponse generally increased with increasing incentive value (Booker
2011). Reminder letters, repeat questionnaires and reminder calls
also increased response rates. Furthermore, the Edwards et al.
Cochrane methodology review on methods to increase response
rates to postal and electronic questionnaires found that including
monetary incentives, keeping the questionnaire short and contact-
ing people before sending the questionnaire were ways to increase
response rates (Edwards 2009). That review was not restricted
to research exclusively within randomised trials and covered both
healthcare and non-healthcare settings and it is difficult to know
which of these strategies would be applicable to randomised trials
in health care. Reasons for drop-out in cohort studies and surveys
may differ from those in randomised trials. For example, in tri-
als, participants may be randomised to a study group that is not
their preferred choice and factors around randomisation and the
type of intervention mean that strategies increasing retention in
cohort studies and surveys cannot necessarily be extrapolated to
randomised trials.
The challenges of boosting recruitment to randomised trials is of-
ten described alongside retention in the literature. Some similar
strategies may be used in an attempt to both increase recruitment
and improve retention, such as giving incentives together with ex-
tra information. Rendell et al. assessed the evidence for the effect
of disincentives and incentives on the extent to which clinicians in-
vite eligible people to participate in randomised trials of healthcare
interventions (Rendell 2007). No randomised trials of interven-
tions were identified and the authors concluded that some aspects
of the conduct of the trial might affect a clinician’s willingness to
invite people to participate, for example, the way the clinician is
invited to take part and the availability of support staff. In another
Cochrane methodology review, Treweek et al. assessed strategies
to improve recruitment to research studies (Treweek 2010), but
recruitment to trials presents different challenges to participant
engagement and follow-up. For example, strategies to market a
trial and win over participants during the recruitment phase may
be different to strategies to keep participants engaged in a trial
(Francis 2007).
Many untested strategies are used by researchers to try to improve
retention in randomised trials. Therefore, because loss to follow-
up can compromise the validity of a trial’s findings, delay results
and, in some circumstances, increase the costs of the research,
a systematic review is needed to assess the effect of strategies to
improve retention in randomised trials.
O B J E C T I V E S
To quantify the effect of strategies to improve retention in ran-
domised trials.
To investigate if the effect varies by the type of strategy, trial setting
and healthcare area.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included completed randomised trials that compared strategies
to increase retention embedded inhost randomised trials (hereafter
referred to as retention trials). The retention trials were embedded
in real trials (host trials) and not hypothetical trials. The retention
trials included at least one randomised comparison of two or more
strategies to improve retention, or compared one ormore strategies
with no strategy. In anticipationof few trials, we included retention
trials if they were randomised or quasi-randomised (e.g. had used
alternation, date of birth or case record number as a method of
allocating participants) (Lefebvre 2008).
Strategies to improve retention were designed for impact after par-
ticipants were recruited and randomised to either the intervention
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or control group of the main and the retention trial. We included
trials to increase response to postal and electronic questionnaire.
We excluded trials to increase recruitment only. We excluded co-
hort studies with embedded randomised retention trials, which
were the subject of a separate systematic review (Booker 2011).
Types of data
We included randomised and quasi-randomised retention trials
within the context of a host randomised trial with participants
from any age, gender, ethnic, cultural, language and geographic
groups. We included unpublished and published participant re-
tention data from randomised trials addressing healthcare (includ-
ing all disciplines and disease areas) and non-healthcare (educa-
tion, social sciences) topics. We also included trials set in the com-
munity that were healthcare related.
Types of methods
We considered any strategy aimed at increasing retention, directed
towards the clinician, researcher or participant.We included strate-
gies compared with each other or with usual study procedures. We
also included trials with any combination of strategies to increase
retention. Strategies could be participant or trial management fo-
cused and include any of the following:
• strategies to motivate participants and clinicians (e.g.
incentives or gifts);
• strategies to improve communication with participants or
trial sites (e.g. enhanced letters);
• methodology strategies (e.g. shorter length of follow-up or
variation in follow-up visit frequency);
• strategies to improve social support for participant
retention.
Types of outcome measures
Primary outcomes
We used retention (the proportion of participants retained) at
the primary analysis point as defined in each individual retention
trial as the primary outcome because it is easier to interpret than
attrition/loss to follow-up (i.e. the proportion lost or not retained).
In cases where the time point for measurement of the primary
outcome was not predefined, we took the first time point reported
for analysis. In most cases, this was final response. If retention at
a number of time points was reported and no clear time point for
the primary outcome for the retention trial was stated, we took
data for the nearest time point to the intervention in the retention
trial analyses.
Secondary outcomes
Retention of participants at secondary analysis points.
Search methods for identification of studies
We designed a search strategy to identify published and unpub-
lished randomised and quasi-randomised trials that assessed strate-
gies to improve retention in randomised trials in healthcare, ed-
ucation and social science settings. We searched bibliographic
databases for published trials and trial registers for trials that had
not been fully published, or were unpublished or ongoing. We
applied no language restrictions.
Electronic searches
Each search comprised an established filter to identify randomised
trials plus free-text terms and database subject headings relating to
reducing loss to follow-up or increasing retention (Appendix 1).
Electronic databases searched included:
• the Cochrane Central Register of Controlled Trials
(CENTRAL) (to May 2012);
• PreMEDLINE (to April 2010);
• MEDLINE (1950 to May 2012) (Appendix 2), EMBASE
(1980 to May 2012) (Appendix 3) and PsycINFO (1806 to May
2012) (Appendix 4), searched using an Ovid platform;
• Database of Abstracts of Reviews of Effects (DARE, in The
Cochrane Library May 2012);
• CINAHL (Cumulative Index to Nursing and Allied
Health; 1981 to May 2012) (Appendix 5), using the
EBSCOHost platform;
• Campbell Collaboration’s Social, Psychological,
Educational and Criminological Trials Register (C2-SPECTR
http://geb9101.gse.upenn.edu/: searched May 2009 (website no
longer accessible)) (Appendix 6);
• Education Resource Information Centre (ERIC) 1966 to
May 2009) (Appendix 7), using Dialog Datastar.
Searching other resources
We handsearched the reference lists of relevant publications and
reviews to identify further trial reports (Horsley 2011) (Appendix
8). We also searched the abstracts of Society for Clinical Trials
(SCT) meetings from 1980 to 2012, the Current Controlled Tri-
als metaRegister of Controlled Trials (mRCT) (www.controlled-
trials.com/mrct), the Cochrane Methodology Register (in The
Cochrane Library to April 2012) and the World Health Organiza-
tion (WHO) trials platform (apps.who.int/trialsearch). We con-
ducted a survey of Clinical Trial Units in theUK to identify further
eligible trials not identified through other sources and the review
was presented at the Society for Clinical Trials 31st Conference in
Baltimore, USA in May 2010 and advertised on the Conference
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notice board with the aim of identifying potentially eligible trials
from outside the UK.
Data collection and analysis
Selection of studies
One review author (VB) selected potentially eligible trials from the
titles and abstracts retrieved by the searches, using a predesigned
study eligibility screening form. We were over inclusive when
screening, 0.7% (168/24,304) of records identified were sent for
screening to a second review author (GR), which is 23% (168/
735) of all potentially eligible records identified.We obtained full-
text papers and two review authors (VB, GR) reviewed potentially
eligible trials for inclusion. We contacted study authors for elec-
tronic copies of papers that we could not access through library
sources. We were able to obtain copies of all the potentially eligible
papers that we wanted to screen. We resolved disagreements by
discussion with a third review author (SS). When necessary, we
sought information from the original investigators for potentially
eligible trials where we wished to clarify eligibility.
Data extraction and management
One review author (VB) extracted data from eligible retention
trial and associated host trial papers and a second review author
(JT) checked the entries. We reached consensus on any dispari-
ties by discussion with a third review author (SS). Data extracted
for the host trial were aim, setting, disease area, comparators, pri-
mary outcome, sample size calculation, inclusion exclusion crite-
ria, sequence generation and allocation concealment, and num-
bers randomised to each group. For the embedded retention trial,
we extracted data for onset in relation to the host trial, source of
the sample, aim, primary outcome and type of follow-up. The
retention strategy details included type, frequency and timing of
administration method of randomisation, numbers randomised,
included and retained at primary analysis, and data required for
the risk of bias assessment.
Assessment of risk of bias in included studies
To assess the validity of each retention trial we judged them against
the four domains of the Cochrane ’Risk of bias’ tool (Higgins
2008a). To assess selection bias, we recorded how the allocation
sequence was generated at study level and the methods used to
conceal the allocation. We assessed performance bias by recording
methods used to blind participants if considered appropriate to do
so. For some interventions, participants could not be blinded to the
intervention (e.g. where vouchers, cash or gifts were administered).
However, in these cases, study personnel could be blinded to the
allocation if administration of the intervention was carried out by
someone unaware of the allocation.
As retention is the subject of our review, and retention of partic-
ipants is the primary outcome, attrition from the trials does not
constitute a bias and has not been included in the ’Risk of bias’
tables. We assessed each included retention trial for selective out-
come reporting by recording the primary outcome for the trial and
the outcomes for which results were reported. A judgement was
made about each trial for each risk of bias domain assessed. For
completed host trials (within which retention trials were embed-
ded), we only assessed sequence generation and allocation con-
cealment, in order to ensure the host trial was randomised.
Measures of the effect of the methods
We calculated risk ratios (RR) and their 95% confidence intervals
(CI) for retention to determine the effect of strategies on this
outcome.
Unit of analysis issues
For retention trials that randomised individuals and clusters, the
unit of analysis was the participant. For cluster randomised trials
that ignored clustering in the analysis, we inflated the standard
errors (SE) to avoid overprecise estimates of effect as follows (
Higgins 2008b).
1. We calculated the RR, 95% CI and SE based on
participants in the usual way (i.e. ignoring clustering).
2. This standard error was then inflated using the design effect
to get an adjusted SE: adjusted SE = SE X
√
design effect. With
the design effect calculated as follows: design effect = 1 + (M - 1)
ICC where M = mean cluster size, ICC = the intracluster
correlation coefficient.
3. Where published ICCs were not available, we used the
mean ICC from appropriate external estimates for Land 2007.
This was the mean of estimates for the return of EuroQol
questionnaires (ICC = 0.054) from a source recommended by
the Cochrane Handbook for Systematic Reviews of Interventions
(Section 16.3.4) (Higgins 2008b) and www.abdn.ac.uk/hsru/
documents/iccs-web.xls (last accessed 27 September 2013).
4. We entered the effect estimate and the new updated SE into
Review Manager 5 using the generic inverse variance (RevMan
2012).
Where the number of participants randomised was not clearly
stated in the included study report, we contacted the study authors
for this information.
Dealing with missing data
We contacted study authors for data for the risk of bias assessment,
numbers randomised to each group and numbers retained in each
group at the primary endpoint. We described outcomes with in-
sufficient data qualitatively. For time-to-event outcomes, we used
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the time point of the host study primary outcome, taking account
of censoring if necessary and if the data were available.
Assessment of heterogeneity
We measured heterogeneity of the intervention effect using the
Chi2 statistic at a significance level of 0.10 and the I2 statistic
(Higgins 2003), and explored through subgroup analyses.
Assessment of reporting biases
We would have investigated reporting bias using tests for funnel
plot asymmetry if sufficient data had been available (Egger 1997;
Sterne 2008).
Data synthesis
If there was no substantial heterogeneity, we pooled RRs using
the fixed-effect model. If heterogeneity was detected and could
not be explained by subgroup or sensitivity analyses, we used the
random-effects model or did not pool results.
For factorial trials (Sharp 2006a-h, Kenton 2007a-d), all main
effects were included as separate trial comparisons if they ad-
dressed different categories of strategies. Where the main effects
addressed two or more strategies within the same category (e.g.
Bowen 2000abc), we combined the relevant intervention groups
and compared them with the control group. We also compared
each intervention group with the control group, as separate trial
comparisons, in exploratory analyses. For one 2 x 2 x 2 x 2 factorial
trial (Renfroe 2002a-d), the numbers randomised for each group
were not available at the time of analysis so comparison groups
were collapsed as far as possible and then treated as separate trial
comparisons in the appropriate analyses. For two three-armed tri-
als that compared two similar intervention groups with one con-
trol group, we combined the intervention groups and compared
it with the control group for the main analyses (Bauer 2004ab,
Khadjesari 2011 1abc).We also compared each intervention group
as separate trial comparisons in exploratory analyses.
These approaches allowed full exploration of the data and also
avoided double counting and over-precise pooled estimates of ef-
fect in our main analyses. However, this also meant that there were
occasionally a greater number of trial comparisons than trials.
Computations for the absolute benefits of effective strategies on
questionnaire response and trial retention were based on abso-
lute risk reductions derived from meta-analysis RRs (Cochrane
Handbook for Systematic Reviews of Interventions, Section 12.5.4.2:
Schünemann 2008).
Subgroup analysis and investigation of heterogeneity
To explore the effect of different strategies on trial retention, we
planned the following subgroup analyses by the type of strategy
used in included retention trials.
• Whether the strategy was compared with usual follow-up or
other strategies.
• Whether in healthcare or non-healthcare settings.
• Whether assessment of retention was immediate or longer
term (e.g. if a response to a questionnaire was expected
immediately or at later time points).
• Whether the strategy was participant or management
focused.
However, we identified such a diversity of retention trials and in-
terventions that these analyses were inappropriate or not possible.
Therefore, different types of strategies were analysed separately and
new subgroups were defined within these before we conducted the
analyses.
(a) Incentives
We subgrouped retention trials or trial comparisons evaluating the
addition of an incentive strategy versus none as follows for analysis.
1. Monetary incentives given upfront, defined as money given
to the trial participant prior to data collection in cheque, cash or
voucher format.
2. Non-monetary incentives, defined as gifts, for example,
pens or certificates.
3. Offers of monetary incentives after data collection, defined
as a promise of the incentive after return of outcome data
through attendance for scheduled follow-up or receipt of follow-
up questionnaires.
4. Offers of non-monetary incentives defined as a promise of
the non-monetary incentive after return of outcome data
through attendance for scheduled follow-up or receipt of follow-
up questionnaires.
We subgrouped retention trials or trial comparisons comparing
different values of monetary incentives into:
1. those offering incentives;
2. those both giving and offering an incentive for any
subsequent data (e.g. sending GBP5 with a questionnaire with
an offer of GBP5 if the questionnaire is returned).
We analysed retention trials evaluating the addition of a monetary
incentive versus either an offer of a monetary incentive or follow-
up by telephone separately.
(b) Communication
We grouped retention trials or trial comparisons of the effect of
different communication strategies into letter, post and reminder
strategies for analysis as follows.
1. Enhanced versus standard cover letter.
2. Total design method versus standard postal communication
strategy.
3. Priority versus regular post.
4. Additional reminders versus usual reminders to trial sites.
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5. Additional reminders versus usual follow-up to trial
participants.
6. Early versus late administration of questionnaire (i.e.
sending questionnaires two to three weeks after a follow-up visit
versus one to four months after a follow-up visit).
7. Recorded delivery versus telephone reminder.
(c) Questionnaire structure
We subgrouped trials of questionnaire strategies into length of
questionnaire, clarity of meaning, order of questions and layout
as follows.
1. Short versus long questionnaire.
2. Long and clear questionnaire versus short and condensed
questionnaire.
3. Medical condition questions first versus generic questions
first.
4. Relevance of questionnaires: alcohol versus mental health
questionnaires.
There were no subgroups for behavioural, case management and
methodology retention trials.
Our analyses focused on the primary endpoint of retention. We
initially pooled retention trials within subgroups using the fixed-
effect model and quantified heterogeneity. We assessed whether
these subgroups had a differential impact on retention using the
test for interaction. We did not pool trials if results were inconsis-
tent or heterogeneity was excessive.
Sensitivity analysis
To assess the robustness of the results we planned sensitivity anal-
yses that excluded quasi-randomised retention trials.
R E S U L T S
Description of studies
The studies are described in the Characteristics of included
studies, Characteristics of studies awaiting classification, and
Characteristics of excluded studies tables.
Results of the search
We identified 24,304 abstracts, titles and other records from
database searches to May 2012, handsearches of reviews, lists of
references in included papers, SCT conference abstracts (to 2012),
personal contact with trialists, and the survey of UKClinical Trials
Units (Figure 1). We screened 735 full-text papers, reports and
manuscripts for eligible studies. Of 68 potentially eligible studies,
we found 30 to be subsequently ineligible. This left 38 retention
trials for inclusion in the review. The retention trials were embed-
ded in real trials (host trials). We identified 11retention trials from
CENTRAL, MEDLINE and CINAHL; 14 from handsearching
reviews, conference abstracts, and references lists of eligible papers;
and 13 through personal communications or correspondence with
clinical trials units. We evaluated six broad types of strategy to im-
prove retention in randomised trials. Most strategies were targeted
at increasing questionnaire response. The strategies used for this
were incentives, communication, methodology and questionnaire
design strategies. There was minimal evidence for the use of be-
havioural and case management strategies to improve retention.
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Figure 1. Attrition study flow diagram.
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Included studies
Of the 38 eligible retention trials, 28 were published in full, one
as an abstract (Kenton 2007a-d), and one as part of a PhD thesis
(Nakash 2007). Four retention trial publications contained two
trials each (Khadjesari 2011; McCambridge 2011; McColl 2003;
Severi 2011). Eight retention trials are unpublished as of June
2013 (Bailey 1; Bailey 2; Edwards 2001; Land 2007; Letley 2000;
MacLennan; Marson 2007; Svoboda 2001).
Host trials
Twenty-two host trials included a single retention trial (AVID
investigators 1997; Boyd 2002; Chaffin 2009; Cooke 2009; Cox
2008; Gail 1992; Dennis 2009; Hughes 1984; International
Stroke Trial Group 1997; Kenyon2001; Lamb 2007; Leigh Brown
2001;Marson 2007 (2);Omenn 2006; Porterhouse 2005; Rothert
2006; Tai 1999; Tilbrook 2011; TOMBOLA2009a; TOMBOLA
2009b; UK BEAM 2004). Two host trials from this group were
unpublished (for the retention trials by Ashby 2011 and Land
2007).
The other host trials included multiple retention trials (one un-
published for the retention trials by Bailey 1 and Bailey 2). Two
retention trials (Ford 2006; Subar 2001) were embedded in the
US-based Prostate, Lung, Colorectal, Ovarian (PLCO) screen-
ing trial of Prorok 2000; two (Avenell 2004; MacLennan) in
the RECORD fracture prevention trial (RECORD 2007); two
(Edwards 2001; Svoboda 2001) in theCRASH trial (CRASHTrial
collaborators 2004); four (Khadjesari 2011 1abc; Khadjesari 2011
2; McCambridge 2011 1; McCambridge 2011 2) in the Down
your Drink Trial (Murray 2007); two (Bailey 1; Bailey 2) in a
feasibility study for the Sex unzipped website (unpublished); two
(Severi 2011 1; Severi 2011 2) in the Text to Stop smoking cessa-
tion trial (Free 2011); and two (McColl 2003 1; McColl 2003 2)
in the COGENT trial (Eccles 2002).
Participants and settings
Included retention trials were conducted in a broad spectrum
of clinical conditions and geographical settings (see Appendix
9). Eight included retention trials were embedded in trials
for the treatment of alcohol and smoking dependency (Bauer
2004ab; Hughes 1989; Khadjesari 2011 1abc; Khadjesari 2011
2; McCambridge 2011 1; McCambridge 2011 2; Severi 2011 1;
Severi 2011 2), and four in trials investigating treatments for in-
juries (Edwards 2001; Gates 2009; Nakash 2007; Svoboda 2001).
Six retention trials were set in treatment trials for cancer, cardiovas-
cular disease, epilepsy and back pain (Dorman 1997; Land 2007;
Letley 2000; Man 2011; Marson 2007; Renfroe 2002a-d), and
four were embedded in screening trials for cancer, postnatal de-
pression, and elderly diseases (Ford 2006; Kenton 2007a-d; Sharp
2006a-h; Subar 2001). Seven retention trials were embedded in
prevention trials, which included two cancer prevention trials for
lung and breast cancer (Bowen 2000abc; Sutherland 1996), one
migraine prevention trial (Ashby 2011), and three fracture pre-
vention trials (Avenell 2004; Cockayne 2005; MacLennan). Four
retention trials were conducted in clinical management trials for
orthopaedics, asthma, diabetes and angina (Leigh Brown 1997;
McColl 2003 1; McColl 2003 2; Tai 1997). Six retention tri-
als were conducted in other areas: exercise (Cox 2008), parent-
ing (Chaffin 2009), weight management (Couper 2007), neonatal
medicine (Kenyon 2005), and sexual health promotion (Bailey 1;
Bailey 2).
Twenty-five retention trials were UK based, nine were USA based
and two were set in Canada. The remainder were set in Czech
Republic and Australia (see Characteristics of included studies
table).
Retention trials were embedded in host trials that recruited partic-
ipants from different settings. Five trials recruited participants di-
rectly from the community. Sixteen trials were conducted through
secondary care facilities. One trial recruited participants through a
combination of state workers compensation programmes, occupa-
tional and physician clinic, a surveillance programme and union
records. Six UK trials recruited solely through general practitioner
(GP) practices and twoused a combinationof recruitment through
GP practices and the media. Seven trials recruited participants via
the Internet, six of these were UK based and the other was US
based. For one US-based smoking cessation trial, it was unclear
how participants were recruited (see Characteristics of included
studies table).
Design of included retention trials
One trial was hosted in a clustered randomised trial and used
this design to evaluate a strategy to improve retention (Land
2007). Four retention trials used different factorial designs (Bowen
2000abc; Kenton 2007a-d; Renfroe 2002a-d; Sharp 2006a-h).
There was also one three-armed trial (Bauer 2004ab), and three
four-armed trials (Khadjesari 2011 1abc; McCambridge 2011 1;
McCambridge 2011 2).
Five trials used quasi-randomisation to allocate participants (
Bowen 2000abc; Ford 2006; Gates 2009;McColl 2003 1;McColl
2003 2). Two used participant identification numbers (Ford 2006;
Gates 2009), and two allocated the first half of a simple random
sample of participants to receive one version of a questionnaire,
while the remaining half was allocated to a second version (McColl
2003 1; McColl 2003 2). One retention trial used day of clinic
visit to allocate participants (Bowen 2000abc).
10Strategies to improve retention in randomised trials (Review)
Copyright © 2013 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
All trials targeted individual trial participants, except one that tar-
geted trial sites (Land 2007).
We recorded the timing of randomisation in the host trial ver-
sus the timing of randomisation in the retention trial. Four tri-
als commenced during a randomised pilot study for the host
trial (Khadjesari 2011 1abc; Letley 2000; McCambridge 2011 1;
Sutherland 1996). One study started before the host trial (Chaffin
2009). Twenty-nine trials commenced during follow-up for the
host trial (Ashby 2011; Avenell 2004; Bailey 1; Bailey 2; Bowen
2000abc; Cockayne 2005; Couper 2007; Cox 2008; Dorman
1997; Edwards 2001; Ford 2006; Gates 2009; Khadjesari 2011 2;
Land 2007; Leigh Brown 1997; MacLennan; Man 2011; Marson
2007; McCambridge 2011 2; McColl 2003 1; McColl 2003 2;
Nakash 2007; Renfroe 2002a-d; Severi 2011 1; Severi 2011 2;
Sharp 2006a-h; Subar 2001; Svoboda 2001; Tai 1997). For one
trial, it was unclear when the retention trial started in relation
to the host trial (Kenton 2007a-d). Three retention trials started
after the host trial had finished (Bauer 2004ab; Hughes 1989;
Kenyon 2005): Kenyon 2005 followed-up seven-year-old children
of mothers enrolled in the ORACLE trial (Kenyon 2001), Bauer
2004ab followed up participants in the COMMIT smoking cessa-
tion trial (Gail 1992), eight years after the original trial was com-
pleted and Hughes 1989 followed up participants in a smoking
cessation trial six months after that study finished (Hughes 1984).
Strategies to improve retention
Retention in trials and response to questionnaires were the out-
comes measured for all included trials. The included trials evalu-
ated six different types of strategies to improve response or reten-
tion. Incentives, communication strategies, variation in question-
naire design, methodology strategies, and combinations of com-
munication and incentive strategies evaluated improving response
to postal and electronic questionnaires. Behavioural strategies, case
management and some non-monetary incentives were used to en-
courage participants to return to trial sites for follow-up visits.
Each type of strategy is described separately below.
Outcome measures in the included trials
Thirty-four retention trials measured response to questionnaires.
Among these, the questionnaires were by post in 26 trials, elec-
tronically in four and one was done by interview. For another three
retention trials, response was return of biomedical kits or biomedi-
cal kits plus a questionnaire (see Characteristics of included studies
table).
Four included trials measured the number of participants remain-
ing in the trial (Bowen 2000abc; Chaffin 2009; Cox 2008; Ford
2006)
Ten included trials specified that their primary outcome was ques-
tionnaire response at a particular time point: McCambridge 2011
1 measured response at one and three months, McCambridge
2011 2measured response at three and 12 months, and Khadjesari
2011 1abc and Khadjesari 2011 2 measured response within 40
days of the first reminder. For Severi 2011 1, the primary out-
come was completed follow-up at 30 weeks from randomisation,
Severi 2011 2 used return of specimens one month after a tele-
phone call, Avenell 2004 used retention at one year measured by
questionnaire return but also reported retention at four and eight
months. Cockayne 2005 and Sharp 2006a-h had final follow-up
questionnaire response at any time as their primary outcome.
Two included trials reported questionnaire response at one time
point only but without specifying that this was the primary out-
come for the trial (Edwards 2001; Svoboda 2001). These trials
measured response at three months from the questionnaire being
sent.One trial reported trial retention at one time point only (three
years) but without specifying that this was the primary outcome
for the trial (Ford 2006). This was measured as completing the
next cancer screening in a cancer screening trial. In each of these
three trials, we used these data for analyses.
Two trials recorded questionnaire response at two time points
without stating which was the primary outcome (Dorman 1997;
Gates 2009). One trial recorded retention at two time points with-
out stating which was the primary outcome (Cox 2008). We used
data for response/retention after the first contact with respondents
as the primary outcome for analyses. One trial reported response
at three time points (4 weeks, 12 weeks and 9 months), which
were all stated as the primary outcome (Nakash 2007). We used
the data for week four in our main analysis.
Five trials reported data in survival curves. For these, we used the
final analysis point (Ashby 2011; Bowen 2000abc; Chaffin 2009;
Land 2007; Sutherland 1996). Authors confirmed data when it
had been extracted. Fifteen trials reported the number of ques-
tionnaires returned with no time point specified (Bauer 2004ab;
Couper 2007; Hughes 1989; Kenton 2007a-d; Kenyon 2005;
Leigh Brown 1997; Letley 2000;MacLennan;Man 2011;Marson
2007; McColl 2003 1; McColl 2003 2; Renfroe 2002a-d; Subar
2001; Tai 1997).
Addition of incentive versus none
There were 14 retention trials of incentives and 19 trial compar-
isons (Table 1). Thirteen trials were aimed at improving question-
naire response in trials and one trial was aimed at improving re-
turn for follow-up at trial site (Bowen 2000abc). The different in-
centive strategies aimed at improving questionnaire response were
vouchers, cash, a charity donation, entry to prize draws, cheques,
a certificate of appreciation and offers of study results. Incentive
strategies aimed at improving retention were: certificates of appre-
ciation and lapel pins. The value of incentives used in UK evalu-
ations ranged from GBP5 to GBP20 and were in cash, cheque or
voucher format. The value of incentives used in US-based studies
was USD2 to USD10. For offers of entries into prize draws, the
values were higher, ranging fromGBP25 to GBP250 for UK prize
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draws and USD50 for US-based prize draws. One trial evaluated
giving a monetary incentive with a promise of a further incentive
for return of trial data (Bailey 2).
Communication strategies
There were 14 retention trials of communication strategies to im-
prove response to postal questionnaires or return of biomedical test
kits, or both, in randomised trials. There were 20 trial comparisons
(Table 2). Strategies evaluated were: enhanced letters, additional
reminders to participants, priority mailing of questionnaires, time
of questionnaire administration, telephone contact and reminders
to trial sites of upcoming assessments. One trial used a combina-
tion of postal communication strategies known as the total design
method (TDM) (Sutherland 1996). This included sending let-
ters in a white envelope with a hospital logo and commemorative
stamp, a hand-signed letter on headed notepaper, with a reply self
addressed stamped envelope, enclosing the contents. Follow-up
was with a postcard sent after seven days followed by two reminder
letters. This was compared with a customary method for postal
follow-up. One trial evaluated the addition of an electronic SMS
(short message service) text reminder on the day participants were
due to receive their postal questionnaire (Man 2011).
Five trials evaluated a combination of communication strate-
gies and incentives to improve retention from randomised tri-
als (Couper 2007; Kenton 2007a-d; Renfroe 2002a-d; Sharp
2006a-h). The communication strategies were; first- and sec-
ond-class outward post (Kenton 2007a-d; Renfroe 2002b; Sharp
2006a-h), stamped and business reply envelopes (Sharp 2006a-h),
letters signed by different study personnel (Renfroe 2002c), letters
posted at different times (Renfroe 2002d), text messages (Man
2011; Severi 2011 1), and a telephone survey (Couper 2007).
Questionnaire format
The effect of a change in questionnaire format on response to
randomised trial questionnaires was evaluated in eight trials with
10 comparisons (Table 3). Formats evaluated were question-
naire length: short versus long (Dorman 1997; Edwards 2001;
McCambridge 2011 1b; McCambridge 2011 2b; Svoboda 2001),
long and clear versus short and condensed (Subar 2001), and the
order of questions (Letley 2000; McColl 2003 1; McColl 2003
2).
Two further included trials evaluated the effect of the rele-
vance of a questionnaire on response (McCambridge 2011 1a;
McCambridge 2011 2a). Relevance was defined as assessing alco-
hol problems rather than mental health in the context of an In-
ternet-based intervention for hazardous drinkers (McCambridge
2011 1; McCambridge 2011 2).
Behavioural strategies
There were two trials of behavioural strategies used for retention in
randomised trials (Chaffin 2009; Cox 2008). Cox 2008 compared
motivational workshops versus information sheets. Chaffin 2009
compared self motivation orientation versus standard information
in the context of a parenting programme. In this case, the retention
trial was run prior to the host trial with the intention of improving
retention in the subsequent parenting programme evaluation trial.
The analysis was based on the number eligible for inclusion in
the primary analyses for the subsequent parenting programme
because we do not know the allocation of those who dropped
out between first and second randomisations. Complete time-to-
event data were not available for Chaffin 2009, but, as only two
participants were censored in the analysis, this is unlikely to have
biased the results.
Case management
One retention trial evaluated the effect of intensive case manage-
ment procedures on retention of African American male partici-
pants in a cancer screening trial (Ford 2006).
Methodology strategies
One included trial used a trial design where people knew which
treatment they received. The trial compared questionnaire re-
sponse in an open versus blind trial (Avenell 2004).
Studies excluded from analyses
Two eligible trials could not be included in the analysis (Leigh
Brown 1997; Letley 2000). Host trial participants in the reten-
tion trial by Leigh Brown 1997 were divided into two groups; one
randomised, the other determined by preference of the referring
primary care practitioner. The author confirmed that participants
in the retention trial were from both randomised and non-ran-
domised groups of the host trial and that these could not be sep-
arated.
One recently completed, unpublished trial that is not included
in the review examined the effect of newsletters on retention (
Mitchell). This trial will be included in the review update.
Excluded studies
See Characteristics of excluded studies table.
We excluded trials because they were either part of a non-ran-
domised host study, or they were not a randomised retention trial,
or the primary outcome was type of data item missingness. Other
excluded trials were aimed at increasing treatment compliance
or baseline questionnaire response. We contacted investigators to
confirm aspects of eligibility.
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Risk of bias in included studies
See Characteristics of included studies.
Allocation
All included retention trials reported that participants were ran-
domly allocated to groups for comparison. Twenty-four included
trials described adequate sequence generation by a computerised
random number generator, block randomisation or use of a ta-
ble of random numbers table (Avenell 2004; Bailey 1; Bailey
2; Bowen 2000abc; Chaffin 2009; Cockayne 2005; Cox 2008;
Hughes 1989; Kenyon 2005; Khadjesari 2011 1abc; Khadjesari
2011 2; Land 2007; Leigh Brown 1997; Letley 2000;MacLennan;
Man 2011; Marson 2007; McCambridge 2011 1; McCambridge
2011 2; Nakash 2007; Renfroe 2002a-d; Severi 2011 1; Severi
2011 2; Sutherland 1996). There was insufficient information
about the sequence generation for 10 included trials, these were all
described as randomised in the retention trial publications (Ashby
2011; Bauer 2004ab; Couper 2007; Dorman 1997; Edwards
2001; Kenton 2007a-d; Sharp 2006a-h; Subar 2001; Svoboda
2001; Tai 1997). Five included trials used quasi-randomisation
to allocate participants (Bowen 2000abc; Ford 2006; Gates 2009;
McColl 2003 1; McColl 2003 2).
Several methods were used to avoid foreseen allocation of par-
ticipants; sequence generation by a trial statistician and imple-
mented by a trial manager; sequence generation by an indepen-
dent researcher, a central randomisation service, or by a nurse us-
ing a preprogrammed computer; or allocation by sealed envelopes
or sequentially numbered packs. Fifteen trials reported both ad-
equate sequence generation and allocation concealment (Avenell
2004; Bailey 1; Bailey 2; Cockayne 2005; Cox 2008; Hughes
1989; Kenyon 2005; Khadjesari 2011 1abc; Khadjesari 2011 2;
Letley 2000; MacLennan; Man 2011; McCambridge 2011 1;
McCambridge 2011 2; Nakash 2007).
Blinding
Blinding of participants was generally not possible in included
trials. For example, it is not possible to blind participants to
the following strategies to increase trial retention or response to
questionnaires: incentive or offer of incentive, behavioural (Cox
2008), or case management strategies (Ford 2006), different types
of communication strategies, or questionnaire format strategies.
In a number of trials, authors mentioned that participants were
aware of the intervention they were getting but were unaware that
this was being evaluated (Bowen 2000abc; Chaffin 2009; Kenton
2007a-d; Kenyon 2005; Leigh Brown 1997;MacLennan;Marson
2007; McColl 2003 1; McColl 2003 2). For other trials, blinding
of participants or study personnel to the outcome or intervention
was not reported. For one trial, a judgement about blinding was
not applicable because the study evaluated the effect of blind ver-
sus open trials on retention (Avenell 2004).
Incomplete outcome data
The primary outcome measure for this review was retention, and
thiswaswell reported.We contacted authors for clarificationof any
exclusions after randomisation if this was unclear from retention
trial reports.
Selective reporting
Although retention trial protocols were not available for included
trials, the included published and unpublished papers reported all
expected outcomes for retention.
Other potential sources of bias
There were few other potential sources of bias identified from re-
ports of included retention trials. For the behavioural trial by Cox
2008, the authors identified that the “walk and swim sessions were
not separated according to the behavioural intervention. Partic-
ipants were asked not to discuss written materials in the practi-
cal sessions”. Therefore, potential contamination between study
groups could have led to biased results.
Effect of methods
1. Incentive strategies
There were 14 trials of incentives giving 19 trial comparisons with
16,253 participants. There was considerable heterogeneity across
incentive subgroups (P value < 0.00001) (Analysis 1.1), so we
decided not to pool the results for incentives.
Addition of incentive
The three trials (3166 participants) that evaluated the effect of giv-
ing monetary incentives to participants showed that the addition
of monetary incentives was more effective than no incentive at in-
creasing response to postal questionnaires (RR 1.18; 95% CI 1.09
to 1.28, P value < 0.0001) (Analysis 1.1). A sensitivity analysis
excluding the quasi-randomised trial by Gates 2009 still showed
that the addition of a monetary incentive remained more effec-
tive than none (RR 1.31; 95% CI 1.11 to 1.55, P value = 0.002)
(Analysis 2.1).
Based on two Internet-based trials (3613 participants), an offer of
a monetary incentive promoted greater return of electronic ques-
tionnaires than no offer (RR 1.25; 95% CI 1.14 to 1.38, P value <
0.00001; heterogeneity P value = 0.14) (Analysis 1.1). However, a
single trial comparison suggested that an offer of a monetary do-
nation to charity did not increase response to electronic question-
naires (RR 1.02; 95% CI 0.78 to 1.32; P value = 0.90) (Analysis
1.1).
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Based on six trials (6322 participants), there was no clear evidence
that the addition of non-monetary incentives improved question-
naire response (RR 1.00; 95% CI 0.98 to 1.02, P value = 0.91),
but there was some heterogeneity (P value = 0.02) (Analysis 1.1).
A sensitivity analysis excluding the quasi-randomised trial (Bowen
2000abc) showed a similar effect (RR 1.00; 95% CI 0.93 to 1.08,
P value = 0.99) (Analysis 2.1) and heterogeneity (P value = 0.01).
Two trials (1138 participants) evaluating offers of non-monetary
incentives suggest that an offer of a non-monetary incentive is
neither more nor less effective than no offer (RR 0.99; 95% CI
0.95 to 1.03, P value = 0.60) at improving questionnaire response
(Analysis 1.1).
In exploratory analyses, the different incentive arms thatwere com-
bined for the main analysis did not appear to show differential
effects (Analysis 3.1).
Addition of monetary incentive to both study arms
Two trials (902 participants) show that higher value incentives are
better at increasing response to postal questionnaires than lower
value incentives (RR 1.12; 95% CI 1.04 to 1.22, P value = 0.005)
irrespective of how they are given (Analysis 5.1).
Addition of monetary incentive versus offer of a monetary
incentive
Two trials (297 participants) provided no evidence that giving a
monetary incentive is better than an offer of entry into a prize
draw for improving response to postal questionnaires (RR 1.04;
95% CI 0.91 to 1.19, P value = 0.56) Analysis 6.1.
Addition of an offer of entry into a prize draw versus none
We excluded one trial from the analysis (Leigh Brown 1997). The
results showed higher responses in the group offered entry into a
prize draw compared with the group not offered entry into the
draw (70.5% versus 65.8%).
2. Communication strategies
There were 14 trials of communication strategies and 20 compar-
isons with 9822 participants.
Addition of telephone survey versus monetary incentive plus
questionnaire
One trial (700 participants) showed no clear evidence that a tele-
phone survey was either more or less effective than a monetary
incentive and a questionnaire for improving response (RR 1.08;
95% CI 0.94 to 1.24, P value = 0.27) (Analysis 4.1).
Enhanced versus standard letters
Results from two trials (2479 participants) showed that an en-
hanced letter was neither more nor less effective than a standard
letter for increasing response to trial postal questionnaires (RR
1.01; 95% CI 0.97 to 1.05, P value = 0.70) (Analysis 7.1).
Total design method versus customary method
Although based on a single trial (226 participants) the TDMpack-
age was more effective than a customary postal communication
method at increasing questionnaire return (RR 1.43; 95%CI 1.22
to 1.67, P value < 0.0001) (Analysis 8.1).
Priority versus regular post
Based on the relevant arms of seven trials (1888 participants), there
was no clear evidence that priority post was either more or less
effective than regular post at increasing trial questionnaire return
(RR 1.02; 95% CI 0.95 to 1.09, P value = 0.55) (Analysis 9.1).
Additional reminder versus usual follow-up practices
Six trials (3401 participants) evaluated the effect of different ad-
ditional types of reminders to participants on questionnaire re-
sponse. There was no evidence that a reminder was either more
or less effective than no reminder at improving trial questionnaire
response (RR 1.03; 95%CI 0.99 to 1.06, P value = 0.13) (Analysis
10.1).
Additional reminder to trial site versus usual reminder
Based on one cluster randomised trial (272 participants), a
monthly reminder to trial sites of upcoming assessment was nei-
ther more nor less effective than the usual follow-up (RR 0.96;
95% CI 0.83 to 1.11, P value = 0.57) (Analysis 11.1).
Early versus late questionnaire administration
Based on one trial (664 participants), there was no clear evidence
that sending questionnaires early either increased or decreased re-
sponse (RR 1.10; 95% CI 0.96 to 1.26, P value = 0.19 (Analysis
12.1).
Recorded delivery versus telephone reminder
One small trial (192 participants) found that recorded delivery
was more effective than a telephone reminder (RR 2.08; 95% CI
1.11 to 3.87; P value = 0.02) (Analysis 13.1).
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3. New questionnaire strategies
New versus standard questionnaire
Eight trials with 10 comparisons (21,505 participants) evaluated
the effect of a newquestionnaire format onquestionnaire response.
Although there was some heterogeneity between the questionnaire
subgroups (P value = 0.11) (Analysis 14.1), it did not seem rea-
sonable to pool the results based on such different interventions.
Five trials (7277 participants) compared the effect of short ques-
tionnaires versus long on postal questionnaire response. There was
only a suggestion that short questionnaires may be better (RR
1.04; 95% CI 1.00 to 1.08, P value = 0.07) (Analysis 14.1).
Based on one trial (900 participants; Subar 2001), there is no
evidence that long and clear questionnaires were either more or
less effective than shorter condensed questionnaires for increasing
trial questionnaire response (RR 1.01; 95% CI 0.95 to 1.07, P
value = 0.86) (Analysis 14.1).
Two trials (9435 participants; McColl 2003 1; McColl 2003 2)
found no evidence that placing disease/condition questions before
generic questions is either a more or less effective strategy than
a generic questions before disease/condition questions strategy at
increasing trial questionnaire response (RR 1.00; 95% CI 0.97 to
1.02, P value = 0.75) (Analysis 14.1). It should be noted that these
were quasi-randomised trials (Analysis 15.1).
One trial in this category was not included in the analysis by Letley
2000, outcome data were not available for each study arm when
this review was submitted and the overall response rate for this
trial was 87%.
In the context of research on reducing alcohol consumption, there
was also evidence that more relevant questionnaires (i.e. those
relating to alcohol use) increased response rates (RR 1.07; 95%
CI 1.01 to 1.14, P value = 0.03).
4. Behavioural/motivational strategies
Two community-based trials (273 participants; Chaffin 2009;
Cox 2008) showed no evidence that the behavioural/motivational
strategies used are either more or less effective than standard in-
formation for retaining trial participants (RR 1.08; 95% CI 0.93
to 1.24, P value = 0.31) (Analysis 16.1).
5. Case management
One trial (703 participants; Ford 2006) evaluated the effect of
intensive case management procedures on retention. There is no
evidence that intensive case management was either more or less
effective than usual follow-up in the population examined (RR
1.00; 95% CI 0.97 to 1.04, P value = 0.99) (Analysis 17.1).
6. Methodology strategies
One fracture prevention trial (538 participants; Avenell 2004)
evaluated the effect of participants knowing their treatment al-
location (open trial) compared with participants blind/unaware
of their allocation on questionnaire response. Using a trial design
where people know which treatment they will receive led to higher
questionnaire response rates (RR 1.37; 95% CI 1.16 to 1.63, P
value = 0.0003) (Analysis 18.1).
Reporting bias
Although we planned to investigate potential reporting bias, there
were too few studies in most strategies to allow formal testing.
However, we were able to obtain considerable data from unpub-
lished trials and those published with limited information, reduc-
ing the risk of such biases.
Absolute benefits of strategies to improve retention
The absolute benefits of effective strategies on questionnaire re-
sponse are illustrated in Table 4. The baseline response rates were
broadly typical of the response rates seen in trials. The number of
questionnaires returned were based on the assumed control arm
risk.
Based on a 40% baseline response rate for postal questionnaires,
the addition of a monetary incentive was estimated to increase
response by 92 questionnaires per 1000 sent (95% CI 50 to 131).
With the addition of an offer of a monetary incentive in an Inter-
net-based trial, based on a baseline response rate of 30%, trialists
could expect an increase of 140 questionnaires per 1000 (95% CI
86 to 193).
For trials hoping to increase the return of postal questionnaires
with chlamydia test kits, the number of kits returnedwas estimated
to increase by 33 per 1000 sent when GBP20 was offered as an
incentive, rather than GBP10 (95% CI 11 to 54).
D I S C U S S I O N
Summary of main results
Thirty-eight randomised retention trials were included in this re-
view, evaluating six broad types of strategies to increase question-
naire response and retention in randomised trials. In 34 trials,
strategies for increasing response to questionnaires were: incen-
tives, communication strategies, new questionnaire format and
methodological interventions. Four trials evaluated strategies to
improve retention, these were: participant case management, be-
havioural and non-monetary incentive strategies. Trials were con-
ducted across a spectrum of disease areas, countries, healthcare and
community settings.
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Strategies with the clearest impact on questionnaire response were:
addition of monetary incentives compared with no incentive for
return of postal questionnaires, addition of an offer of a mone-
tary incentive when compared with none for return of electronic
questionnaires, and an offer of GBP20 vouchers when compared
with GBP10 for return of postal questionnaires and biomedical
test kits. The evidence was less clear about whether shorter ques-
tionnaires rather than longer questionnaires increased response.
The evidence was also less clear whether in the context of research
on reducing alcohol consumption more relevant questionnaires
increased response.
The addition of a non-monetary incentive, an offer of a non-mon-
etary incentive compared with no incentive or, ’enhanced’ letters,
letters delivered by priority post, or additional reminders com-
pared with standard communication strategies did not increase or
decrease trial questionnaire response. Questionnaire structure also
did not seem to increase response.
Although each was based on the results of a single trial, recorded
delivery (proof of posting and an electronic copy of the signa-
ture available online) of questionnaires seemedmore effective than
telephone reminders, and a ’package’ of postal communication
strategies with reminder letters appeared better than standard pro-
cedures. A trial design where participants knew which treatment
they were to receive also appeared more effective than a trial de-
sign where they were unaware of the treatment they were about to
receive for return of questionnaires in a fracture prevention trial.
Further evaluation of these strategies may be needed. Posting ques-
tionnaires early, questionnaire order, offers of charity donations or
sending reminders to trial sites did not improve response.
Many trial outcome measures were collected using questionnaires,
therefore, if response rates can be increased, retention will also
be improved. No strategy had a clear impact on increasing the
number of participants returning to trial sites for follow-up visits.
Overall completeness and applicability of
evidence
The addition of a GBP5 voucher to usual follow-up procedures
was effective for return of postal questionnaires in trials conducted
between 2005 and 2009. The more recent unpublished studies by
Bailey 1 Bailey 2 found GBP20 vouchers were more effective than
GBP10 vouchers for return of postal questionnaires. Splitting the
monetary incentive into money given before and after receipt of
data could be more effective as a strategy to increase questionnaire
follow-up with different population groups and in different trial
settingswhere questionnaire response is low (e.g. with hard to reach
groups that may include young male healthy adults, teenagers or
residents in areas of high economic deprivation). This could be a
cost-effective strategy because if questionnaires are not returned
then money is saved. The value of the monetary incentive should
not be so high as to be perceived as payment for data butmore as an
appreciation for efforts made by participants. Offering monetary
incentives may increase the number of questionnaires returned per
1000 participants by at least asmuch as givingmonetary incentives
and giving higher valued monetary incentives, but has only been
tested in online questionnaires.Offers ofmonetary incentives were
also an effective strategy in the context of an online electronic
questionnaire. These could be less costly to increase retention than
the addition of a monetary incentive as only those who return
the data are reimbursed. This would need further evaluation as
the results were based on two Internet-based trials. It would be
beneficial for trialists to know which is more effective: an offer of
a monetary incentive or an upfront monetary incentive. We did
not find any trials that made this direct comparison.
Shorter postal questionnaires have wide applicability to trials and
could be considered as a useful strategy to increase trial question-
naire response in online Internet-based trials but there is only a
suggestion that these are effective.
Several strategies showed no clear effect. The addition of non-
monetary incentives in the form of pens, lapel pins and certificates
of appreciation, or offers of non-monetary incentives through of-
fering study results did not increase response or retention. A pos-
sible explanation might be how these items are valued by partic-
ipants, or how they perceive their time is valued. Nevertheless,
this result has the potential to reduce trial costs because associated
saving could be channelled towards monetary incentives that have
been shown to be effective.
The evidence showed that priority post (first-class post or equiva-
lent) did not increase response. It is expensive as a means of com-
municating with participants and savings can be made by using
regular (2nd-class) post instead.
Additional reminders sent to non-responders or as questionnaires
were posted; enhanced letters, that is, letters signed by the princi-
pal investigator, or letters further explaining the anticipated length
of time to complete a questionnaire, were not effective strategies
to increase response. Enhanced letters and different types of addi-
tional reminders are used by trialists in current research practice.
Too many reminders could be counterproductive to improving
retention in randomised trials and details of the time expected to
undertake specific tasks might be informative but off putting for
participants. Nevertheless, letters and reminders are part of the re-
search process and play a role in participant engagement especially
if there is little face-to-face contact or in trials with long intervals
between data collection time points.
Several strategies to increase questionnaire response need further
evaluation to determine their effect but there is only a suggestion
that these were effective. If participants are well and engaged with
a trial, questionnaire length may not impact on response rates be-
cause participants may be happy to feedback on their condition in
this way. For other conditions, for example, cancers and terminal
illnesses, trial participants might prefer shorter questionnaires if
their symptoms are problematic. Telephone follow-up compared
with monetary incentive sent with a questionnaire needs further
evaluation possibly with a cost-benefit analysis, as both could be
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expensive in time and human resources. Although appearing very
effective, the total design method for postal questionnaires could
be labour intensive to implement, expensive and may no longer be
applicable to some participant groups (e.g. young people), or in
trials using email, text or the Internet to collect data. Recorded de-
livery could be useful to ensure trial follow-up supplies reach their
intended destination (e.g. biomedical specimen kits and question-
naires). Careful planning of day, date and time of delivery with
each participant to avoid inconvenience might be necessary but
again this strategy has the potential to be burdensome for trial
co-ordinating centres and trial sites to administer. While trialists
are assured that follow-up supplies are delivered with this strategy,
participants might have the added burden of an extra visit to col-
lect supplies from a sorting post office and this could be costly.
The use of open trials to increase questionnaire response can only
be applied to trials where blinding is not required and could be
counterproductive if a participant or clinician has a treatment
preference. Bias associated with loss to follow-up resulting from
these preferences could be avoided in blind trials.
Evaluations of strategies that encourage participants to return to
trial sites for follow-up visits and monitoring were fewer than
strategies to increase response to postal and electronic question-
naires, without further evidence casemanagement andbehavioural
strategies cannot be recommended for use to encourage partici-
pant return.
This review identified no trials from low-income countries. All in-
cluded studies were conducted in higher-income countries. There-
fore, the strategies to increase retention identified by this review
may not be generalisable to trials conducted in low-income coun-
tries because the interventions identifiedmight not be socially, cul-
turally or economically appropriate for trials run in these regions.
The results may also not be applicable to all social groups as we
were unable to examine response/retention by social characteristics
such as economic disadvantage and social class. Most of the evi-
dence in this review relates to increasing questionnaire follow-up
in randomised trials for either the primary or secondary outcome
for the host trial. The diversity between strategies and insufficient
numbers in each of these categories meant that we could not do
subgroup analyses by trial setting and disease area as planned.
Quality of the evidence
The extent of unpublished trials evaluating retention strategies is
unknown; however, this review includes several unpublished trials
and we made an effort to capture UK-based unpublished trials
through our survey and research contacts. For some comparisons,
results were based on one or two trials in a particular context. The
inclusion of any further published and unpublished trials in future
updates would improve the precision of the results of this review.
The six types of strategies that we identified targeted retention of
trial participants in randomised trials. We believe response and
retention were the relevant dichotomous outcomes to be reported
for this review. Many other strategies used by trialists in practice
to reduce attrition/increase response or retention in trials were
not identified by this review (e.g. social support strategies; child
care, Loue 2008; family support, De Sousa 2008; reduction in the
number of visits, Schulz 2002). Evaluations of trial management
strategies are also under-represented in the review (e.g. evaluations
of site-specific reports, El Khorazaty 2007; levels of contact by the
co-ordinating centre, Senturia 1998; training project staff ).
Both published and unpublished included retention trials were
fairly well conducted but could be improved. Five of the 39 trials
included in the review were quasi-randomised. The motivation
for conducting many of the included retention trials was reactive
rather than planned upfront (i.e. when loss to follow-up became a
problem during trial follow-up, rather than planned prior to host
trial commencement).
Most trials used appropriate methods for randomisation or at least
stated that they were randomised. For trials that did not describe
their methods well or provide further information, there remains a
potential risk of selection bias. Sensitivity analyses excluding quasi-
randomised trials did not affect the results. In this context, where
motivating participants to provide data or attend clinics is often
the target of the interventions and so appropriately influences the
outcome, lack of blinding is less of a concern. Retention is the out-
come and was obtained for all but two trials, so similarly, attrition
and selective outcome reporting bias are unimportant. Although
the retention trials were fairly well conducted, they could be im-
proved and they were often poorly reported. This may be because
they were designed when loss to follow-up became a problem in a
trial, rather than preplanned prior to host trial commencement.
Potential biases in the review process
Many words are used to describe loss to follow-up, for example, at-
trition, withdrawal and questionnaire non-response. We included
these in our search strategy. We attempted to obtain unpublished
trials and data by contacting authors and writing to UK clinical
trials units and presenting at national and international confer-
ences. We are confident that we have captured most studies and
the spectrum of strategies that have been evaluated to date. It
is conceivable, however, that less well-reported, ongoing, unpub-
lished trials or trials conducted outside of the UKmight have been
missed. Most trials used appropriate methods for sequence gener-
ation or at least stated that they were randomised and concealed
allocation. There is small risk that those that did not describe their
methods well or provide further information did not use adequate
methods for allocation and concealment and may have biased the
results. However, sensitivity analyses excluding quasi-randomised
trials did not affect the results. Blinding is hard to achieve in this
context, where motivating participants to provide data or attend
clinics is often the target of the interventions and so appropriately
influences the outcome.
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Agreements and disagreements with other
studies or reviews
The strategies that improve retention are, in some cases, the same
as or similar to those found to be effective for cohort and cross-
sectional study designs. However, prior to our review, it was not
clear which of these strategies could be extrapolated to randomised
trials. Successful retention strategies used in other study designs
may be effective in trials settings and should be tested. Edwards’
review on methods to increase response to postal and electronic
questionnaires included 513 trials and identified many strategies
to increase response to questionnaires (Edwards 2009). Included
trials were embedded in surveys, cohort studies and trials, which
may explain some of the heterogeneity in effects seen in Edwards’
review and reliance on the random-effects model. Unexplained
heterogeneity was not a particular problem in this review. Ed-
wards found monetary incentives effective for increasing response
to postal questionnaires (Edwards 2009). However, unlike our re-
view, Edwards found that non-monetary incentives were effective
for postal and electronic questionnaires. Other strategies found to
be effective by Edwards, in agreement with our review, included
recorded delivery of questionnaires and shorter questionnaires, al-
though in our review shorter questionnaires need further eval-
uation. Edwards also found that use of hand-written addresses,
stamped return envelopes as opposed to franked return envelopes
and first-class outward mailing improved response. Our review
found that a ’package’ including an enhanced letter incorporating
several reminders was effective, but the effectiveness of first-class/
priority mail to increase response in randomised trials was unclear.
Booker’s narrative review of methods to increase retention in pop-
ulation-based cohort studies was based on only 11 randomised
trials and no meta-analysis (Booker 2011). The results suggested
that incentives were associated with an increase in retention.
Nakash’s systematic review of ways to increase response to postal
questionnaires in health care focused on randomised trials of ways
to increase response to postal questionnaires in healthcare research
on participant populations (Nakash 2006 (2). Fifteen trials were
included in this meta-analysis, which found that reminder letters,
telephone contact and short questionnaires increased response to
postal questionnaires in the context of healthcare research. There
was no evidence that incentives were effective. Again, this review
was not exclusive to evaluations conducted in randomised trials.
The Edwards review was broad and focused specifically on meth-
ods to enhance response to questionnaires and included studies in
non-healthcare settings (Edwards 2009). The reviews by Nakash
and Booker focused on retention in specific research areas, health
care and cohort studies (Booker 2011; Nakash 2006 (2)). Unlike
these reviews, our review focused specifically on a range of strate-
gies evaluated within trials. Therefore, it specifically addressed the
question of retention of study participants within randomised tri-
als, which was beyond the scope of the other reviews. Application
of these results would depend on trial setting, population, dis-
ease area, data collection and follow-up procedures. Moreover, we
identified additional strategies that may improve trial retention,
for example, methodological strategies.
This review is the most comprehensive to date on strategies specif-
ically designed to improve retention in randomised trials. We in-
cluded seven unpublished trials and 18 other trials not included
by Edwards (Edwards 2009).
A U T H O R S ’ C O N C L U S I O N S
Implication for methodological research
Trialists may consider including well thought out and adequately
powered evaluations of strategies to increase retention in ran-
domised trials. This could include a clear definition of retention
strategies and of measures of retention. Trialists conducting fu-
ture methodology trials can consider incorporating evaluations of
strategies to increase retention at the design stage so that power,
sample size and funding arrangements are taken into account.
Retention trials were often poorly reported without consort di-
agrams, clear primary outcomes, sample size, sociodemographic
composition or power calculations. Considerable time was spent
contacting authors for unreported data needed for a robust meta-
analysis. Trialists in their reports might consider adhering to the
consort guidelines for trial reporting, which would facilitate the
synthesis of results in future methodology reviews. There is less
research on ways to increase return of participants to trial sites for
follow-up and on the effectiveness of strategies to retain trial sites
in cluster and individual randomised trials. Research in both areas
would be very beneficial to trialists. There is no current system for
identifying methodological trials in progress, until a system is set
up it may be useful for systematic review authors to incorporate
contacting trials units into their search strategy.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ashby 2011
Methods 2-arm randomised trial
Data Adults aged 18-65 years who provided email or mobile telephone contact details for receiving
electronic reminders for follow-up in a migraine prevention trial
Comparisons 1. Electronic reminder: either SMS text message, email message, or both sent after the 4-week
follow-up study questionnaire sent
2. No electronic reminder sent
Outcomes Primary: questionnaire response rate defined as proportion of questionnaires returned by
participants at final analysis at 40 days
Secondary: time to response
Notes Retention trial embedded in a randomised trial evaluating the effectiveness of food elimination
diet based on the ELISA test for food sensitivity for prevention of migraine. Primary outcome
for the migraine prevention trial (host trial): change in the number of headache days over
12 weeks using the migraine disability assessment questionnaire (MIDAS). Retention trial
identified through mail out to UK clinical trials units
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Authors response “an independent data manager at the trials unit
was responsible for generating the allocation sequence and assigning
participants”
Adequate sequence generation? Unclear “Randomly generated numbers used to list all participants by ID
[identification] number who had provided a mobile phone number
and/or and email address. The first half of listed participants were
allocated to the intervention group the remaining participants were
allocated to the control group”
Blinding? Unclear No reference to blinding of either participants or outcome assessors
in the study report
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
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Avenell 2004
Methods Randomised trial
Data Adults aged ≥ 70 years with a low trauma osteoporotic fracture in the past 10 years recruited
in 1 centre of the RECORD trial
Comparisons 1. An open version of the RECORD trial otherwise identical in design
2. RECORD trial, a randomised double-blind placebo-controlled factorial design of oral
calcium 1 g daily and or vitamin D 800 IU/20 µg supplementation
Outcomes Proportion of eligible participants recruited
Proportion remaining in the trial at 1 year
Proportion compliant on pill counts at 8 months
Notes Open version of the Randomised Evaluation of Calcium or Vitamin D (RECORD) Trial
treated as the intervention group in the analysis. Proportion retained at 4, 8 and 12 months
were reported. Primary outcome for the randomised double-blind placebo-controlled version
of the RECORD trial was all new low-energy fractures
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Nurse used a pre programed laptop computer”
Adequate sequence generation? Yes “A pre programed laptop computer to generate random allocation”
Blinding? Yes Double-blind randomised trial design compared with an open trial
design. For the double-blind randomised trial “allocation remained
concealed until the final analyses”. “All outcomes were reported or
verified by people who were masked to the allocation scheme”
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
Bailey 1
Methods Randomised trial embedded in the sex unzipped website feasibility trial
Data UK English speaking people aged 16-20 years
Comparisons 1. Offer of GBP20 voucher
2. Offer of GBP10 voucher
Outcomes Retention of participants at 3-month follow-up, i.e. completion of sexual health survey
Notes Retention trial identified through personal correspondence with the author
Sexunzipped website evaluated in an online trial
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Bailey 1 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Authors response “the trial statisticians gener-
ated the randomisation sequence with partic-
ipants identified by ID [identification] num-
ber only and the trial manager implemented
it manually”
Adequate sequence generation? Yes Authors response “participants were ran-
domised after recruitment but before follow-
up to a GBP10 or GBP20 incentive. Ran-
domisation to increased incentivewas through
simple permutation of the list of remaining
recruits”
Blinding? Unclear Authors response “allocation sequences were
generated without participants’ knowledge”.
“For those allocated to the increased amount
of GBP20, this was revealed in a 3 month fol-
low-up email. Those allocated to GBP10 were
not aware that otherswere offeredGBP20 (un-
less friends had enrolled and had discussed the
study). Since the trial recruited participants
online from all over the UK, this will have re-
duced the chance of bias due to contamina-
tion”
Free of selective outcome reporting? Yes Reports the primary outcome
Bailey 2
Methods Randomised trial
Data UK English speaking people aged 16-20 years
Comparisons 1. Offer of GBP20 voucher: GBP10 in advance and GBP10 on receipt of questionnaire and
chlamydia kit
2. Offer of GBP10 voucher: GBP5 in advance and GBP5 on receipt of questionnaire and
chlamydia kit
Outcomes Retention of participants at 3-month follow-up, i.e. completion of sexual health survey and
return of chlamydia kit
Notes Study identified through personal correspondence with author
Sex unzipped website evaluated in an online trial
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Bailey 2 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Authors response “the trial statisticians generated the randomisation
sequence (with participants identified by ID [identification] number
only), and the trial manager implemented it manually”
Adequate sequence generation? Yes Authors response “participants were randomised after recruitment but
before follow-up to a GBP10 or GBP20 incentive. Randomisation
to increased incentive was through simple permutation of the list of
remaining recruits”
Blinding? Unclear Authors response “allocation sequences were generated without par-
ticipants’ knowledge”. “For those allocated to the increased amount
of GBP20, this was revealed in a 3 month follow-up email. Those
allocated to GBP10 were not aware that others were offered GBP20
(unless friends had enrolled and had discussed the study). Since the
trial recruited participants online from all over the UK, this will have
reduced the chance of bias due to contamination”
Free of selective outcome reporting? Yes Reports the primary outcome
Bauer 2004a
Methods 3-arm randomised trial (first incentive vs. no incentive)
Data Pilot study of 15 randomly selected participants from each of 20 communities participating
in COMMIT trial
Comparisons Enclosed with mouthwash swish collection kits sent to participants “subjects were further
randomised to receive” either:
1. USD10 cheque told to keep the cheque whether or not they participated, sent with
covering letter and prepaid envelope
2. No incentive, kit sent with covering letter and prepaid envelope
All sent 2 weeks after an advance letter with a professionally rendered brochure
Outcomes Percentage of mouthwash kits returned reported. No time point given
Notes Study embedded in the cluster randomised Community Intervention Trial for Smoking Cessa-
tion (COMMIT) trial. Primary outcome: quit rate among heavy smokers. Several attempts to
contact authors regarding allocation sequence. Data extracted from Edwards Cochrane review
on response to postal questionnaires
Risk of bias
Item Authors’ judgement Description
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Bauer 2004a (Continued)
Allocation concealment? Unclear No reply from author
Adequate sequence generation? Unclear “Subjects were further randomised to receive
an incentive of.....”
Blinding? Unclear Insufficient information to make a judgement
about this, no reply from author
Free of selective outcome reporting? Unclear No reply from author
Other sources of bias? Unclear Insufficient information to make a judgement
Bauer 2004ab
Methods 3-arm randomised trial (combined incentive vs. no incentive)
Data Pilot study of 15 randomly selected participants from each of 20 communities participating
in COMMIT trial
Comparisons Enclosed with mouthwash swish collection kits sent to participants “subjects were further
randomised to receive” either:
1. USD10 cheque told to keep the cheque whether or not they participated sent with
covering letter and prepaid envelope or
2. USD2 cheque with covering letter and prepaid envelope or
3. No incentive, kit sent with covering letter and prepaid envelope
All sent 2 weeks after an advance letter with a professionally rendered brochure
Outcomes Percentage of mouthwash kits returned reported. No time point given
Notes Study embedded in the cluster randomised Community Intervention Trial for Smoking Cessa-
tion (COMMIT) trial. Primary outcome: quit rate among heavy smokers. Several attempts to
contact authors regarding allocation sequence. Data extracted from Edwards Cochrane review
on response to postal questionnaires
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No reply from author
Adequate sequence generation? Unclear “Subjects were further randomised to receive
an incentive of.....”
Blinding? Unclear Insufficient information to make a judgement
about this no reply from author
Free of selective outcome reporting? Unclear No reply from author
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Bauer 2004ab (Continued)
Other sources of bias? Unclear Insufficient information to make a judgement
Bauer 2004b
Methods 3-arm randomised trial (second incentive vs. no incentive)
Data Pilot study of 15 randomly selected participants from each of 20 communities participating
in COMMIT trial
Comparisons Enclosed with mouthwash swish collection kits sent to participants, “subjects were further
randomised to receive” either:
1. USD2 check with covering letter and prepaid envelope
2. No incentive, kit sent with covering letter and prepaid envelope
All sent 2 weeks after an advance letter with a professionally rendered brochure
Outcomes Percentage of mouthwash kits returned reported. No time point given
Notes Study embedded in the cluster randomised Community Intervention Trial for Smoking Cessa-
tion (COMMIT) trial. Primary outcome: quit rate among heavy smokers. Several attempts to
contact authors regarding allocation sequence. Data extracted from Edwards Cochrane review
on response to postal questionnaires
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No reply from author
Adequate sequence generation? Unclear “Subjects were further randomised to receive
an incentive of.....”
Blinding? Unclear Insufficient information to make a judgement
about this
Free of selective outcome reporting? Unclear No reply from author
Other sources of bias? Unclear Insufficient information to make a judgement
Bowen 2000a
Methods Randomised 2 x 2 factorial trial (first incentive vs. no incentive)
Data Adults aged 50-69 years recruited from 2 CARET trial sites, participating in the Participant
Retention Item Distribution Evaluation (PRIDE) trial
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Bowen 2000a (Continued)
Comparisons 1. Certificate of appreciation preprinted on an 8.5 x 11 inch (21.59 x 27.94 cm)bond off-
white paper with gold trim and bold, black lettering. The certificate read “[participant’s
name] in recognition of your contribution to an important national study for the prevention
of lung cancer, CARET, CancerPrevention Study, sponsored by The National Cancer
Institute”. The participant’s name was computer printed in an attractive font on the
certificate. Each certificate had the signatures of the Co-ordinating Center’s principal
investigator, study centre investigator and CARET’s project officer from the National Cancer
Institute, given during a visit for randomisation or follow-up
2. No incentive
Outcomes Primary: time of first inactivation (stop taking vitamins or placebos) during the 2-year follow-
up period of PRIDE
Notes Primary disease outcome for the Carotene and Retinol Efficacy Trial (CARET): lung cancer
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Author response “the Coordination Center
supplied one date-labelled envelope for each
day in the enrolment period to the two partici-
pating study centres. The envelopes contained
the randomisation assignment for the given
day. At the end of each day during the ran-
domisation period, study centre staff opened
the envelope containing the intervention as-
signment for the next day. Study centre staff
members were otherwise blinded to the allo-
cation sequence”
Adequate sequence generation? Yes Author response “we used a block randomisa-
tion approach (stratified by study centre) with
a 1:1:1:1 intervention arm allocation ratio,
where the randomisation unit was the date of
enrolment”. Note: treated this as quasi-ran-
domised in the analysis
Blinding? Yes Author response “with IRB [Institutional Re-
view Board] approval, the study was con-
ducted without participants’ knowledge of
this research. Thus, participants were blinded
to their own intervention only in the sense
that they were unaware they were randomised
to receive particular item(s)”
Free of selective outcome reporting? Yes Cumulative incidence of individuals who be-
came inactive during 2-year follow-up re-
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Bowen 2000a (Continued)
ported
Other sources of bias? Unclear Insufficient information to make a judgement
Bowen 2000abc
Methods Randomised 2 x 2 factorial trial (combined incentive vs. no incentive)
Data Adults aged 50-69 years recruited from 2 CARET trial sites, participating in the Participant
Retention Item Distribution Evaluation (PRIDE) trial
Comparisons 1. Certificate of appreciation preprinted on an 8.5 x 11 inch (21.59 x 27.94 cm)bond off-
white paper with gold trim and bold, black lettering. The certificate read ’[participant’s
name] in recognition of your contribution to an important national study for the prevention
of lung cancer, CARET, CancerPrevention Study, sponsored by The National Cancer
Institute’. The participant’s name was computer printed in an attractive font on the
certificate. Each certificate had the signatures of the Co-ordinating Center’s principal
investigator, study centre investigator, and CARET’s project officer from the National
Cancer Institute, given during a visit for randomisation or follow-up (arm a)
2. Lapel pin 1 inch (2.5 cm) in size and designed in cloisonne. Choice between a pin with
6 colours with inscription ’CARET NCI prevention study’ and an orange carrot in the
middle of the pin or a pin with 5 colours with inscription ’PARTICIPNAT CARET Cancer
Prevention Study’ and ’Sponsored by NCI’ and given during a visit for randomisation or
follow-up (arm b)
3. Certificate of appreciation (details as before) and lapel pin (details as before) and given
during a visit for randomisation or follow-up (arm c)
4. No incentive
Outcomes Primary: time of first inactivation (stop taking vitamins or placebos) during the 2-year follow-
up period of PRIDE
Notes Primary disease outcome for the Carotene and Retinol Efficacy Trial (CARET): lung cancer
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Author response “the Coordination Center
supplied one date-labelled envelope for each
day in the enrolment period to the two partici-
pating study centres. The envelopes contained
the randomisation assignment for the given
day. At the end of each day during the ran-
domisation period, study centre staff opened
the envelope containing the intervention as-
signment for the next day. Study centre staff
members were otherwise blinded to the allo-
cation sequence”
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Bowen 2000abc (Continued)
Adequate sequence generation? Yes Author response “we used a block randomisa-
tion approach (stratified by study centre) with
a 1:1:1:1 intervention arm allocation ratio,
where the randomisation unit was the date of
enrolment”
Blinding? Yes Author response “with IRB [Institutional Re-
view Board] approval, the study was con-
ducted without participants’ knowledge of
this research. Thus, participants were blinded
to their own intervention only in the sense
that they were unaware they were randomised
to receive particular item(s)”
Free of selective outcome reporting? Yes Cumulative incidence of individuals who be-
came inactive during 2 year follow-up re-
ported
Other sources of bias? Unclear Insufficient information to make a judgement
Bowen 2000b
Methods Randomised 2 x 2 factorial trial (second incentive vs. no incentive)
Data Adults aged 50-69 years recruited from 2 CARET trial sites, participating in the Participant
Retention Item Distribution Evaluation (PRIDE) trial
Comparisons 1. Lapel pin 1 inch (2.5 cm) in size and designed in cloisonne. Choice between a pin with
6 colours with inscription ’CARET NCI prevention study’ and an orange carrot in the
middle of the pin or a pin with 5 colours with inscription ’PARTICIPNAT CARET Cancer
Prevention Study’ and “Sponsored by NCI” and given during a visit for randomisation or
follow-up
2. No incentive
Outcomes Primary: time of first inactivation (stop taking vitamins or placebos) during the 2-year follow-
up period of PRIDE
Notes Primary disease outcome for the Carotene and Retinol Efficacy Trial (CARET): lung cancer
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Author response “the Coordination Center
supplied one date-labelled envelope for each
day in the enrolment period to the two partici-
pating study centres. The envelopes contained
the randomisation assignment for the given
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Bowen 2000b (Continued)
day. At the end of each day during the ran-
domisation period, study centre staff opened
the envelop containing the intervention as-
signment for the next day. Study centre staff
members were otherwise blinded to the allo-
cation sequence”
Adequate sequence generation? Yes Author response “we used a block randomisa-
tion approach (stratified by study centre) with
a 1:1:1:1 intervention arm allocation ratio,
where the randomisation unit was the date of
enrolment”
Blinding? Yes Author response “with IRB [Institutional Re-
view Board] approval, the study was con-
ducted without participants’ knowledge of
this research. Thus, participants were blinded
to their own intervention only in the sense
that they were unaware they were randomised
to receive particular item(s)”
Free of selective outcome reporting? Yes Cumulative incidence of individuals who be-
came inactive during 2-year follow-up re-
ported
Other sources of bias? Unclear Insufficient information to make a judgement
Bowen 2000c
Methods Randomised 2 x 2 factorial trial (third incentive vs. no incentive)
Data Adults aged 50-69 years recruited from 2 CARET trial sites, participating in the Participant
Retention Item Distribution Evaluation (PRIDE) trial
Comparisons 1. Certificate of appreciation (details as before) and lapel pin (details as before) and given
during a visit for randomisation or follow-up
2. No incentive
Outcomes Primary: time of first inactivation (stop taking vitamins or placebos) during the 2-year follow-
up period of PRIDE
Notes Primary disease outcome for the Carotene and Retinol Efficacy Trial (CARET): lung cancer
Risk of bias
Item Authors’ judgement Description
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Bowen 2000c (Continued)
Allocation concealment? Unclear Author response “the Coordination Center
supplied one date-labelled envelope for each
day in the enrolment period to the two partici-
pating study centres. The envelopes contained
the randomisation assignment for the given
day. At the end of each day during the ran-
domisation period, study centre staff opened
the envelop containing the intervention as-
signment for the next day. Study centre staff
members were otherwise blinded to the allo-
cation sequence”
Adequate sequence generation? Yes Author response “we used a block randomisa-
tion approach (stratified by study centre) with
a 1:1:1:1 intervention arm allocation ratio,
where the randomisation unit was the date of
enrolment”
Blinding? Yes Author response “with IRB [Institutional Re-
view Board] approval, the study was con-
ducted without participants’ knowledge of
this research. Thus, participants were blinded
to their own intervention only in the sense
that they were unaware they were randomised
to receive particular item(s)”
Free of selective outcome reporting? Yes Cumulative incidence of individuals who be-
came inactive during 2-year follow-up re-
ported
Other sources of bias? Unclear Insufficient information to make a judgement
Chaffin 2009
Methods 2-arm randomised trial
Data All parents referred for parenting services at a small inter-city non-profit community agency
operating a parenting programme
Comparisons 1. Initial preparenting orientation condition self motivation group
2. Initial preparenting orientation condition standard informational group
Outcomes Dropout from the parenting group at 12 weeks
Notes A second randomisation was performed after completion of the orientation programme to
parent child interactive therapy vs. standard didactic parenting condition. Dropout recorded
at 2-week intervals up to 12 weeks
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Chaffin 2009 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No “Unblinded randomisation list”
Adequate sequence generation? Yes “Computer generated randomisation list”
Blinding? Yes Author response “they (parents) were informed only in general terms
that we were interested in which types of services helped”. Partici-
pant interviews were conducted by computer. Blinding of person-
nel: observational parent-child interaction coding was done by per-
sonnel who were not informed about intervention condition assign-
ment
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? No “It is possible that therapist effects may have played a role in the
outcomes”
Cockayne 2005
Methods 2-arm randomised trial
Data Women aged ≥ 70 years randomised at 1 centre for a fracture prevention trial due to receive
their final follow-up questionnaire in March 2004
Comparisons 1. Final follow-up questionnaire additional question offering results of the trial delivered by
post
2. Final follow-up questionnaire no offer of study results delivered by post
Both groups received a personalised cover letter showing university sponsorship, along with a
business reply envelope. Non-responders within 3 weeks were sent up to 2 reminder letters,
questionnaires and business reply envelopes, 3 and 6 weeks after the initial mailing
Outcomes Return of final follow-up questionnaire by participants. Time point not specified
Notes Authors contacted to confirm numbers randomised to each arm
The Fracture Prevention Trial: calcium 1000 mg plus vitamin D3 800 IU plus information
sheet on dietary calcium intake and falls prevention vs. information sheet. Primary outcome
for the fracture prevention trial: all clinical fractures excluding those of the digits, rib, face and
skull
Risk of bias
Item Authors’ judgement Description
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Cockayne 2005 (Continued)
Allocation concealment? Yes “An independent researcher from the York trials unit randomised
eligible women”
Adequate sequence generation? Yes “Randomised eligible women in a 3:1 ratio by computer”
Blinding? Unclear “Administration of the questionnaire was not blind to the group
allocation”
Free of selective outcome reporting? Yes All outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
Couper 2007
Methods 2-arm randomised trial (incentive plus postal questionnaire vs. telephone survey)
Data Adults ≥ 18 years, BMI of ≥ 25 participating in an Internet-based weight management trial
who did not respond to the 12-month questionnaire
Comparisons 1. Telephone call and survey by trained interviewers. Repeated up to 15 times. Attempts made
on various days and at various times of the day
2. Postal questionnaire with return address and covering letter signed by directors plus a USD5
bill
Outcomes Questionnaire response. No time point given
Notes Internet-based weight management trial compared Internet-based tailored weight manage-
ment materials with Internet-based non-tailored user navigated weight management materials.
Primary outcome for the Internet-based trial: percentage of baseline weight lost
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Not described
Adequate sequence generation? Unclear Author response “randomly assigned”
Blinding? Unclear Not described
Free of selective outcome reporting? Unclear Unclear at the outset what is to be reported
Other sources of bias? Unclear Insufficient information to make a judgement
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Cox 2008
Methods 2-arm randomised trial
Data All sedentary women aged 50-70 years participating in the SWEAT2 trial
Comparisons 1. 12 work sheets with strategies for goal setting, time management and overcoming barriers
to attendance, mini workshops, received worksheets to complete at home - after 6 months
received newsletters only. Intervention delivered by a trained facilitator, before an exercise
session
2. Information sheets about programme requirements exercise techniques, safety plus 9
newsletters and a report on fitness at 6 months delivered by principle investigator plus 9
newsletters
Outcomes Programme retention at 6 and 12 months
Notes Contact with authors to clarify if withdrawals occurred before or after randomisation
SWEAT2 compared moderate walking programme vs. swimming programme. Primary out-
come adherence to the programme
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Computer generated random numbers by a statistician”
Adequate sequence generation? Yes “Computer generated random numbers”
Blinding? Unclear “Not practical to blind the participants or the research staff to the
group assignment” (see other sources of bias below)
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Yes “Walk and swim sessions were not separated according to the be-
havioural intervention participants asked not to discuss written ma-
terials in the practical sessions”
Dorman 1997
Methods 2-arm randomised trial
Data All UK participants entered into the International Stroke Trial between 2 March 1993 and 31
May 1995 who were still alive
Comparisons 1. Short EuroQol posted with personalised letter and reply paid envelope. 1 reminder sent
after 2 weeks
2. Long SF36 questionnaire postedwith personalised letter and reply paid envelope. 1 reminder
sent after 2 weeks
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Dorman 1997 (Continued)
Outcomes Frequency of response after first and reminder mail out. Data for response to first mail out
used
Notes International Stroke Trial compared heparin 125,000 IU twice daily + aspirin 300 mg vs.
heparin 125,000 IU twice daily; heparin 5000 IU twice daily + aspirin 300 mg daily vs. heparin
5000 IU twice daily vs. aspirin 300 mg daily vs. no heparin or aspirin. Primary outcome: death
within 14 days or dependency at 6 months
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Authors response “generated by computer”
Adequate sequence generation? Unclear Author response “generated by computer”
Blinding? Unclear Authors report “there was no blinding for either study staff or par-
ticipants”
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
Edwards 2001
Methods 2-arm randomised trial
Data Adults aged ≥ 16 years with head injury in the UK CRASH trial
Comparisons 1. 1-page, 7-question functional dependence questionnaire with covering letter and stamped
return envelope. Reminders after 4 and 8 weeks
2. 3-page, 16-question functional dependence questionnaire with covering letter and stamped
return envelope. Reminders after 4 and 8 weeks
Outcomes No of questionnaires returned within 3 months
Notes Authors provided numbers randomised and responded
Primary outcome for the CRASH: death from any cause within 2 weeks of injury and death
or disability at 6 months
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Central computer”
Adequate sequence generation? Unclear “Central computer”
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Edwards 2001 (Continued)
Blinding? Unclear Author response “questionnaires were packaged and sent to patients
by personnel who were independent of the study”
Free of selective outcome reporting? Yes Reported non-response
Other sources of bias? Unclear Insufficient information to make a judgement
Ford 2006
Methods 2-arm quasi-randomised trial
Data African American men aged 55 years enrolled in the intervention screening arm of the PLCO
trial
Comparisons 1. Indepth case management. Case management monthly telephone calls to participants, as-
sistedmaking medical appointments, helpedparticipants obtain health insurance information,
legal aid, transportation services, food programmes, financial support, medication assistance,
free medical care, information related to health risks facing African Americans. Provision of
PLCO Cancer Screening Trial screening information and the scheduling of annual screening
appointments.
2. Regular trial screening procedures. Participants called annually to schedule screening exam-
inations
Outcomes Number completing the next scheduled PLCO cancer screen at 3 years
Notes PLCO trial compared digital rectal examination, transvaginal ultrasound and chest x-ray at
baseline and 5 years to usual follow-up. PSA and cancer antigen CA125 at baseline, and
annually for 5 years. Primary outcome mortality from 4 PLCO cancers
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Not described
Adequate sequence generation? No “Randomised by participant id number”
Blinding? Unclear Insufficient information to make a judgement about this
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement on this
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Gates 2009
Methods 2-arm quasi-randomised trial
Data All participants enrolled in the MINT trial due a follow-up questionnaire at 4 or 8 months
after whiplash injury
Comparisons 1. GBP5 voucher redeemable at shops www.highstreetvouchers.com plus questionnaire, cover
letter included a sentence explaining that the voucher is to thank participants for their time
and effort, delivered by post
2. No voucher and a standard covering letter with the questionnaire
Outcomes Number of questionnaires returned after first contact with participants
Notes Number of questionnaires returned in the incentive arm checked with authors
Primary outcome for theManaging Injuries of the Neck Trial (MINT) was returned to normal
after whiplash injury measured using the Neck Disability Index (NDI)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Author response “lack of concealment of allocations before
randomisation was not a major concern because it would have
been very difficult for the staff in the study office who were
sending out the questionnaires to have selectively allocated
systematically different patients to the trial arm”
Adequate sequence generation? No Author response “allocation to study arms was according to
whether a specific digit of the patients study number was odd
or even”
Blinding? Unclear Author response “trial office staff were unblinded, they had no
influence over any participant’s decision to return the ques-
tionnaire, and postal and telephone follow-up contacts were
performed in a standardised way for all participants, without
any reference to whether or not they were participating in the
incentive study”
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement on this
Hughes 1989
Methods 2-arm randomised trial
Data All smokers for > 1 year in the nicotine gum vs. placebo gum trial
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Hughes 1989 (Continued)
Comparisons 1. A letter promising a free reprint of the study results in return for sending in the questionnaire
2. No offer of results
Outcomes Questionnaire response. No time point given
Notes Author contacted regarding numbers randomised
Nicotine gum trial was double blind. The primary outcome was alleviation of signs and
symptoms of tobacco withdrawal measured using a rating list and POMS (profile of mood
states) questionnaire and DSM III criteria for tobacco withdrawal
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Author response “by a non involved researcher sequence in sealed
envelope, never opened during study”
Adequate sequence generation? Yes Author response “using a table of random numbers”
Blinding? Unclear Author response “participants fully aware of each condition and
which they were in”
Free of selective outcome reporting? Yes Response rates reported
Other sources of bias? Unclear Insufficient evidence to make a judgement on this
Kenton 2007a
Methods Randomised 2 x 2 factorial trial (incentive vs. offer of incentive)
Data Newmothers with Edinburgh postnatal depression scale score > 9 participating in postpartum
depression peer support trial
Comparisons 1. USD2 coin mailed with questionnaire
2. Offer of entry into prize draw for USD50 gift certificate
Outcomes Questionnaire response. No time point given
Notes The postpartum depression peer support trial enrolled women < 2 weeks’ postpartum at high
risk for postnatal depression. New proactive individualised telephone-based peer support with
standard postpartum care. The primary outcome was postnatal depression measured using the
Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)
Risk of bias
Item Authors’ judgement Description
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Kenton 2007a (Continued)
Allocation concealment? Yes Author response “allocation sequence stored
in a password protected file only accessed by
an external researcher, computer generated”
Adequate sequence generation? Unclear Author response “computer generated”
Blinding? Yes Author response “participants were not aware
of the sub-study and didn’t know other partic-
ipants were receiving different types of mail-
ings. The trial coordinator was not blinded to
the study group”
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Kenton 2007a-d
Methods Randomised 2 x 2 factorial trial
Data Newmothers with Edinburgh, postnatal depression scale score > 9 participating in postpartum
depression peer support trial
Comparisons 1. USD2 coin mailed with questionnaire
2. Offer of entry into prize draw for USD50 gift certificate
3. USD2 coin with questionnaire sent with high-priority postage stamp
4. Offer of entry into lottery draw for USD50 gift certificate with high-priority postage stamp
Outcomes Questionnaire response. No time point given
Notes The postpartum depression peer support trial enrolled women < 2 weeks’ postpartum at high
risk for postnatal depression. New proactive individualised telephone-based peer support with
standard postpartum care. The primary outcome was postnatal depression measured using the
Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Author response “allocation sequence stored in a password
protected file only accessed by an external researcher, com-
puter generated”
Adequate sequence generation? Unclear Author response “computer generated”
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Kenton 2007a-d (Continued)
Blinding? Yes Author response “participants were not aware of the sub-
study and didn’t know other participants were receiving
different types of mailings. The trial coordinator was not
blinded to the study group”
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement on this
Kenton 2007b
Methods Randomised 2 x 2 factorial trial (incentive + priority mail vs. offer of incentive + priority mail)
Data Newmothers with Edinburgh postnatal depression scale score > 9 participating in postpartum
depression peer support trial
Comparisons 1. USD2 coin with questionnaire sent with high-priority postage stamp
2. Offer of entry into lottery draw for USD50 gift certificate with high-priority postage stamp
Outcomes Questionnaire response. No time point given
Notes The postpartum depression peer support trial enrolled women < 2 weeks’ postpartum at high
risk for postnatal depression. New proactive individualised telephone-based peer support with
standard postpartum care. The primary outcome was postnatal depression measured using the
Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Author response “allocation sequence stored
in a password protected file only accessed by
an external researcher, computer generated”
Adequate sequence generation? Unclear Author response “computer generated”
Blinding? Yes Author response “
participants were not aware of the sub-study
and didn’t know other participants were re-
ceiving different types of mailings. The trial
coordinator was not blinded to the study
group”
Free of selective outcome reporting? Yes Expected outcomes reported
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Kenton 2007b (Continued)
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Kenton 2007c
Methods Randomised 2 x 2 factorial trial (priority mail vs. no priority mail)
Data Newmothers with Edinburgh postnatal depression scale score > 9 participating in postpartum
depression peer support trial
Comparisons 1. USD2 coin sent by high-priority postage stamp plus questionnaire
2. USD2 coin plus questionnaire
Outcomes Questionnaire response. No time point given
Notes The postpartum depression peer support trial enrolled women < 2 week’ postpartum at high
risk for postnatal depression. New proactive individualised telephone-based peer support with
standard postpartum care. The primary outcome was postnatal depression measured using the
Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Author response “allocation sequence stored
in a password protected file only accessed by
an external researcher, computer generated”
Adequate sequence generation? Unclear Author response “computer generated”
Blinding? Yes Author response “participants were not aware
of the sub-study and didn’t know other partic-
ipants were receiving different types of mail-
ings. The trial coordinator was not blinded to
the study group”
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
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Kenton 2007d
Methods Randomised 2 x 2 factorial trial (offer of entry into prize draw plus high-priority postage stamp
vs. offer of entry into prize draw)
Data Newmothers with Edinburgh postnatal depression scale score > 9 participating in postpartum
depression peer support trial
Comparisons 1. Offer of entry into prize draw for USD50 gift certificate plus high-priority postage stamp
2. Offer of entry into prize draw for USD50 gift certificate
Outcomes Questionnaire response. No time point given
Notes The postpartum depression peer support trial enrolled women < 2 weeks’ postpartum at high
risk for postnatal depression. New proactive individualised telephone-based peer support with
standard postpartum care. The primary outcome was postnatal depression measured using the
Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Author response “allocation sequence stored
in a password protected file only accessed by
an external researcher, computer generated”
Adequate sequence generation? Unclear Author response “computer generated”
Blinding? Yes Author response “participants were not aware
of the sub-study and didn’t know other partic-
ipants were receiving different types of mail-
ings. The trial coordinator was not blinded to
the study group”
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Kenyon 2005
Methods 2-arm randomised trial
Data Women in ORACLE 1 and 2 participating in the evaluation of health and development study
Comparisons 1. GBP5 voucher mailed with questionnaire redeemable at many high street shops
2. No incentive
Outcomes Questionnaire response rate. No time point given
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Kenyon 2005 (Continued)
Notes ORACLE trial: women with preterm prelabour rupture of fetal membranes and women with
intact membranes in preterm labour, randomised to erythromycin 250 mg, co-amoxiclav
325 mg, erythromycin 250 mg plus co-amoxiclav 325 mg or placebo x 10 days or until
birth. Primary outcome composite of neonatal death, chronic lung disease or major cerebral
abnormality before discharge from hospital
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Randomly assigned by concealed computer generated allocation”
Adequate sequence generation? Yes “Randomly assigned by ”computer“ ”
Blinding? Yes Author response “both the participants and the study personnel were
blinded to the allocation”
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement on this
Khadjesari 2011
Methods Khadjesari 1: 4-arm randomised trial
Khadjesari 2: 2-arm randomised trial
Data See ’Table of characteristics’ for Khadjesari 2011 1abc; Khadjesari 2011 2
Comparisons See ’Table of characteristics’ for Khadjesari 2011 1abc; Khadjesari 2011 2
Outcomes See ’Table of characteristics’ for Khadjesari 2011 1abc; Khadjesari 2011 2
Notes See ’Table of characteristics’ for Khadjesari 2011 1abc; Khadjesari 2011 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed”, “randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes All outcomes reported
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Khadjesari 2011 (Continued)
Other sources of bias? Unclear Insufficient information to make a judgement
about this
Khadjesari 2011 1a
Methods 4-arm randomised trial (offer of incentives vs. no offer)
Data Non-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire.
Adults aged ≥ 18 scoring 5 or more on the AUDIT-C test
Comparisons 1. Offer of GBP5 Amazon.co.uk voucher. Emailed voucher code on receipt of response (arm
a)
2. Email with no offer of incentive (control)
Outcomes Proportion completing questionnaire after 40 days
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
Khadjesari 2011 1abc
Methods 4-arm randomised trial
Data Non-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire.
Adults aged ≥ 18 scoring 5 or more on the AUDIT-C test
Comparisons 1. Offer of GBP5 Amazon.co.uk voucher. Emailed voucher code on receipt of response (arm
a)
2. Offer of GBP5 donation to Cancer Research UK. Emailed hyperlink to charity’s website
showing donation when response received (arm b)
3. Offer of entry into GBP250 prize draw emailed confirmation of entry when response
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Khadjesari 2011 1abc (Continued)
received (arm c)
4. Email prompt for completion of questionnaires with no offer of incentive (control arm)
Outcomes Proportion completing questionnaire after 40 days
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation could not be subverted by
the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement about this
Khadjesari 2011 1ac
Methods 4-arm randomised trial (incentives combined vs. no incentive)
Data Non-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire.
Adults aged ≥ 18 scoring 5 or more on the AUDIT-C test
Comparisons 1. Offer of GBP5 Amazon.co.uk voucher. Emailed voucher code on receipt of response (arm
a)
2.Offer of entry into GBP250 prize draw emailed confirmation of entry when response
received (arm c)
3. Email with no offer of incentive (control arm)
Outcomes Proportion completing questionnaire after 40 days
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Separate comparison for arm b of attrition trial see Khadjesari 2011 1b
Risk of bias
Item Authors’ judgement Description
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Khadjesari 2011 1ac (Continued)
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
Khadjesari 2011 1b
Methods 4-arm randomised trial (offer of donation to charity vs. no offer)
Data Non-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire.
Adults aged ≥ 18 scoring 5 or more on the AUDIT-C test
Comparisons 1. Offer of GBP5 donation to Cancer Research UK. Emailed hyperlink to charity’s website
showing donation when response received (arm b)
2. Email with no offer of incentive (control)
Outcomes Proportion completing questionnaire after 40 days
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
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Khadjesari 2011 1c
Methods 4-arm randomised trial (offer of entry into prize draw vs. no offer)
Data Non-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire.
Adults aged ≥ 18 scoring 5 or more on the AUDIT-C test
Comparisons 1. Offer of entry into GBP250 prize draw emailed confirmation of entry when response
received (arm c)
2. Email with no offer of incentive (control arm)
Outcomes Proportion completing questionnaire after 40 days
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
Khadjesari 2011 2
Methods 2-arm randomised trial
Data All DYD trial study participants
Comparisons 1. Offer of a GBP10 Amazon.co.uk voucher. Email with voucher code sent on completion of
questionnaire
2. Reminder email with no voucher offer
Outcomes The proportion of participants that completed the questionnaire after 40 days
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
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Khadjesari 2011 2 (Continued)
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed”, “randomisation could not be subverted
by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes All outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement about this
Land 2007
Methods 2-arm randomised trial
Data Research sites participating in the NSABP B35 trial
Comparisons 1. Automated prospective monthly reminder to trial sites of upcoming participant-reported
outcome assessments. Reminder listed participants expected to complete Behavioral andHealth
Outcomes forms in upcoming 3 months
2. No monthly assessment reminder
Outcomes Receipt of questionnaire at any time
Notes B35 Anastrozole vs. tamoxifen for the treatment of ductal carcinoma in situ women aged 55
years plus. Primary outcome: time to first breast cancer reoccurrence
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Author response to question “describe the methods if any, used to
conceal the allocation sequence for the prospective reminder study
in B35”, “not applicable. Institutions were all randomly assigned
before trial initiation, so there was no sequence”
Adequate sequence generation? Yes Author response “prospective reminder in B-35, three strata were
generated, and half in each were randomly assigned to receive the
reminder”
Blinding? No Author response “there was no blinding the prospective reminder
was received by clinical staff ”
Free of selective outcome reporting? Yes Primary outcome reported
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Land 2007 (Continued)
Other sources of bias? Unclear Insufficient information to make a judgement
Leigh Brown 1997
Methods 2-arm randomised trial
Data Participants inOMENSdue to receive follow-upquestionnaires betweenMarch andDecember
1995
Comparisons 1. Offer of GBP25 gift voucher monthly prize draw. Postcard reminder after 10 days and 3
weeks with reference to offer
2. No offer. Post card reminders after 10 days and 3 weeks with no reference to offer
Outcomes Questionnaire response. No time point given
Notes OMENS effectiveness of musculoskeletal medicine vs. care by orthopaedic surgeon-led ser-
vices for the treatment of non-surgical orthopaedic outpatients Primary outcomes: change in
participant reported health (SF-36 and EuroQol) and marginal health
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No Author response “table of random numbers”
Adequate sequence generation? Yes Author response “table of random numbers”
Blinding? Unclear Author response “those randomised to take part in the prize draw
were aware of the intervention and those randomised to be excluded
from the draw were unaware. The trial team were aware of the
allocation so that they could arrange the monthly draw”
Free of selective outcome reporting? Yes Defined outcomes reported outcome reported
Other sources of bias? Unclear Insufficient evidence to make a judgement about this
Letley 2000
Methods 2-arm randomised trial
Data Participants in the UKBEAM feasibility trial, aged 18-65 years with low back pain and a score
of 4 or more on the RDQ
Comparisons Review author (VB) checked which was control and which was intervention
1. RDQ before SF-36in a 26-page questionnaire
2. SF-36 before RDQ in a 26-page questionnaire
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Letley 2000 (Continued)
Outcomes Questionnaire response at 3 months
Notes Study complete, no data available at 8 September 2011. UKBEAM: compared the effectiveness
of exercise, manipulation, exercise and manipulation. Primary outcome for UKBEAM scores
on the RDQ at 3 and 12 months
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Author reported “sequence generation was via remote service ensur-
ing allocation concealment”
Adequate sequence generation? Yes Author reported “sequence generation was random using ran-
domised permuted blocks”
Blinding? Unclear No data
Free of selective outcome reporting? Yes Overall response rates reported
Other sources of bias? Unclear No data
MacLennan
Methods 2-arm randomised trial
Data Participants who had not returned questionnaires at 12, 24 and 36 months in the RECORD
trial
Comparisons 1. Telephone call from RECORD office before first reminder questionnaire sent. Participant
asked to complete questionnaire and to try to fill in all questions. Further telephone call from
study nurse or RECORD office if not returned after 3 weeks
2. Repeat mailing of usual follow-up letter and questionnaire. Telephone call by study nurse
or RECORD office if not returned after 3 weeks (routine follow-up)
Outcomes Proportion of first reminder questionnaires returned
Proportion of questionnaires returned at 4 months
Completeness of data
Notes Primary outcome all new low-energy fractures (self reported) EQ-5D Short form-12. Trial
identified through mail out to UK clinical trial units
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Author response “central randomisation service”
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MacLennan (Continued)
Adequate sequence generation? Yes Author response “randomised to receive the ”intervention“ or not
using the central randomisation service”
Blinding? Yes Author response “blinding was not possible in the ”intervention“
arm. The control were blinded. Trial staff phoning were not blinded
Outcome assessment in the sub-study was objective: questionnaire
returned yes/no. Trial staff and trial participants were blinded to the
RECORD trial allocation”
Free of selective outcome reporting? Yes All defined outcomes reported
Man 2011
Methods 2-arm randomised trial
Data Adults 18-65 years sent a 6-month follow-up questionnaire in a trial of yoga for chronic back
pain
Comparisons 1. SMS text message: “Yoga trial: You should receive a questionnaire any day now. The data is
important to us so please return it as soon as you can. Many thanks”
2. Email message: “Thank you for taking part in the Yoga for Low Back Pain Trial. This is
an automatic reminder. You should receive your six month questionnaire any day now. The
answers you give in the questionnaire are very important to the trial. Therefore, we should be
most grateful if you would complete and return the questionnaire (and any other documents)
as soon as possible please. Thank you”
3. SMS text message plus email message
4. No SMS test message or email message
Outcomes Postal questionnaire response
Notes Yoga for chronic back pain trial: primary outcome functional limitations and disability mea-
sured by the RDQ. Setting 13 non-national health service settings in the UK. Participants
were recruited through general practices
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Computer-generated sequence to randomly allocate participants
Adequate sequence generation? Yes Independent data manager generated a computer sequence
Blinding? Unclear No data
Free of selective outcome reporting? Yes Reported response to questionnaires
Other sources of bias? Unclear No data
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Marson 2007
Methods 2-arm randomised trial
Data Participants in SANAD due a QoL questionnaire at 1 year
Comparisons 1. Cover letter with estimate of the length of time required to complete questionnaire
2. Standard cover letter without estimate of the length of time required to complete question-
naire
Outcomes Response rate. No time point given
Notes SANAD compared the long-term effects of antiepileptic drugs in people with epilepsy. Partic-
ipants randomised to arm a received carbamazepine, gabapentin, lamotrigine, oxcarbazepine,
or topiramate and valproate, lamotrigine, or arm B received topiramate. Primary outcome
time to treatment failure and time to achieve a 12-month remission of seizures
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No Author response “the list was given to the study researcher who
worked sequentially through the list from left to right from top to
bottom”
Adequate sequence generation? Yes Author response “list of allocations was generated electronically us-
ing random permuted blocks of length 20”
Blinding? Yes Author response “this was a postal study, blinding was not necessary
for participants; they received either a time-framed letter or non
time-framed letter. Clinical personnel did not see the letters, as these
were sent postally directly to participants from the study research
office”
Free of selective outcome reporting? Yes Attrition reported
Other sources of bias? Unclear Insufficient evidence to make a judgement about this
McCambridge 2011
Methods McCambridge 1: 4-arm randomised trial in the pilot phase of the DYD trial; McCambridge
2: 4-arm randomised trial in the host DYD trial
Data See ’Table of characteristics’ forMcCambridge 2011 1;McCambridge 2011 1a;McCambridge
2011 1b; McCambridge 2011 2; McCambridge 2011 2a; McCambridge 2011 2b
Comparisons See ’Table of characteristics’ forMcCambridge 2011 1;McCambridge 2011 1a;McCambridge
2011 1b; McCambridge 2011 2; McCambridge 2011 2a; McCambridge 2011 2b
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McCambridge 2011 (Continued)
Outcomes See ’Table of characteristics’ forMcCambridge 2011 1;McCambridge 2011 1a;McCambridge
2011 1b; McCambridge 2011 2; McCambridge 2011 2a; McCambridge 2011 2b
Notes See ’Table of characteristics’ forMcCambridge 2011 1;McCambridge 2011 1a;McCambridge
2011 1b; McCambridge 2011 2; McCambridge 2011 2a; McCambridge 2011 2b
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes See ’Risk of bias’ table McCambridge 2011 1;
McCambridge 2011 1a; McCambridge 2011
1b; McCambridge 2011 2; McCambridge
2011 2a; McCambridge 2011 2b
Adequate sequence generation? Yes See ’Risk of bias’ table McCambridge 2011 1;
McCambridge 2011 1a; McCambridge 2011
1b; McCambridge 2011 2; McCambridge
2011 2a; McCambridge 2011 2b
Blinding? Unclear See ’Risk of bias’ table McCambridge 2011 1;
McCambridge 2011 1a; McCambridge 2011
1b; McCambridge 2011 2; McCambridge
2011 2a; McCambridge 2011 2b
Free of selective outcome reporting? Yes See ’Risk of bias’ table McCambridge 2011 1;
McCambridge 2011 1a; McCambridge 2011
1b; McCambridge 2011 2; McCambridge
2011 2a; McCambridge 2011 2b
Other sources of bias? Unclear See ’Risk of bias’ table McCambridge 2011 1;
McCambridge 2011 1a; McCambridge 2011
1b; McCambridge 2011 2; McCambridge
2011 2a; McCambridge 2011 2b
McCambridge 2011 1
Methods 4-arm randomised trial in the pilot phase of the DYD trial
Data Adults aged ≥ 18 years scoring ≥ 5 on the AUDIT-C test participating in the pilot phase of
the DYD trial 1-month data used
Comparisons 1. APQ 23 items
2. AUDIT 10
3. LDQ 10
4. CORE-OM 23/34 items (mental health assessment)
60Strategies to improve retention in randomised trials (Review)
Copyright © 2013 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
McCambridge 2011 1 (Continued)
Outcomes Response to electronic questionnaires
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
McCambridge 2011 1a
Methods 4-arm randomised trial (’relevance’ of questionnaire: alcohol vs. mental health data)
Data Adults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the pilot
phase of the DYD trial 1-month data used
Comparisons 1. APQ 23 items
2. CORE-OM 23/34 items (Mental health assessment)
Outcomes Response to electronic questionnaires
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
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McCambridge 2011 1a (Continued)
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
McCambridge 2011 1b
Methods 4-arm randomised trial (short vs. long questionnaire comparison)
Data Adults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the DYD
trial. For this comparison 1-month follow-up data from McCambridge 2011 1 used
Comparisons 1. AUDIT 10 items + LDQ 10 items
2. APQ 23 items
Outcomes Response to electronic questionnaires
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
McCambridge 2011 2
Methods 4-arm randomised trial in the host DYD trial
Data Adults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the pilot
phase of the DYD trial 3-month data used
Comparisons 1. APQ 23 items
2. AUDIT 10
3. LDQ 10
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McCambridge 2011 2 (Continued)
4. CORE-OM 23/34 items (Mental health assessment)
Outcomes Response to electronic questionnaires
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
McCambridge 2011 2a
Methods 4-arm randomised trial (’relevance’ of questionnaire alcohol vs. mental health)
Data Adults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the DYD
trial. For this comparison 3-month follow-up data from McCambridge 2011 2 used
Comparisons 1. AUDIT 10 items + LDQ 10 items
2. CORE-10
Outcomes Response to electronic questionnaires
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
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McCambridge 2011 2a (Continued)
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
McCambridge 2011 2b
Methods 4-arm randomised trial (short vs. long questionnaire)
Data Adults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the DYD
trial. For this comparison, 3-month follow-up data from McCambridge 2011 2 used
Comparisons 1. AUDIT 10 items + LDQ 10 items
2. APQ 23 items
Outcomes Response to electronic questionnaires
Notes Primary outcome for DYD: total past week alcohol consumption measured using the TOT-
AL measure of total alcohol consumption. Trial identified through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Allocation was concealed randomisation
could not be subverted by the study team”
Adequate sequence generation? Yes Computer-generated randomisation sequence
Blinding? Unclear Unclear
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
about this
McColl 2003
Methods 2-arm randomised trial
Data 40 adults aged≥ 18 years with asthma from62 general practices participating in theCOGENT
trial
Comparisons See ’Table of characteristics’ for McColl 2003 1; McColl 2003 2
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McColl 2003 (Continued)
Outcomes See ’Table of characteristics’ for McColl 2003 1; McColl 2003 2
Notes See ’Table of characteristics’ for McColl 2003 1; McColl 2003 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No See ’Risk of bias’ table McColl 2003 1; McColl 2003 2
Adequate sequence generation? Unclear See ’Risk of bias’ table McColl 2003 1; McColl 2003 2
Blinding? Yes See ’Risk of bias’ table McColl 2003 1; McColl 2003 2
Free of selective outcome reporting? Yes See ’Risk of bias’ table McColl 2003 1; McColl 2003 2
Other sources of bias? Unclear See ’Risk of bias’ table McColl 2003 1; McColl 2003 2
McColl 2003 1
Methods 2-arm randomised trial
Data 40 adults aged≥ 18 years with asthma from62 general practices participating in theCOGENT
trial
Comparisons 1. Asthma specific instruments (NASQ and AQLQ) followed by generic questions in medical
outcomes SF-36 version 1 and EQ-5D
2. Generic questions followed by condition specific
Outcomes Questionnaire response rates, speed and patterns. No time point given
Notes COGENT before and after cluster randomised, 2 x 2 factorial trial. Evaluated use of comput-
erised support system for decision making for implementing evidenced-based clinical guide-
lines for the management of asthma (and angina see McColl 2003 2). General practices ran-
domised to computerised guidelines for the management of angina or asthma. Primary out-
come adherence to guidelines
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No Author response “practices provided us with a computerised list of
all patients fulfilling eligibility criteria. We drew a simple random
sample of patients from that list first 40 from list received version
1, second 40 version 2”
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McColl 2003 1 (Continued)
Adequate sequence generation? Unclear Author response “practices provided us with a computerised list of
all patients fulfilling eligibility criteria. We drew a simple random
sample of patients from that list. First 40 received version 1, second
40 version 2. Logistically, truly random allocation of the 80 patients
to versions 1 and 2 would have been impractical to implement”
Blinding? Yes Author response “respondents were not alerted to the fact that we
were experimenting with the order of instruments”
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient evidence to make a judgement about this
McColl 2003 2
Methods 2-arm randomised trial
Data 40 adults aged≥ 18 years with asthma from62 general practices participating in theCOGENT
trial
Comparisons 1. Angina-specific instruments (SAQ) followed by generic questions (SF-36 version 1 and EQ-
5D)
2. Generic questions followed by condition-specific questions
Outcomes Questionnaire response rates, speed and patterns. No time point given
Notes COGENT before and after cluster randomised, 2 x 2 factorial trial. Evaluated use of comput-
erised support system for decision making for implementing evidenced-based clinical guide-
lines for the management of angina (and asthma see McColl 2003 1). General practices ran-
domised to computerised guidelines for the management of angina or asthma. Primary out-
come adherence to guidelines
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No Author response “practices provided us with a computerised list of
all patients fulfilling eligibility criteria. We drew a simple random
sample of patients from that list. First 40 from list received version
1, second 40 version 2”
Adequate sequence generation? Unclear Author response “practices provided us with a computerised list of
all patients fulfilling eligibility criteria. We drew a simple random
sample of patients from that list. First 40 received version 1, second
40 version 2. Logistically, truly random allocation of the 80 patients
to versions 1 and 2 would have been impractical to implement”
66Strategies to improve retention in randomised trials (Review)
Copyright © 2013 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
McColl 2003 2 (Continued)
Blinding? Yes Author response “respondents were not alerted to the fact that we
were experimenting with the order of instruments”
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient evidence to make a judgement about this
Nakash 2007
Methods 2-arm randomised trial
Data Participants aged ≥ 16 years from 5 trial centres randomised to CAST between November
2003 and July 2005
Comparisons 1.Trial calendar:monthly customised calendar, includedprenotification captionon themonths
the participant is due to receive the questionnaire with reminder caption the following month
2. No trial calendar
Outcomes Questionnaire response at 4, 12 weeks and 9 months. Response at 4 weeks used for analysis
Amount of prompting required to return questionnaires at each time point
Percentage of missing data of the core outcome
Notes CAST tubular bandage, below knee cast, Aircast® ankle brace and Bledsoe® boot compared
in people with acute severe ankle sprain. Primary outcome FAOS, FLP, SF-12 and EuroQol 5
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes “Baseline packs compiled in advance and stored at trial sites. On
randomisation the next consecutively numbered pack was taken.
Allocation concealed until participant recruited intoCASTandpack
opened”
Adequate sequence generation? Yes “Computer generated random sequence”
Blinding? Yes “No blinding of participants or clinic staff ”, “data inputting was
blind to allocation”
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient evidence to make a judgement about this
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Renfroe 2002a
Methods 2 x 2 x 2 x 2 factorial randomised trial (certificate of appreciation vs. no certificate)
Data All surviving participants at AVID study termination
Comparisons 1. Certificate of appreciation with cover letter signed by physician or co-ordinator sent either
by express or standard post, 2-3 weeks after last AVID follow-up visit or 1-4 months after last
AVID follow-up visit
2. No certificate with cover letter signed by physician or co-ordinator, sent either by express or
standard post, 2-3 weeks after last AVID follow-up visit or 1-4 months after last AVID follow-
up visit
Outcomes Questionnaire response. No time point given
Notes AVID conducted in people resuscitated from ventricular fibrillation or cardioverted for ven-
tricular tachycardia. Compared implanted cardioverter defibrillator vs. antiarrhythmic drugs.
Primary outcome overall mortality
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear The AVIDCTC prepared the resulting 16 sets
of distinct participant survey packets. These
participant-specific packets were then mailed
to the study co-ordinators, who distributed
them to participants as instructed
Adequate sequence generation? Yes Author response “all patients in the study
were randomised. Details of the randomisa-
tion scheme are no longer extant, but given
the factorial design I think it’s safe to assume
that the randomization for each factor was by
permuted blocks of size 2”
Blinding? Yes Participants were instructed to mail the com-
pleted surveys directly to the CTC in postage-
paid, self-addressed return envelopes. Only
their AVID study number identified partici-
pants, assuring confidentiality of their survey
responses
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
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Renfroe 2002a-d
Methods 2 x 2 x 2 x 2 factorial randomised trial
Data All surviving participants at AVID study termination
Comparisons 1. Certificate of appreciation
2. No certificate of appreciation
3. Overnight express delivery
4. Regular post
5. Cover letter signed by physician
6. Cover letter signed by study co-ordinator
7. Early administration
8. Late administration
Outcomes Questionnaire response. No time point given
Notes AVID conducted in people resuscitated from ventricular fibrillation or cardioverted for ven-
tricular tachycardia. Compared implanted cardioverter defibrillator vs. antiarrhythmic drugs.
Primary outcome overall mortality
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear The AVIDCTCprepared the resulting 16 sets of dis-
tinct participant survey packets. These participant-
specific packets were then mailed to the study co-
ordinators, who distributed them to participants as
instructed
Adequate sequence generation? Yes Author response “all patients in the study were ran-
domised.Details of the randomisation scheme are no
longer extant, but given the factorial design I think
it’s safe to assume that the randomization for each
factor was by permuted blocks of size 2”
Blinding? Yes Participants were instructed to mail the completed
surveys directly to the CTC in postage-paid, self ad-
dressed return envelopes. Only their AVID study
number identified participants, assuring confiden-
tiality of their survey responses
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement on
this
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Renfroe 2002b
Methods 2 x 2 x 2 x 2 factorial randomised trial (express vs. regular post)
Data All surviving participants at AVID study termination
Comparisons 1. Overnight express delivery with cover letter signed by physician or co-ordinator with or
without a certificate of appreciation 2-3 weeks after last AVID follow-up visit or 1-4 months
after last AVID follow-up visit
2. Regular postwith cover letter signedby physician or co-ordinatorwith or without a certificate
of appreciation 2-3 weeks after last AVID follow-up visit or 1-4months after last AVID follow-
up visit
Outcomes Questionnaire response. No time point given
Notes AVID conducted in people resuscitated from ventricular fibrillation or cardioverted for ventric-
ular tachycardia. Compared implanted cardioverter defibrillator with antiarrhythmic drugs.
Primary outcome overall mortality
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear The AVIDCTC prepared the resulting 16 sets
of distinct participant survey packets. These
participant-specific packets were then mailed
to the study co-ordinators, who distributed
them to participants as instructed
Adequate sequence generation? Yes Author response “all patients in the study
were randomised. Details of the randomisa-
tion scheme are no longer extant, but given
the factorial design I think it’s safe to assume
that the randomisation for each factor was by
permuted blocks of size 2”
Blinding? Yes Participants were instructed to mail the com-
pleted surveys directly to the CTC in postage-
paid, self-addressed return envelopes. Only
their AVID study number identified partici-
pants, assuring confidentiality of their survey
responses
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
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Renfroe 2002c
Methods 2 x 2 x 2 x 2 factorial randomised trial (physician vs. study co-ordinator signed cover letter)
Data All surviving participants at AVID study termination
Comparisons 1. Cover letter signed by physician sent either by express or standard post, with or without a
certificate of appreciation, 2-3 weeks after last AVID follow-up visit or 1-4 months after last
AVID follow-up visit
2. Cover letter signed by study co-ordinator sent either by express or standard post, with or
without a certificate of appreciation 2-3 weeks after last AVID follow-up visit or 1-4 months
after last AVID follow-up visit
Outcomes Questionnaire response. No time point given
Notes AVID conducted in participants resuscitated from ventricular fibrillation or cardioverted
for ventricular tachycardia. Compared implanted cardioverter defibrillator vs. antiarrhythmic
drugs. Primary outcome overall mortality
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear The AVIDCTC prepared the resulting 16 sets
of distinct participant survey packets. These
participant-specific packets were then mailed
to the study co-ordinators, who distributed
them to participants as instructed
Adequate sequence generation? Yes Author response “all patients in the study
were randomised. Details of the randomisa-
tion scheme are no longer extant, but given
the factorial design I think it’s safe to assume
that the randomisation for each factor was by
permuted blocks of size 2”
Blinding? Yes Participants were instructed to mail the com-
pleted surveys directly to the CTC in postage-
paid, self-addressed return envelopes. Only
their AVID study number identified partici-
pants, assuring confidentiality of their survey
responses
Free of selective outcome reporting? Yes Report all outcomes
Other sources of bias? Unclear Insufficient information to make a judgement
on this
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Renfroe 2002d
Methods 2 x 2 x 2 x 2 factorial randomised trial (early vs. late administration of questionnaire)
Data All surviving participants at AVID study termination
Comparisons 1. Questionnaire sent 2-3 weeks after last AVID follow-up visit by express or standard post with
cover letter signed by physician or co-ordinator with or without a certificate of appreciation
2. Questionnaire sent 1-4 months after last AVID follow-up visit, by express or standard
post with cover letter signed by physician or co-ordinator with or without a certificate of
appreciation
Outcomes Questionnaire response. No time point given
Notes AVID conducted in people resuscitated from ventricular fibrillation or cardioverted for ven-
tricular tachycardia. Compared implanted cardioverter defibrillator vs. antiarrhythmic drugs.
Primary outcome overall mortality
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear The AVIDCTC prepared the resulting 16 sets
of distinct participant survey packets. These
participant-specific packets were then mailed
to the study co-ordinators, who distributed
them to participants as instructed
Adequate sequence generation? Yes Author response “all patients in the study
were randomised. Details of the randomisa-
tion scheme are no longer extant, but given
the factorial design I think it’s safe to assume
that the randomisation for each factor was by
permuted blocks of size 2”
Blinding? Yes Participants were instructed to mail the com-
pleted surveys directly to the CTC in postage-
paid, self-addressed return envelopes. Only
their AVID study number identified partici-
pants, assuring confidentiality of their survey
responses
Free of selective outcome reporting? Yes All defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
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Severi 2011
Methods Two 2-arm randomised trials
Data UK smokers aged ≥ 16 years participating in the Txt2stop trial
Comparisons See ’Table of characteristics’ for Severi 2011 1 and Severi 2011 2
Outcomes See ’Table of characteristics’ for Severi 2011 1 and Severi 2011 2
Notes See ’Table of characteristics’ for Severi 2011 1 and Severi 2011 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear “Concealed from the investigators”
Adequate sequence generation? Yes “Allocated through minimisation using minim software”
Blinding? Yes “Single blind controlled trial, with those recording and assess-
ing outcomes blind to the intervention”
Free of selective outcome reporting? Yes All defined outcomes reported
Severi 2011 1
Methods 2-arm randomised trial
Data UK smokers aged ≥16participating in the Txt2stop trial
Comparisons 1. Text message “Be proud of yourself for helpingmedical research! Thank you for filling in the
txt 2 stop questionnaire” plus a fridge magnet: the message on the fridge magnet was placed
in a sealed envelope, this said: “medical research is important to society” and pointed out that
by taking part in TxT2stop the participants are benefiting society. Fridge magnet sent by post
16-20 weeks after randomisation. Text message sent 3 days after TxT2stop postal follow-up
questionnaire
2. Text message reminding the participant the follow-up questionnaire was due 3 days after
the TxT2stop questionnaire had been sent. The text message said “Thank you for filling in
the TxT2stop questionnaire”. Sent 3 days after the text to stop postal follow-up questionnaire
Outcomes Primary outcome: completed follow-up questionnaires at 30 weeks from randomisation
Secondary outcome: completed follow-up questionnaires at 26 weeks from randomisation
Notes Txt2stop UK-based smoking cessation trial evaluating the effectiveness of the Txt2stop mobile
phone text messaging smoking cessation programme on biochemically verified continuous
smoking abstinence at 6 months. Compared Txt2stop motivational messages vs. behaviour
change support to text messages unrelated to quitting
Risk of bias
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Severi 2011 1 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear “Concealed from the investigators”
Adequate sequence generation? Yes “Allocated through minimisation using minim software”
Blinding? Yes “Single blind controlled trial, with those recording and assessing
outcomes blind to the intervention”
Free of selective outcome reporting? Yes All defined outcomes reported
Severi 2011 2
Methods 2-arm randomised trial
Data UK smokers aged ≥ 16 years participating in the Txt2stop trial
Comparisons 1. Telephone call from female principal investigator (senior clinician and researcher) to par-
ticipants 6 weeks overdue returning specimen to increase participant follow-up plus standard
Txt2stop follow-up procedures
2. Standard Txt2stop follow-up procedures
Outcomes Completed cotinine sample follow-up at the end of May 2009 for Txt2stop (1 month after a
telephone call)
Notes Txt2stop UK-based smoking cessation trial evaluating the effectiveness of the Txt2stop mo-
bile phone text messaging smoking cessation program on biochemically verified continuous
smoking abstinence at 6 months. Compared Txt2stop motivational messages vs. behaviour
change support to text messages unrelated to quitting
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear “Concealed from the investigators”
Adequate sequence generation? Yes “Allocated through minimisation using minim software”
Blinding? Yes “Single blind controlled trial, with those recording and assessing
outcomes blind to the intervention”
Free of selective outcome reporting? Yes All defined outcomes reported
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Sharp 2006a
Methods 2 x 2 x 2 factorial randomised trial (trial-branded pen vs. no pen: comparison 1)
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 months’ follow-up
Comparisons 1. TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed
return envelope
2.NoTOMBOLA-brandedpen+despatch first-class post + second-class stampedpreaddressed
return envelope
Outcomes Response rates at any time
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative inci-
dence of cervical intraepithelial neoplasia grade ≥ 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Sharp 2006a-h
Methods 2 x 2 x 2 factorial randomised trial
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 months’ follow-up
Comparisons 1. TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed
return envelope
2.NoTOMBOLA-brandedpen+despatch first-class post + second-class stampedpreaddressed
return envelope
3. TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope
4. No TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope
5. TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed
return envelope
6. No TOMBOLA-branded pen + despatch second-class post + second-class stamped pread-
dressed return envelope
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Sharp 2006a-h (Continued)
7. TOMBOLA-branded pen + despatch second-class post + free post business-reply envelope
8. No TOMBOLA-branded pen + despatch second-class post + free post business-reply enve-
lope
Outcomes Response rates at any time
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative inci-
dence of cervical intraepithelial neoplasia grade ≥ 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement on this
Sharp 2006b
Methods 2 x 2 x 2 factorial randomised trial (trial-branded pen vs. no pen: comparison 2)
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 months’ follow-up
Comparisons 1. TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope
2. No TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope
Outcomes Response rates at any time
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative inci-
dence of cervical intraepithelial neoplasia grade ≥ 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
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Sharp 2006b (Continued)
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Sharp 2006c
Methods 2 x 2 x 2 factorial randomised trial (trial branded pen vs. no pen: comparison 3)
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 months’ follow-up
Comparisons 1. TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed
return envelope
2. No TOMBOLA-branded pen + despatch second-class post + second-class stamped pread-
dressed return envelope
Outcomes Defined outcomes reported
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative inci-
dence of cervical intraepithelial neoplasia grade ≥ 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
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Sharp 2006d
Methods 2 x 2 x 2 factorial randomised trial (trial-branded pen vs. no pen: comparison 4)
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 month follow-up
Comparisons 1. TOMBOLA-branded pen + despatch second-class post + free post business-reply envelope
2. No TOMBOLA-branded pen + despatch second-class post + free post business-reply enve-
lope
Outcomes Response rates at any time
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative inci-
dence of cervical intraepithelial neoplasia grade ≥ 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Sharp 2006e
Methods 2 x 2 x 2 factorial randomised trial (first vs. second-class post comparison 1)
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 months’ follow-up
Comparisons 1. TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed
return envelope
2. TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed
return envelope
Outcomes Defined outcomes reported
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence
of cervical intraepithelial neoplasia grade ≥ 2
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Sharp 2006e (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Sharp 2006f
Methods 2 x 2 x 2 factorial randomised trial (first vs. second-class post comparison 2)
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 months’ follow-up
Comparisons 1.NoTOMBOLA-brandedpen+despatch first-class post + second-class stampedpreaddressed
return envelope
2. No TOMBOLA-branded pen + despatch second-class post + second-class stamped pread-
dressed return envelope
Outcomes Response rates at any time
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence
of cervical intraepithelial neoplasia grade ≥ 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Defined outcomes reported
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Sharp 2006f (Continued)
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Sharp 2006g
Methods 2 x 2 x 2 factorial randomised trial (first vs. second-class comparison 3)
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 months’ follow-up
Comparisons 1. TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed
return envelope
2. TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope
Outcomes Response rates at any time
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative inci-
dence of cervical intraepithelial neoplasia grade ≥ 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Defined outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Sharp 2006h
Methods 2 x 2 x 2 factorial randomised trial (first vs. second-class comparison 4)
Data Women due to receive a TOMBOLA psychosocial questionnaire during June-August 2003
for 12, 18, 24, 30, 34, 36 month follow-up
Comparisons 1.NoTOMBOLA-brandedpen+despatch first-class post + second-class stampedpreaddressed
return envelope
2. No TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope
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Sharp 2006h (Continued)
Outcomes Response rates at any time
Notes TOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women
20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence
of cervical intraepithelial neoplasia grade ≥ 2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear 2 authors did randomisation
Adequate sequence generation? Unclear “Computer randomised”
Blinding? Unclear Outcome not influenced by lack of blinding
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement
on this
Subar 2001
Methods 2-arm randomised trial
Data Participants aged 55-74 years from 3 centres participating in PLCO trial (control arm)
Comparisons 1. Diet history questionnaire DHQ (36-page food frequency questionnaire) plus 1-page ques-
tionnaire on time taken to complete questionnaire
2. PLCO food frequency questionnaire (16-page food frequency questionnaire) plus 1-page
questionnaire on time taken to complete questionnaire
Outcomes Response rate. No time point given
Notes PLCO trial compared digital rectal examination, transvaginal ultrasound and chest x-ray at
baseline and at 5 years vs. usual follow-up. PSA and cancer antigen CA125 at baseline, and
annually for 5 years. Primary outcome: mortality from PLCO cancers
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No Author response “none known”
Adequate sequence generation? Unclear Author response “at each centre half were randomised to received”.
Authors contacted “we would have likely used some computer gen-
erated randomisation scheme”
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Subar 2001 (Continued)
Blinding? Unclear Author response “the respondents were not blinded. Not known if
personnel were ’blinded”’
Free of selective outcome reporting? Yes Expected outcome reported
Other sources of bias? Unclear Insufficient information to make a judgement about this
Sutherland 1996
Methods 2-arm randomised trial
Data 226 women taking part in the feasibility study for the Canadian diet and breast cancer pre-
vention feasibility trial
Comparisons 1. Total design method for postal follow-up: white envelope with hospital logo and commem-
orative stamp; headed notepaper; reply self addressed stamped envelope enclosing contents,
hand signature on letters. Postcard sent after 7 days, reminders sent twice
2. Customary method for postal follow-up: brown envelope with return address stamped on,
computer-printed labels, no signature on letter, reply self addressed stamped envelope folded
and inserted behind forms, no reminder
Outcomes Time to return of questionnaire at 70 days
Notes Canadian diet and breast cancer prevention feasibility trial compared teaching women aged
over 30 years of age with at least 50% of breast volume occupied by radiological changes
of dysplasia how to reduce dietary fat to a level of 15% of calories vs. no teaching. Primary
outcome recruitment and retention
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Not clear
Adequate sequence generation? Yes Author response “computer generated random numbers”
Blinding? Unclear Author response “personel knew the allocation a subject had received
but their only contact with subjects was the follow-up phone call in
some allocated to the ”customary“ method”
Free of selective outcome reporting? Yes Expected outcome reported
Other sources of bias? Unclear Insufficient information to make a judgement about this
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Svoboda 2001
Methods 2-arm randomised trial
Data Adults ≥ 16 years with head injury in the CRASH trial (Czech)
Comparisons 1. 1-page, 7-question functional dependence questionnaire sent with a covering letter and a
stamped return envelope. Reminders sent after 4 and 8 weeks
2. 3-page, 16-question functional dependence questionnaire sent with a covering letter and a
stamped return envelope. Reminders sent after 4 and 8 weeks
Outcomes Number of questionnaires returned within 3 months
Notes Numbers randomised and responded provided by authors. Primary outcome for the CRASH
trial death from any cause within 2 weeks of injury and death or disability at 6 months
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Author response “central computer”
Adequate sequence generation? Yes Author response “random allocation central computer”
Blinding? Unclear Author response “the questionnaires were packaged and sent to pa-
tients by personnel who were independent of the study”
Free of selective outcome reporting? Yes Expected outcome reported
Other sources of bias? Unclear Insufficient information to make a judgement about this
Tai 1997
Methods 2-arm randomised trial
Data All host study participants lost to follow-up in the evaluation of general practice computer
templates trial
Comparisons 1. Recorded delivery reminder letter with QoL questionnaire included, sent once
2.Telephone calls repeated up to3 times at 10-12 a.m. or 2-5.30p.m.Message left on answering
machine after third call
Outcomes Number of questionnaires returned. No time point given
Notes Evaluation of general practice computer templates cluster randomised trial compared comput-
erised templates for asthma and diabetes management in general practice. Primary outcome
frequency of use of computer templates assessed by examining computerised records of those
who responded to QoL questionnaires
Risk of bias
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Tai 1997 (Continued)
Item Authors’ judgement Description
Allocation concealment? Yes Author response “computer generated by statistician independent
to trial manager”
Adequate sequence generation? Unclear Author response “computer generated by statistician”
Blinding? Unclear Study personnel were not blind to the intervention the participants
received
Free of selective outcome reporting? Yes Expected outcomes reported
Other sources of bias? Unclear Insufficient information to make a judgement about this
APQ-23: Alcohol Problems Questionnaire; AQLQ: Asthma Quality of Life Questionnaire; AUDIT-C: Alcohol Use Disorders Identi-
fication Test; AVID: Antiarrhythmics Versus Implantable Defibrillators; CTC: Clinical Trial Centre; COGENT: COlorectal cancer
GENeTics; CORE OM: CORE Outcome Measure; CRASH: Cortiocosteriod Randomisation after Significant Head injury trial;
DYD: Down Your Drink; ELISA: enzyme-linked immunosorbent assay; FAOS: Foot and Ankle Outcome Score; FLP: Functional
Limitations Profile; LDQ: Leeds Dependency Questionnaire; MIDAS:MIgraine Disability Assessment Questionnaire; NASQNew-
castle Asthma Symptoms Questionnaire; NSABP: National Surgical Adjuvant Breast and Bowel project; PLCO: Prostate, Lung,
Colorectal, Ovarian; PSA: prostate-specific antigen; QoL: quality of life; RDQ: Roland Disability Questionnaire; RECORD: Ran-
domised Evaluation of Calcium Or Vitamin D; SANAD: Standard And New Antiepileptic Drugs; SF-36: Short form-36-item
health survey; TOMBOLA: Trial OfManagement of Borderline and Other Low-grade Abnormal smears; UKBEAM: UK Back pain
Exercise And Manipulation.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Arnevik 2009 This retention trial was not embedded in a randomised trial
Atherton 2010 Comparison of Internet vs. postal questionnaires not randomised
Barry 1996 Retention trial compared distribution of scores for subjects completing different questionnaire versions. Author
confirmed retention/questionnaire return was not an outcome measure
Bednarek 2008 Retention trial outcome is continuation of treatment
Cox 2003 Retention trial outcome treatment compliance
Day 1998 Retention trial measured adherence to treatment. Authors do not have retention data
Eaker 2004 Retention trial embedded in a cohort
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(Continued)
Edelstein 2005 Retention study is not a randomised trial. Incentives not randomised. Author confirmed these were not instituted
to help with retention but with adherence to pill taking and life style modification requirements
Grabowski 1995 Substudy aim is retention in treatment comparing different follow-up schedules for addiction treatment trial
Hall 1975 Not a randomised/quasi-randomised retention trial
Hall 1978 Not a randomised/quasi-randomised retention trial
Hoffman 1998 Retention trial embedded in a blood bank cohort
Hopkins 1983 Retention trial embedded in a survey
Iglesias 2000 Retention trial embedded in a cohort of general practitioner practice participants
Iglesias 2001 Retention trial embedded in the recruitment phase of the host trial
Johnson 2004 Retention study not embedded in a randomised trial
Katz 2001 Retention study is not a randomised trial. Authors confirmed the effectiveness of gift incentives was not evaluated
in a substudy for the Pride in Parenting trial
Leidy 2000 Retention study appears to be a randomised trial but no response from authors to establish if retention was an
outcome. For the substudy, trial sites randomised to 1of 2 orders of administration of quality of life questionnaires.
Response rates not reported.Missing data, internal consistency reliability,mean score values, relationship between
the 2 measures evaluated
Marsh 1999 Host study was not a randomised trial. “Practices were randomly allocated to the intervention group using
random number tables. Each intervention practice matched with one control practice”
McAuley 1994 Retention study is not a randomised trial. There is a single randomisation stratified by classes in the morning
and early evening. No response from authors regarding randomisation to class times
McBee 2009 Retention study not a randomised trial. Authors confirm strategies to improve retention were not evaluated in
an Age-Related Eye Disease Study 2 (AREDS2) substudy
Poling 2006 Substudy aim is about diagnostic compliance. 4-arm trial comparing contingency management with or without
active bupropion and voucher control with or without active bupropion. Here contingency management and
voucher control are aimed at getting information on the disease condition/response to treatment for the primary
outcome of the host trial i.e. negative urine sample for cocaine and opioids. Contingency management and
voucher control are not related to retention in the host trial but related to diagnostic compliance
Puffer 2004 Retention RCT was embedded in a survey. Authors confirmed that the 2 x 2 factorial study testing four different
questionnaire designs was embedded in a survey
Rhoades 1998 Substudy retention in treatment. 2 x 2 trial of dose and visit frequency of attending a clinic either 2 or 5 days
per week. Primary outcome was retention in treatment for all randomizations. Similar to Grabowski 1995 trial
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(Continued)
Roberts 2000 Retention trial embedded in a survey about menopause services
Schmitz 2005 Substudy about compliance to treatment and pill taking behaviour rather than trial retention
Smeeth 2001ab Substudy about response to baseline assessment
Stoner 1998 Retention study was not a randomised trial. Host study was a cluster randomised trial. Effectiveness of vouchers
not evaluated in a substudy
Tassopoulos 2007 Not a retention randomised trial
Wu 1997 Substudy designed to evaluate whether scores are different using 3 modes of questionnaire administration, rather
than retention
Characteristics of ongoing studies [ordered by study ID]
Land 2007 2
Trial name or title Randomised Evaluation of NSABP BAHO Compliance Initiatives
Methods Randomised trial embedded in Protocol B36
Data Participants or trial sites/institutions participating in the B36 trial. Pre- and postmenopausal women aged >
18 years, with histologically confirmed invasive breast adenocarcinoma
Comparisons Menstrual history calendar
Usual procedures
Outcomes To improve form submission compliance in Behavioural and Health Outcomes (BAHO) protocols
Starting date Unclear
Contact information Land@nsabp.pitt.edu
Notes Study identified through personal correspondence with author
B36: US-based comparison of 2 combination chemotherapy regimens to treat women with breast cancer
Mitchell
Trial name or title A Randomised Controlled Trial of Combined Pre-Contact and Participant Update for Increasing Question-
naire Response Rates in Older Women
Methods Randomised trial embedded in the SCOOP screening trial
Data Women aged 70-85 years not receiving treatment for osteoporosis
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Mitchell (Continued)
Comparisons 1. Prenotification to complete the 2-year follow-up questionnaire plus a study update
2. No study update
Outcomes Response to postal questionnaires at 2-year follow-up
Starting date 2010
Contact information natasha.mitchell@york.ac.uk
Notes Study identified through mail out to UK clinical trials units
SCOOP: UK-based pragmatic randomised controlled trial of the effectiveness of screening for osteoporosis in
older women for the prevention of fractures. 10-year absolute risk of fracture calculated from aWorld Health
Organization algorithm based on screening questionnaire data, x-ray and dual-energy x-ray absorptiometry
scan results compared with usual care
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D A T A A N D A N A L Y S E S
Comparison 1. Addition of incentive vs none: main analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 14 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Addition of monetary
incentive
3 3166 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [1.09, 1.28]
1.2 Addition of offer of
monetary incentive/prize draw
2 3613 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [1.14, 1.38]
1.3 Addition of non-monetary
incentive
6 6322 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.98, 1.02]
1.4 Addition of offer of
non-monetary incentive
2 1138 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.95, 1.03]
1.5 Addition of offer of
monetary donation to charity
1 815 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.78, 1.32]
Comparison 2. Addition of incentive: sensitivity analysis: quasi-randomised trials removed
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 7 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Addition of monetary
incentive
2 1022 Risk Ratio (M-H, Fixed, 95% CI) 1.31 [1.11, 1.55]
1.2 Addition of non-monetary
incentive
5 1594 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.93, 1.08]
Comparison 3. Addition of incentive: separating research arms of non-factorial trials (three-/four-arm trials)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 14 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Addition of monetary
incentive
3 3066 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [1.09, 1.27]
1.2 Offer of monetary
incentive
3 4224 Risk Ratio (M-H, Fixed, 95% CI) 1.24 [1.13, 1.37]
1.3 Addition of non-monetary
incentive
8 10793 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.98, 1.01]
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Comparison 4. Addition of telephone follow-up vs incentive
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Telephone survey vs.
monetary incentive and
questionnaire
1 700 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.94, 1.24]
Comparison 5. Addition of monetary incentive to both study arms
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 2 902 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [1.04, 1.22]
1.1 Addition of GBP10 plus
offer of GBP10 vs. addition of
GBP5 plus offer of GBP5
1 485 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [1.04, 1.30]
1.2 Addition of GBP20
voucher offer vs. addition of
GBP10 voucher offer
1 417 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.97, 1.21]
Comparison 6. Addition of monetary incentive vs offer of incentive
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 2 297 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.91, 1.19]
1.1 Addition of monetary
incentive vs. offer of entry into
prize draw
2 297 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.91, 1.19]
Comparison 7. Enhanced letter versus standard letter: main analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Enhanced letter vs.
standard letter
2 2479 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.97, 1.05]
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Comparison 8. Communication strategies letter: total design method
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Total design method
for postal questionnaires vs.
customary method
1 226 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [1.22, 1.67]
Comparison 9. Communication strategies post: main analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 7 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Priority vs. regular post 7 1888 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.95, 1.09]
Comparison 10. Communication strategies: additional reminder vs usual follow-up: main analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 6 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Additional reminder vs.
usual follow-up procedures
6 3401 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.99, 1.06]
Comparison 11. Communication strategies additional reminder to trial site vs usual reminder (ICC 0.054)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 1 Risk Ratio (Fixed, 95% CI) Subtotals only
1.1 Monthly reminder of
upcoming assessments to trial
site vs. usual reminders
1 272 Risk Ratio (Fixed, 95% CI) 0.96 [0.83, 1.11]
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Comparison 12. Communication strategies: questionnaire administered early vs late
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Early vs. late
administration
1 664 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.96, 1.26]
Comparison 13. Communication strategies: type of reminder: main analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Recorded delivery vs.
telephone reminder
1 192 Risk Ratio (M-H, Fixed, 95% CI) 2.08 [1.11, 3.87]
Comparison 14. Questionnaire strategies: new vs standard questionnaire: main analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 10 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Short vs. long
questionnaire
5 7277 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [1.00, 1.08]
1.2 Long and clear vs. short
and condensed questionnaires
1 900 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.95, 1.07]
1.3 Question order: condition
first vs. generic first questions
2 9435 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.97, 1.02]
1.4 Questionnaire: relevant vs.
less relevant to condition
2 3893 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [1.01, 1.14]
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Comparison 15. Questionnaire strategies: new vs standard questionnaire: sensitivity analysis quasi-randomised
trial McColl
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 8 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Short vs. long
questionnaire
5 7277 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [1.00, 1.08]
1.2 Long and clear vs. short
and condensed questionnaires
1 900 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.95, 1.07]
1.3 Questionnaire: relevant vs.
less relevant to condition
2 3893 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [1.01, 1.14]
Comparison 16. Behavioural strategies: main analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Motivation vs.
information
2 273 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.93, 1.24]
Comparison 17. Case management
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Case management vs.
usual follow-up
1 703 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.97, 1.04]
Comparison 18. Methodology strategies
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Retention 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Open vs. blind trial design 1 538 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [1.16, 1.63]
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Analysis 1.1. Comparison 1 Addition of incentive vs none: main analysis, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 1 Addition of incentive vs none: main analysis
Outcome: 1 Retention
Study or subgroup Addition of incentive No incentive Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Addition of monetary incentive
Bauer 2004ab 77/200 34/100 7.0 % 1.13 [ 0.82, 1.57 ]
Gates 2009 560/1070 493/1074 76.0 % 1.14 [ 1.05, 1.24 ]
Kenyon 2005 156/369 108/353 17.0 % 1.38 [ 1.13, 1.68 ]
Subtotal (95% CI) 1639 1527 100.0 % 1.18 [ 1.09, 1.28 ]
Total events: 793 (Addition of incentive), 635 (No incentive)
Heterogeneity: Chi2 = 3.13, df = 2 (P = 0.21); I2 =36%
Test for overall effect: Z = 4.21 (P = 0.000026)
2 Addition of offer of monetary incentive/prize draw
Khadjesari 2011 1ac 120/411 162/611 26.4 % 1.10 [ 0.90, 1.35 ]
Khadjesari 2011 2 476/1296 364/1295 73.6 % 1.31 [ 1.17, 1.46 ]
Subtotal (95% CI) 1707 1906 100.0 % 1.25 [ 1.14, 1.38 ]
Total events: 596 (Addition of incentive), 526 (No incentive)
Heterogeneity: Chi2 = 2.13, df = 1 (P = 0.14); I2 =53%
Test for overall effect: Z = 4.50 (P < 0.00001)
3 Addition of non-monetary incentive
Bowen 2000abc 3225/3542 1082/1186 76.8 % 1.00 [ 0.98, 1.02 ]
Renfroe 2002a 171/332 203/332 9.6 % 0.84 [ 0.74, 0.96 ]
Sharp 2006a 79/115 70/116 3.3 % 1.14 [ 0.94, 1.38 ]
Sharp 2006b 85/125 71/107 3.6 % 1.02 [ 0.86, 1.23 ]
Sharp 2006c 81/118 63/115 3.0 % 1.25 [ 1.02, 1.54 ]
Sharp 2006d 81/118 75/116 3.6 % 1.06 [ 0.89, 1.27 ]
Subtotal (95% CI) 4350 1972 100.0 % 1.00 [ 0.98, 1.02 ]
Total events: 3722 (Addition of incentive), 1564 (No incentive)
Heterogeneity: Chi2 = 13.06, df = 5 (P = 0.02); I2 =62%
Test for overall effect: Z = 0.11 (P = 0.91)
4 Addition of offer of non-monetary incentive
Cockayne 2005 (1) 721/788 233/250 91.0 % 0.98 [ 0.94, 1.02 ]
Hughes 1989 37/50 35/50 9.0 % 1.06 [ 0.83, 1.35 ]
Subtotal (95% CI) 838 300 100.0 % 0.99 [ 0.95, 1.03 ]
Total events: 758 (Addition of incentive), 268 (No incentive)
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(. . . Continued)
Study or subgroup Addition of incentive No incentive Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.53 (P = 0.60)
5 Addition of offer of monetary donation to charity
Khadjesari 2011 1b 55/204 162/611 100.0 % 1.02 [ 0.78, 1.32 ]
Subtotal (95% CI) 204 611 100.0 % 1.02 [ 0.78, 1.32 ]
Total events: 55 (Addition of incentive), 162 (No incentive)
Heterogeneity: not applicable
Test for overall effect: Z = 0.13 (P = 0.90)
Test for subgroup differences: Chi2 = 35.55, df = 4 (P = 0.00), I2 =89%
0.5 0.7 1 1.5 2
Favours no incentive Favours incentive
(1) data for overall response used for ockayne
Analysis 2.1. Comparison 2 Addition of incentive: sensitivity analysis: quasi-randomised trials removed,
Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 2 Addition of incentive: sensitivity analysis: quasi-randomised trials removed
Outcome: 1 Retention
Study or subgroup Incentive No incentive Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Addition of monetary incentive
Bauer 2004ab 77/200 34/100 29.1 % 1.13 [ 0.82, 1.57 ]
Kenyon 2005 156/369 108/353 70.9 % 1.38 [ 1.13, 1.68 ]
Subtotal (95% CI) 569 453 100.0 % 1.31 [ 1.11, 1.55 ]
Total events: 233 (Incentive), 142 (No incentive)
Heterogeneity: Chi2 = 1.06, df = 1 (P = 0.30); I2 =5%
Test for overall effect: Z = 3.14 (P = 0.0017)
2 Addition of non-monetary incentive
Renfroe 2002a 171/332 203/332 41.5 % 0.84 [ 0.74, 0.96 ]
Sharp 2006a 79/115 70/116 14.3 % 1.14 [ 0.94, 1.38 ]
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(. . . Continued)
Study or subgroup Incentive No incentive Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Sharp 2006b 85/125 71/107 15.7 % 1.02 [ 0.86, 1.23 ]
Sharp 2006c 81/118 63/115 13.1 % 1.25 [ 1.02, 1.54 ]
Sharp 2006d 81/118 75/116 15.5 % 1.06 [ 0.89, 1.27 ]
Subtotal (95% CI) 808 786 100.0 % 1.00 [ 0.93, 1.08 ]
Total events: 497 (Incentive), 482 (No incentive)
Heterogeneity: Chi2 = 13.02, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.02 (P = 0.99)
Test for subgroup differences: Chi2 = 8.06, df = 1 (P = 0.00), I2 =88%
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Analysis 3.1. Comparison 3 Addition of incentive: separating research arms of non-factorial trials (three-
/four-arm trials), Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 3 Addition of incentive: separating research arms of non-factorial trials (three-/four-arm trials)
Outcome: 1 Retention
Study or subgroup Incentive No incentive Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Addition of monetary incentive
Bauer 2004b 34/100 34/100 5.3 % 1.00 [ 0.68, 1.47 ]
Gates 2009 560/1070 493/1074 77.3 % 1.14 [ 1.05, 1.24 ]
Kenyon 2005 156/369 108/353 17.3 % 1.38 [ 1.13, 1.68 ]
Subtotal (95% CI) 1539 1527 100.0 % 1.17 [ 1.09, 1.27 ]
Total events: 750 (Incentive), 635 (No incentive)
Heterogeneity: Chi2 = 3.73, df = 2 (P = 0.16); I2 =46%
Test for overall effect: Z = 4.04 (P = 0.000053)
2 Offer of monetary incentive
Khadjesari 2011 1a 66/206 162/611 15.5 % 1.21 [ 0.95, 1.53 ]
Khadjesari 2011 1c 54/205 162/611 15.4 % 0.99 [ 0.76, 1.29 ]
0.5 0.7 1 1.5 2
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(. . . Continued)
Study or subgroup Incentive No incentive Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Khadjesari 2011 2 476/1296 364/1295 69.1 % 1.31 [ 1.17, 1.46 ]
Subtotal (95% CI) 1707 2517 100.0 % 1.24 [ 1.13, 1.37 ]
Total events: 596 (Incentive), 688 (No incentive)
Heterogeneity: Chi2 = 3.57, df = 2 (P = 0.17); I2 =44%
Test for overall effect: Z = 4.49 (P < 0.00001)
3 Addition of non-monetary incentive
Bowen 2000a 988/1092 1082/1186 21.7 % 0.99 [ 0.97, 1.02 ]
Bowen 2000b 1120/1211 1082/1186 22.9 % 1.01 [ 0.99, 1.04 ]
Bowen 2000c 1117/1239 1082/1186 23.1 % 0.99 [ 0.96, 1.01 ]
Renfroe 2002a 171/332 203/332 4.2 % 0.84 [ 0.74, 0.96 ]
Sharp 2006a 79/115 70/116 1.5 % 1.14 [ 0.94, 1.38 ]
Sharp 2006b 1201/1239 1062/1092 23.6 % 1.00 [ 0.98, 1.01 ]
Sharp 2006c 81/118 75/116 1.6 % 1.06 [ 0.89, 1.27 ]
Sharp 2006d 81/118 63/115 1.3 % 1.25 [ 1.02, 1.54 ]
Subtotal (95% CI) 5464 5329 100.0 % 1.00 [ 0.98, 1.01 ]
Total events: 4838 (Incentive), 4719 (No incentive)
Heterogeneity: Chi2 = 15.47, df = 7 (P = 0.03); I2 =55%
Test for overall effect: Z = 0.38 (P = 0.70)
Test for subgroup differences: Chi2 = 35.91, df = 2 (P = 0.00), I2 =94%
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Analysis 4.1. Comparison 4 Addition of telephone follow-up vs incentive, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 4 Addition of telephone follow-up vs incentive
Outcome: 1 Retention
Study or subgroup Telephone survey
Monetary +
questionnaire Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Telephone survey vs. monetary incentive and questionnaire
Couper 2007 170/300 210/400 100.0 % 1.08 [ 0.94, 1.24 ]
Subtotal (95% CI) 300 400 100.0 % 1.08 [ 0.94, 1.24 ]
Total events: 170 (Telephone survey), 210 (Monetary + questionnaire)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 5.1. Comparison 5 Addition of monetary incentive to both study arms, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 5 Addition of monetary incentive to both study arms
Outcome: 1 Retention
Study or subgroup GBP20 voucher offer
GBP10
voucher
offer Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Addition of GBP10 plus offer of GBP10 vs. addition of GBP5 plus offer of GBP5
Bailey 2 190/249 155/236 51.7 % 1.16 [ 1.04, 1.30 ]
Subtotal (95% CI) 249 236 51.7 % 1.16 [ 1.04, 1.30 ]
Total events: 190 (GBP20 voucher offer), 155 (GBP10 voucher offer)
Heterogeneity: not applicable
Test for overall effect: Z = 2.55 (P = 0.011)
2 Addition of GBP20 voucher offer vs. addition of GBP10 voucher offer
Bailey 1 166/215 144/202 48.3 % 1.08 [ 0.97, 1.21 ]
Subtotal (95% CI) 215 202 48.3 % 1.08 [ 0.97, 1.21 ]
Total events: 166 (GBP20 voucher offer), 144 (GBP10 voucher offer)
Heterogeneity: not applicable
Test for overall effect: Z = 1.38 (P = 0.17)
Total (95% CI) 464 438 100.0 % 1.12 [ 1.04, 1.22 ]
Total events: 356 (GBP20 voucher offer), 299 (GBP10 voucher offer)
Heterogeneity: Chi2 = 0.72, df = 1 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 2.82 (P = 0.0048)
Test for subgroup differences: Chi2 = 0.72, df = 1 (P = 0.40), I2 =0.0%
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Analysis 6.1. Comparison 6 Addition of monetary incentive vs offer of incentive, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 6 Addition of monetary incentive vs offer of incentive
Outcome: 1 Retention
Study or subgroup Monetary incentive Entry into draw Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Addition of monetary incentive vs. offer of entry into prize draw
Kenton 2007a 58/72 53/75 47.9 % 1.14 [ 0.95, 1.37 ]
Kenton 2007b 55/77 55/73 52.1 % 0.95 [ 0.78, 1.15 ]
Total (95% CI) 149 148 100.0 % 1.04 [ 0.91, 1.19 ]
Total events: 113 (Monetary incentive), 108 (Entry into draw)
Heterogeneity: Chi2 = 1.83, df = 1 (P = 0.18); I2 =45%
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable
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Analysis 7.1. Comparison 7 Enhanced letter versus standard letter: main analysis, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 7 Enhanced letter versus standard letter: main analysis
Outcome: 1 Retention
Study or subgroup Enhanced letter Standard letter Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Enhanced letter vs. standard letter
Renfroe 2002c 180/332 181/332 19.2 % 0.99 [ 0.87, 1.14 ]
Marson 2007 756/891 775/924 80.8 % 1.01 [ 0.97, 1.05 ]
Subtotal (95% CI) 1223 1256 100.0 % 1.01 [ 0.97, 1.05 ]
Total events: 936 (Enhanced letter), 956 (Standard letter)
Heterogeneity: Chi2 = 0.06, df = 1 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.39 (P = 0.70)
Test for subgroup differences: Not applicable
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Analysis 8.1. Comparison 8 Communication strategies letter: total design method, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 8 Communication strategies letter: total design method
Outcome: 1 Retention
Study or subgroup Total design method Customary post Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Total design method for postal questionnaires vs. customary method
Sutherland 1996 100/113 70/113 100.0 % 1.43 [ 1.22, 1.67 ]
Subtotal (95% CI) 113 113 100.0 % 1.43 [ 1.22, 1.67 ]
Total events: 100 (Total design method), 70 (Customary post)
Heterogeneity: not applicable
Test for overall effect: Z = 4.39 (P = 0.000011)
Test for subgroup differences: Not applicable
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Analysis 9.1. Comparison 9 Communication strategies post: main analysis, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 9 Communication strategies post: main analysis
Outcome: 1 Retention
Study or subgroup Priority post Regular post Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Priority vs. regular post
Renfroe 2002b 188/332 173/332 29.6 % 1.09 [ 0.95, 1.25 ]
Sharp 2006e 79/115 81/118 13.7 % 1.00 [ 0.84, 1.19 ]
Sharp 2006f 70/116 63/115 10.8 % 1.10 [ 0.88, 1.38 ]
Sharp 2006g 79/115 85/125 14.0 % 1.01 [ 0.85, 1.20 ]
Sharp 2006h 70/116 71/107 12.7 % 0.91 [ 0.74, 1.11 ]
Kenton 2007d 55/73 53/75 9.0 % 1.07 [ 0.88, 1.30 ]
Kenton 2007c 55/77 58/72 10.3 % 0.89 [ 0.74, 1.06 ]
Subtotal (95% CI) 944 944 100.0 % 1.02 [ 0.95, 1.09 ]
Total events: 596 (Priority post), 584 (Regular post)
Heterogeneity: Chi2 = 5.08, df = 6 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.55)
Test for subgroup differences: Not applicable
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Analysis 10.1. Comparison 10 Communication strategies: additional reminder vs usual follow-up: main
analysis, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 10 Communication strategies: additional reminder vs usual follow-up: main analysis
Outcome: 1 Retention
Study or subgroup Additional reminder Usual follow-up Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Additional reminder vs. usual follow-up procedures
Ashby 2011 68/74 64/74 5.0 % 1.06 [ 0.95, 1.19 ]
MacLennan 267/390 227/363 18.2 % 1.09 [ 0.99, 1.22 ]
Man 2011 54/62 53/63 4.1 % 1.04 [ 0.90, 1.20 ]
Nakash 2007 117/152 114/146 9.0 % 0.99 [ 0.87, 1.11 ]
Severi 2011 1 813/976 801/974 62.1 % 1.01 [ 0.97, 1.05 ]
Severi 2011 2 20/65 20/62 1.6 % 0.95 [ 0.57, 1.59 ]
Subtotal (95% CI) 1719 1682 100.0 % 1.03 [ 0.99, 1.06 ]
Total events: 1339 (Additional reminder), 1279 (Usual follow-up)
Heterogeneity: Chi2 = 2.78, df = 5 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 1.52 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 11.1. Comparison 11 Communication strategies additional reminder to trial site vs usual reminder
(ICC 0.054), Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 11 Communication strategies additional reminder to trial site vs usual reminder (ICC 0.054)
Outcome: 1 Retention
Study or subgroup
Additional
site
reminder Usual site reminder log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Monthly reminder of upcoming assessments to trial site vs. usual reminders
Land 2007 129 -0.04082199 (0.07213494) 143 100.0 % 0.96 [ 0.83, 1.11 ]
Subtotal (95% CI) 100.0 % 0.96 [ 0.83, 1.11 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Not applicable
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Analysis 12.1. Comparison 12 Communication strategies: questionnaire administered early vs late,
Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 12 Communication strategies: questionnaire administered early vs late
Outcome: 1 Retention
Study or subgroup Early administration Late administartion Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Early vs. late administration
Renfroe 2002d 189/332 172/332 100.0 % 1.10 [ 0.96, 1.26 ]
Subtotal (95% CI) 332 332 100.0 % 1.10 [ 0.96, 1.26 ]
Total events: 189 (Early administration), 172 (Late administartion)
Heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 13.1. Comparison 13 Communication strategies: type of reminder: main analysis, Outcome 1
Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 13 Communication strategies: type of reminder: main analysis
Outcome: 1 Retention
Study or subgroup Recorded delivery Telephone reminder Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Recorded delivery vs. telephone reminder
Tai 1997 26/98 12/94 100.0 % 2.08 [ 1.11, 3.87 ]
Subtotal (95% CI) 98 94 100.0 % 2.08 [ 1.11, 3.87 ]
Total events: 26 (Recorded delivery), 12 (Telephone reminder)
Heterogeneity: not applicable
Test for overall effect: Z = 2.30 (P = 0.021)
Test for subgroup differences: Not applicable
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Analysis 14.1. Comparison 14 Questionnaire strategies: new vs standard questionnaire: main analysis,
Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 14 Questionnaire strategies: new vs standard questionnaire: main analysis
Outcome: 1 Retention
Study or subgroup New questionnaires
Standard
question-
naires Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short vs. long questionnaire
Edwards 2001 31/50 35/49 1.9 % 0.87 [ 0.66, 1.15 ]
Dorman 1997 747/1125 679/1128 36.3 % 1.10 [ 1.04, 1.17 ]
Svoboda 2001 29/45 31/46 1.6 % 0.96 [ 0.71, 1.29 ]
McCambridge 2011 1b 1049/1888 529/947 37.7 % 0.99 [ 0.93, 1.07 ]
McCambridge 2011 2b 653/1333 316/666 22.5 % 1.03 [ 0.94, 1.14 ]
Subtotal (95% CI) 4441 2836 100.0 % 1.04 [ 1.00, 1.08 ]
Total events: 2509 (New questionnaires), 1590 (Standard questionnaires)
Heterogeneity: Chi2 = 6.87, df = 4 (P = 0.14); I2 =42%
Test for overall effect: Z = 1.82 (P = 0.068)
2 Long and clear vs. short and condensed questionnaires
Subar 2001 369/450 367/450 100.0 % 1.01 [ 0.95, 1.07 ]
Subtotal (95% CI) 450 450 100.0 % 1.01 [ 0.95, 1.07 ]
Total events: 369 (New questionnaires), 367 (Standard questionnaires)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.86)
3 Question order: condition first vs. generic first questions
McColl 2003 1 1522/2382 1537/2369 46.8 % 0.98 [ 0.94, 1.03 ]
McColl 2003 2 1779/2363 1738/2321 53.2 % 1.01 [ 0.97, 1.04 ]
Subtotal (95% CI) 4745 4690 100.0 % 1.00 [ 0.97, 1.02 ]
Total events: 3301 (New questionnaires), 3275 (Standard questionnaires)
Heterogeneity: Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.31 (P = 0.75)
4 Questionnaire: relevant vs. less relevant to condition
McCambridge 2011 2a 653/1333 308/668 45.6 % 1.06 [ 0.96, 1.17 ]
McCambridge 2011 1a 529/947 489/945 54.4 % 1.08 [ 0.99, 1.17 ]
Subtotal (95% CI) 2280 1613 100.0 % 1.07 [ 1.01, 1.14 ]
Total events: 1182 (New questionnaires), 797 (Standard questionnaires)
Heterogeneity: Chi2 = 0.06, df = 1 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 2.12 (P = 0.034)
Test for subgroup differences: Chi2 = 6.13, df = 3 (P = 0.11), I2 =51%
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Analysis 15.1. Comparison 15 Questionnaire strategies: new vs standard questionnaire: sensitivity analysis
quasi-randomised trial McColl, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 15 Questionnaire strategies: new vs standard questionnaire: sensitivity analysis quasi-randomised trial McColl
Outcome: 1 Retention
Study or subgroup New questionnaires
Standard
question-
naires Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short vs. long questionnaire
Dorman 1997 747/1125 679/1128 36.3 % 1.10 [ 1.04, 1.17 ]
Edwards 2001 31/50 35/49 1.9 % 0.87 [ 0.66, 1.15 ]
McCambridge 2011 1b 1049/1888 529/947 37.7 % 0.99 [ 0.93, 1.07 ]
McCambridge 2011 2b 653/1333 316/666 22.5 % 1.03 [ 0.94, 1.14 ]
Svoboda 2001 29/45 31/46 1.6 % 0.96 [ 0.71, 1.29 ]
Subtotal (95% CI) 4441 2836 100.0 % 1.04 [ 1.00, 1.08 ]
Total events: 2509 (New questionnaires), 1590 (Standard questionnaires)
Heterogeneity: Chi2 = 6.87, df = 4 (P = 0.14); I2 =42%
Test for overall effect: Z = 1.82 (P = 0.068)
2 Long and clear vs. short and condensed questionnaires
Subar 2001 369/450 367/450 100.0 % 1.01 [ 0.95, 1.07 ]
Subtotal (95% CI) 450 450 100.0 % 1.01 [ 0.95, 1.07 ]
Total events: 369 (New questionnaires), 367 (Standard questionnaires)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.86)
3 Questionnaire: relevant vs. less relevant to condition
McCambridge 2011 1a 529/947 489/945 54.4 % 1.08 [ 0.99, 1.17 ]
McCambridge 2011 2a 653/1333 308/668 45.6 % 1.06 [ 0.96, 1.17 ]
Subtotal (95% CI) 2280 1613 100.0 % 1.07 [ 1.01, 1.14 ]
Total events: 1182 (New questionnaires), 797 (Standard questionnaires)
Heterogeneity: Chi2 = 0.06, df = 1 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 2.12 (P = 0.034)
Test for subgroup differences: Chi2 = 1.99, df = 2 (P = 0.37), I2 =0.0%
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Analysis 16.1. Comparison 16 Behavioural strategies: main analysis, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 16 Behavioural strategies: main analysis
Outcome: 1 Retention
Study or subgroup Motivation Information Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Motivation vs. information
Cox 2008 50/58 50/62 50.2 % 1.07 [ 0.91, 1.25 ]
Chaffin 2009 51/75 49/78 49.8 % 1.08 [ 0.86, 1.36 ]
Subtotal (95% CI) 133 140 100.0 % 1.08 [ 0.93, 1.24 ]
Total events: 101 (Motivation), 99 (Information)
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours information Favours motivation
Analysis 17.1. Comparison 17 Case management, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 17 Case management
Outcome: 1 Retention
Study or subgroup Case management Usual follow-up Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Case management vs. usual follow-up
Ford 2006 333/352 332/351 100.0 % 1.00 [ 0.97, 1.04 ]
Subtotal (95% CI) 352 351 100.0 % 1.00 [ 0.97, 1.04 ]
Total events: 333 (Case management), 332 (Usual follow-up)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours usual follow-up Favours case management
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Analysis 18.1. Comparison 18 Methodology strategies, Outcome 1 Retention.
Review: Strategies to improve retention in randomised trials
Comparison: 18 Methodology strategies
Outcome: 1 Retention
Study or subgroup Open trial design Blind trial design Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Open vs. blind trial design
Avenell 2004 105/180 152/358 100.0 % 1.37 [ 1.16, 1.63 ]
Subtotal (95% CI) 180 358 100.0 % 1.37 [ 1.16, 1.63 ]
Total events: 105 (Open trial design), 152 (Blind trial design)
Heterogeneity: not applicable
Test for overall effect: Z = 3.61 (P = 0.00031)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Blind trial design Open trial design
A D D I T I O N A L T A B L E S
Table 1. Trials evaluating incentive strategies
Trial or trial comparison Incentive groups Control group Outcome type
Addition of incentive vs. none
Bauer 2004ab a) USD10 cheque
b) USD2 cheque
Arms combined formain analysis
No incentive DNA specimen kit return plus
postal questionnaire response
Gates 2009 GBP5 voucher No incentive Postal questionnaire response
Kenyon 2005 GBP5 voucher No incentive Postal questionnaire response
Khadjesari 2011 1ac a) Offer GBP5 voucher
c) Offer of entry into GBP250
prize draw, groups combined for
No incentive Internet-based questionnaire re-
sponse
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Table 1. Trials evaluating incentive strategies (Continued)
main analysis
Khadjesari 2011 2 Offer of GBP10 Amazon.co.uk
voucher
No incentive Internet-based questionnaire re-
sponse
Bowen 2000abc a) Certificate
b) Pin
c) Pin and certificate groups com-
bined for main analysis
No incentive Participants retention
Renfroe 2002a Certificate of appreciation No certificate of appreciation Postal questionnaire response
Sharp 2006a Pen No pen Postal questionnaire response
Sharp 2006b Pen No pen Postal questionnaire response
Sharp 2006c Pen No pen Postal questionnaire response
Sharp 2006d Pen No pen Postal questionnaire response
Cockayne 2005 Offer of study results No offer Postal questionnaire response
Hughes 1989 Offer of free reprint of results No offer Postal questionnaire response
Khadjesari 2011 1b Offer of GBP5 charity donation No offer Internet-based questionnaire re-
sponse
Addition of monetary incentive to both groups
Bailey 1 unpublished Offer of GBP20 shopping
voucher
Offer of GBP10 shopping
voucher
Postal questionnaire response
Bailey 2 unpublished Shopping voucher:GBP10 in ad-
vance and GBP10 on data return
Shopping voucher: GBP5 in ad-
vance and GBP5 on data return
Questionnaire response and
chlamydia kit return
Addition of monetary incentive vs. offer of incentive
Kenton 2007a USD2 coin Draw for USD50 gift voucher Postal questionnaire response
Kenton 2007b USD2 coin Draw for USD50 gift voucher Postal questionnaire response
Offer of prize draw vs. no offer
Leigh Brown 1997 Aware of monthly prize draw of
GBP25 gift voucher
No offer of draw Postal questionnaire response
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Table 2. Trials evaluating communication strategies
Trial or trial comparison Communication strategy Control arm Outcome type
Enhanced letter vs. standard letter
Renfroe 2002c Cover letter signed by physician Cover letter signed by co-ordina-
tor
Postal questionnaire response
Marson 2007 Letter explaining the approxi-
mate length of time to complete
questionnaire
Standard letter Postal questionnaire response
Total design method vs. customary method
Sutherland 1996 Total design method for postal
follow-up
Standard method for postal fol-
low-up
Postal questionnaire response
Priority vs. regular post
Renfroe 2002b Express delivery Standard delivery Postal questionnaire response
Sharp 2006e Despatch first-class stamp Despatch second-class stamp Postal questionnaire response
Sharp 2006f Despatch first-class stamp Despatch second-class stamp Postal questionnaire response
Sharp 2006g Second-class return envelope Free post return envelope Postal questionnaire response
Sharp 2006h Second-class return envelope Free post return envelope Postal questionnaire response
Kenton 2007c Priority mail Standard mail Postal questionnaire response
Kenton 2007d Priority mail Standard mail Postal questionnaire response
Additional reminder vs. usual follow-up
Ashby 2011 Electronic reminder No electronic reminder Postal questionnaire response
MacLennan unpublished Telephone reminder No telephone reminder Postal questionnaire response
Nakash 2007 Trial calendar given at recruit-
ment with questionnaire due
dates
No calendar Postal questionnaire response
Severi 2011 1 Text message and fridge magnet
both emphasising social benefits
of study participation
Text message reminder sent 3
days after questionnaire
Postal questionnaire response
Severi 2011 2 Telephone reminder from princi-
ple investigator
Standard procedures. Return of cotinine samples
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Table 2. Trials evaluating communication strategies (Continued)
Man 2011 SMS text message as follow-up
questionnaire sent out
No SMS text message Postal questionnaire response
Additional trial site reminder vs. usual reminder
Land 2007 Prospective monthly reminder of
upcoming assessments to trial
sites
No extra reminder to trial sites Postal questionnaire response
Early vs. late administration of questionnaire
Renfroe 2002d Questionnaire sent 2-3 weeks af-
ter last AVID follow-up visit
Questionnaire sent 1-4 months
after last AVID follow-up visit
Postal questionnaire response
Recorded delivery vs. telephone reminder
Tai 1997 Recorded delivery reminder Telephone reminder Postal questionnaire response
Addition telephone follow-up vs. incentive
Couper 2007 Telephone survey by trained in-
terviewer
Postal questionnaire and USD5
bill
Post and questionnaire response
AVID: Antiarrhythmics Versus Implantable Defibrillators; SMS: short message service.
Table 3. Trials evaluating new questionnaire strategies
Trial or trial comparison Questionnaire strategy Control arm Outcome type
Short vs. long
Dorman 1997 Short EuroQol Long SF-36 questionnaire. Postal questionnaire response
Edwards 2001 unpublished 1-page, 7-question functional
dependence questionnaire
3-page, 16-question functional
dependence questionnaire
Postal questionnaire response
Svoboda 2001 unpublished 1-page, 7-question functional
dependence questionnaire
3-page, 16-question functional
dependence questionnaire
Postal questionnaire response
McCambridge 2011 1b AUDIT Short
+
LDQ
APQ Internet-based questionnaire re-
sponse
McCambridge 2011 2b AUDIT Short
+
LDQ
APQ Internet-based questionnaire re-
sponse
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Table 3. Trials evaluating new questionnaire strategies (Continued)
Long and clear vs. short and condensed
Subar 2001 DHQ (36-page food frequency
questionnaire)
PLCO (16-page food frequency
questionnaire)
Postal questionnaire response
and onsite completion
Question order
McColl 2003 1 Asthma condition-specific ques-
tions first followed by generic
Generic questions followed by
condition specific
Postal questionnaire
response
McColl 2003 2 Angina condition-specific ques-
tions followed by generic
Generic questions followed by
condition specific
Postal questionnaire response
Letley 2000 unpublished RDQ at front and SF-36 at back SF-36 at front RDQ at back Postal questionnaire response
Relevance of questionnaire
McCambridge 2011 1a APQ23 items CORE-OM Mental health as-
sessment 23/34 items
Internet-based questionnaire re-
sponse
McCambridge 2011 2a AUDIT Short
+
LDQ
CORE-OM Mental health as-
sessment 10 items
Internet-based questionnaire re-
sponse
APQ: Alcohol Problems Questionnaire; AUDIT: Alcohol Use Disorders Identification Test; LDQ Leeds Dependency Questionnaire;
PLCO: Prostate, Lung, Colorectal, Ovarian; SF-36: Short Form 36 item.
Table 4. Gain in number of questionnaires returned per 1000 questionnaires sent
Exam-
ple of pro-
portion of
question-
naires
returned
in control
arm
30% 40% 50% 60% 70% 80% 90%
Strat-
egy to im-
prove re-
tention
RR 1
RR
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Table 4. Gain in number of questionnaires returned per 1000 questionnaires sent (Continued)
Addition
of mone-
tary incen-
tive versus
none
1.18 0.847 107 92 76 61 5 3 2
Addi-
tion of of-
fer of mon-
e-
tary incen-
tive/prize
draw ver-
sus none
1.25 0.800 140 120 100 80 60 40 20
Addition
of higher
valuemon-
e-
tary incen-
tive versus
addition of
lower
amount
1.12 0.890 77 66 55 44 33 22 11
RR: risk ratio.
A P P E N D I C E S
Appendix 1. Attrition terms
Cochrane Central Register of Controlled Trials (CENTRAL) and Database of Abstracts of Reviews of Effects (DARE in The Cochrane
Library) were searched using attrition terms shown below.
(minimi$ adj2 attrition).ab,ti.
(prevent$ adj2 attrition).ab,ti.
(lessen$ adj2 attrition).ab,ti.
(decreas$ adj2 attrition).ab,ti.
(reduc$ adj2 attrition).ab,ti.
(minimi$ adj2 drop-out).ab,ti.
(prevent$ adj2 drop-out).ab,ti.
(lessen$ adj2 drop-out).ab,ti.
(decreas$ adj2 drop-out).ab,ti.
(reduc$ adj2 drop-out).ab,ti.
(minimi$ adj2 drop-out$).ab,ti.
(prevent$ adj2 drop-out$).ab,ti.
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(lessen$ adj2 drop-out$).ab,ti.
(decreas$ adj2 drop-out$).ab,ti.
(reduc$ adj2 drop-out$).ab,ti.
(minimi$ adj2 drop$-out).ab,ti.
(prevent$ adj2 drop$-out).ab,ti.
(lessen$ adj2 drop$-out).ab,ti.
(decreas$ adj2 drop$-out).ab,ti.
(reduc$ adj2 drop$-out).ab,ti.
minimi$ adj2 dropout$).ab,ti.
(prevent$ adj2 dropout$).ab,ti.
(lessen$ adj2 dropout$).ab,ti.
(decreas$ adj2 dropout$).ab,ti.
(reduc$ adj2 dropout$).ab,ti
(strateg$ adj2 drop$-out) .ab,ti.
(strateg$ adj2 dropout$).ab,ti.
(loss adj2 follow-up).ab,ti.
(lost adj2 follow-up).ab,ti.
(loss adj2 followup).ab,ti.
(lost adj2 followup).ab,ti.
(minimi$ adj2 withdrawal).ab,ti.
(prevent$ adj2 withdrawal).ab,ti.
(lessen$ adj2 withdrawal).ab,ti.
(decreas$ adj2 withdrawal).ab,ti.
(reduc$ adj2 withdrawal).ab,ti.
(minimi$ adj2 withdrawal$).ab,ti.
(prevent$ adj2 withdrawal$).ab,ti.
(lessen$ adj2 withdrawal$).ab,ti.
(decreas$ adj2 withdrawal$).ab,ti.
(reduc$ adj2 withdrawal$).ab,ti.
(strateg$ adj2 attrition).ab,ti.
(strateg$ adj2 drop-out).ab,ti.
(strateg$ adj2 dropout).ab,ti.
(strateg$ adj2 follow-up).ab,ti.
(strateg$ adj2 followup).ab,ti.
(increas$ adj2 retention).ab,ti.
(encourag$ adj2 retention).ab,ti.
(maximi$ adj2 retention).ab,ti.
(promot$ adj2 retention).ab,ti.
(improv$ adj2 retention).ab,ti.
(strateg$ adj2 response$).ab,ti.
(strateg$ adj2 (questionnaire$ adj3 response$)).ab,ti.
(increas$ adj2 (questionnaire$ adj3 response$)).ab,ti.
(encourag$ adj2 (questionnaire$ adj3 response$)).ab,ti.
(maximi$ adj2 (questionnaire$ adj3 response$)).ab,ti.
(promot$ adj2 (questionnaire$ adj3 response$)).ab,ti.
(improv$ adj2 (questionnaire$ adj3 response$)).ab,ti.
(increas$ adj2 response$).ab,ti.
(encourag$ adj2 response$).ab,ti.
(maximi$ adj2 response$).ab,ti.
(promot$ adj2 response$).ab,ti.
(improv$ adj2 response$).ab,ti.
(retention adj2 strateg$).ab,ti.
retention rate$.ab,ti.
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(retention adj2 method$).ab,ti.
(retention adj2 technique$).ab,ti.
attrition rate$.ab,ti.
(questionnaire$ adj3 (response$ adj2 method$)).ab,ti.
(questionnaire$ adj3 (response adj2 technique$)).ab,ti.
(questionnaire adj response rate$).ab,ti. (1145)
(difficult$ adj2 (retain$ or retention)).ab,ti.
Participant Dropouts/
The search syntax was adapted as follows for different search interfaces
MEDLINE; EMBASE; PsycINFO via Ovid,
pt- Publication type.
adj2- words within 2 words of each other.
ab- word in abstract.
sh- sub heading.
ti word in title.
/ - Subject heading Medline.
$ - Truncation symbol.
Codes used to de duplicate in Ovid were:
use mesz
use emez
use psyh
Cochrane Central Register of Controlled Trials (CENTRAL) and Database of Abstracts of Reviews of Effects (DARE) via The
Cochrane Library
* Truncation symbol
NEAR/2 - words within 2 words of each other.
:kw- keyword
Codes used to de duplicate in CENTRAL were:
“accession number ” near pubmed
“accession number ” near2 embase
CINAHL (Cumulative Index to Nursing and Allied Health; 1981 to present) via EBSCOHost
MHMajor heading (CINAHL via EBSCOHost -)
+- (e.g.Treatment Outcomes+) (CINAHL via EBSCOHost -)
N2 - words within 2 words of each other.
* Truncation symbol.
Campbell Collaboration’s Social, Psychological, Educational and Criminological Trials Register (C2-SPECTR http://
geb9101.gse.upenn.edu/
* - Truncation symbol.
Education Resource Information Centre (ERIC) via Dialog datastar.
$ - Truncation symbol
ab- word in abstract.
ti word in title.
MeSH Headings
exp Participant Dropouts/: This was used in MEDLINE, only as a subject heading.
In PsycINFOExperimental attrition was used
In CINAHL plusResearch subject retention was used (“research dropouts” - term scope = mechanisms used to keep study participants
willing and able to contribute to participate in the study for its duration).
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Appendix 2. MEDLINE search strategy
Search strategy forMEDLINE Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: Sensitivity
and precision maximising version, 2008 revision Lefebvre 2008; Ovid format.
#1 randomized controlled trial.pt.
#2 controlled clinical trial.pt.
#3 randomized.ab.
#4 placebo.ab.
#5 clinical trials as topic.sh.
#6 randomly.ab.
#7 trial.ti.
#8 1 or 2 or 3 or 4 or 5 or 6 or 7
#9 exp animals/ not humans. sh.
#10 8 not 9
#11 10 AND Attrition terms (Appendix 1)
Appendix 3. EMBASE search strategy
EMBASE search using a sensitivity and specificity maximising search strategy for identifying clinically sound treatment studies Wong
2006a.
#1 random$.tw.
#2 placebo$.ti,ab,sh.
#3 double-blind$.tw.
#4 1 or 2 or 3
#5 4 AND Attrition terms (Appendix 1)
Appendix 4. PsycINFO search strategy
PsycINFO search strategy for identifying high quality studies on treatment: Sensitivity and specificity maximising version. Eady 2008
#1 double-blind.ab,ti.
#2 “random$ assigned.”.ab,ti.
#3 control.ab,ti.
#4 1 or 2 or 3
#5 4 AND Attrition terms (Appendix 1)
Appendix 5. CINAHL search strategy
CINAHL search strategy for identifying therapy studies and review articles: Sensitivity and specificity maximising versionWong 2006b
#1 PT Clinical trial
#2 (MH “Treatment Outcomes+”)
#3 randomi?ed
#4 1 or 2 or 3
#5 4 AND Attrition terms (Appendix 1)
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Appendix 6. C2-SPECTR search strategy
Campbell Collaboration’s Social, Psychological, Educational and Criminological Trials Register C2-SPECTR advanced search Non-
indexed fields and indexed fields.
Terms used: {retention} OR {attrition} OR {dropout} OR {drop-out} OR {withdrawal} OR {response}.
Appendix 7. ERIC search strategy
ERIC search strategy Petrosino 2000
#1 RANDOMI$.TI,AB.
#2 RANDOM$.TI,AB.
#3 (ALLOCAT$ OR ALLOT$ OR ASSIGN$ OR BASIS OR DIVID$ OR ORDER$).TI,AB.
#4 (2 NEAR 3).TI,AB.
#5 RANDOM$.TI,AB. NOT (4 ADJ or1).TI,AB.
#6 ((SINGL$ OR DOUBL$ OR TREBL$ OR TRIPL$) NEAR (BLIND$ ORMASK$)).TI,AB.
#7 ((COMPAR$ OR CONTROL$ OR EXPERIMENT$ OR INTERVENT$ OR THERAP$ OR TREATMENT$) NEAR
(GROUP$ OR CLASS$)).TI,AB.
#8 (ALLOCAT$ OR ALLOT$ OR ASSIGN$ OR DIVID$ OR ORDER$).TI,AB.
#9 (7 NEAR 8).TI,AB.
#10 crossover.TI,AB.
#11 (LATIN NEAR SQUARE).TI,AB.
#12 ((CLINIC$ OR CONTROL$) NEAR (TRIAL$ OR STUDY$ OR STUDIES$)).TI,AB.
#13 PLACEBO$
#14 (1 OR 4 OR 5 OR 6 OR 9 OR 10 OR 11 OR 12 OR 13).TI,AB.
#15 Attrition
#16 (attrition ADJ research ADJ studies). TI,AB.
#17 14 AND 16
#18 17 AND Attrition terms (Appendix 1)
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Appendix 9. Characteristics of host trials
Clinical area main trial Condition Participants Setting Attrition Study
Treatment of
dependence
Alcohol Adults scoring +5 on
AUDIT-C, mean age
37 years in an online
trial comparing interac-
tive computer interven-
tion plus website infor-
mation vs. website in-
formation for modifying
alcohol intake Murray
2007
Community: online Khadjesari 2011 1abc
Alcohol Adults scoring
+5 on AUDIT-C mean
age 37 years in an on-
line trial comparing in-
Community: online Khadjesari 2011 2
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(Continued)
teractive computer inter-
vention plus website in-
formation vs. website in-
formation for modifying
alcohol intake Murray
2007
Alcohol Adults scoring
+5 on AUDIT-C mean
age 37 years in an on-
line trial comparing in-
teractive computer inter-
vention plus website in-
formation vs. website in-
formation for modifying
alcohol intake Murray
2007
Community: online McCambridge 2011 1
Alcohol Adults scoring
+5 on AUDIT-C mean
age 37 years in an on-
line trial comparing in-
teractive computer inter-
vention plus website in-
formation vs. website in-
formation for modifying
alcohol intake Murray
2007
Community: online McCambridge 2011 2
Smoking Adult smokers aged 38-
77 years in a smoking
cessation trial of pub-
lic education through
media and community
wide events, healthcare
providers work sites and
other organisations vs.
no intervention Gail
1992
USA community Bauer 2004ab
Smoking Adult smokers mean age
36.7 years in a trial of
nicotine gum vs. placebo
gum. Smokers for > 1
year Hughes 1984
USA community Hughes 1989
Smoking Adult smokers willing to
quit aged > 16 years
in a trial compar-
ing Txt2stop motiva-
UK community Severi 2011 1
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(Continued)
tional messages and be-
haviour change support
vs. text messages unre-
lated to quitting Free
2011
Smoking Adult smokers willing to
quit aged > 16 years
in a trial compar-
ing Txt2stop motiva-
tional messages and be-
haviour change support
vs. text messages unre-
lated to quitting Free
2011
UK community Severi 2011 2
Treatment of injury Neck MINT trial: adults with
whiplash injury 18-87
years in a 2 x 2 cluster
randomised trial com-
paring whiplash book vs.
usual advice. Individu-
als randomised to phys-
iotherapy vs. single ad-
vice session reinforcing
advice given Lamb 2007
UK hospital trusts Gates 2009
Ankle Cast trial: adults aged
16-57 years with acute
severe ankle sprain in a
trial comparing tubular
bandage vs. below knee
cast vs. Aircast® ankle
brace vs. Bledsoe® boot
Cooke 2009
UK accident and emer-
gency departments
Nakash 2007*
Head Adults with head injury
aged > 16 years in trial
of 48-hour infusion of
methylprednisolone vs.
placebo CRASH Trial
collaborators 2004
UK hospital intensive
care units
Edwards 2001*
Head Adults with head in-
jury > 16 years CRASH
trial: 48-hour infusion of
methylprednisolone vs.
placebo CRASH Trial
collaborators 2004
Czech republic hospital
intensive care units
Svoboda 2001*
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(Continued)
Treatment of disease Breast cancer Women with ductal car-
cinoma in situ aged >
49 years in a trial com-
paring anastrozole vs. ta-
moxifen (unpublished)
USA, Canada, Puerto
Rico hospitals
Land 2007
Stroke Acute stroke patients 50-
80 years in an interna-
tional stroke trial of hep-
arin 125,000 IU twice
daily + aspirin 300 mg
daily vs. heparin 125,
000 IU twice vs. hep-
arin 5000 IU twice daily
+ aspirin 300 mg daily,
heparin 5000 IU twice
daily vs. aspirin 300
mg daily vs. no heparin
or aspirin International
Stroke Trial Group 1997
UK hospital Dorman 1997
Ventricular fibrillation,
ventricular tachycardia
Adults cardioverted from
ventricular tachycardia
or resuscitated from ven-
tricular fibrillation aged
54-76 years participat-
ing in the AVID trial
comparing an implanted
cardioverter defibrillator
vs. antiarrhythmic drugs
AVID investigators 1997
USA hospital Renfroe 2002a-d
Epilepsy Adults with
epilepsy mean 38.3 years
in the SANAD trial.
Arm a: carbamazepine
vs. gabapentin vs. lamot-
rigine vs. oxcarbazepine
vs. topiramate. Arm b:
valproate vs. lamotrigine
(LTG) vs. vs topiramate
(TPM)Marson 2007 (2)
UK hospital outpatient
departments
Marson 2007†
Back pain Adults with low back
pain aged 18-65 years in
a trial comparing exer-
cise manipulation vs. ex-
ercise plus manipulation
UK BEAM 2004
UK primary care Letley 2000‡
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(Continued)
Back pain Adults aged 18-65 years
in a trial comparing yoga
vs. usual care Tilbrook
2011
UK primary care Man 2011
Screening Prostate, lung, ovarian,
colorectal cancer
Adults aged 55-74 years
in PLCO trial compar-
ing PSA and CA125 at
baseline, and annually
for 5 years. Digital rectal
examination, transvagi-
nal ultrasound and chest
x-ray at baseline and 5
years vs. usual follow-up
Prorok 2000
USA trial sites Subar 2001,
Ford
2006 (African American
men aged ≥ 55 years
only from PLCO)
Cervical Women with low-grade
abnormal cervical smear
aged 20-59 years in the
TOMBOLA trial: Col-
poscopy vs. 6-monthly
smears TOMBOLA
2009a TOMBOLA
2009b
UK Sharp 2006a-h
Postnatal depression Women child-
bearing aged > 18 years
< 2 weeks’ postpartum at
high risk of postnatal de-
pression in a trial com-
paring proactive individ-
ualised telephone-based
peer support vs. standard
postpartum care Dennis
2009
Canada community Kenton 2007a-d
Prevention Fracture Adultswith history of os-
teoporotic fracture > 70
years in the RECORD
trial: oral calcium + vita-
min D vs. oral calcium
vs. vitamin D vs. placebo
RECORD 2007
UK hospital MacLennan*
Fracture Adults with his-
tory of osteoporotic frac-
ture aged > 70 years in
the RECORD trial: oral
calcium + vitamin D vs.
UK hospital Avenell 2004
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oral calcium vs. vitamin
D vs. placebo RECORD
2007
Fracture Women with hip frac-
ture risk factors aged >
70 years in a fracture pre-
vention trial of calcium
1000 mg plus vitamin
D3 800 IUplus informa-
tion sheet on dietary cal-
cium intake and falls pre-
vention vs. information
sheet Porterhouse 2005
UK primary care Cockayne 2005
Migraine Adults history of 2 mi-
graine attacks aged 18-
65 years with migraine
randomised to true diet
vs. sham diet (unpub-
lished)
UK community Ashby 2011
Lung cancer Adults exposed to smok-
ing and asbestos aged >
45 years in the CARET
trial 2 x 2: beta-carotene
+ retinol daily vs. beta-
carotene vs. retinol vs.
placebo Omenn 2006
USA trial sites Bowen 2000abc
Breast cancer Women with 50% of
breast volume dysplasia
> 30 years in Canadian
diet and cancer preven-
tion
trial. Counselling and in-
dividualised dietary pre-
scription vs. taught prin-
cipals of a healthy diet
not counselled to change
fat content Boyd 2002
Canada Hospital clinic Sutherland 1996
Clinical management Asthma Adult with asthma >
70 years in COGENT
trial: computerised deci-
sion support guidelines
for asthma vs. angina
care Eccles 2002
UK primary care McColl 2003
123Strategies to improve retention in randomised trials (Review)
Copyright © 2013 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
(Continued)
Asthma and diabetes Adults
with asthmamean age 47
years. Study template for
diabetes vs. study tem-
plate for asthma Tai
1999
UK primary care Tai 1997
Angina Adult with asthma aged
> 70 years in the CO-
GENT trial: comput-
erised decision support
guidelines for asthma vs
angina care Eccles 2002
UK primary care McColl 2003
Orthopaedics Adults with non-surgi-
cal musculoskeletal con-
dition
≥ 18 years in OMENS
trial: orthopaedic pa-
tients management from
single musculoskele-
tal medicine physician
vs. orthopaedic surgeon-
led management Leigh
Brown 1997
UK Hos-
pital othhopaedic outpa-
tient department
Leigh Brown 1997
Other areas Exercise Women sedentary 50-
70 years. SWEAT2 trial:
moderate walking pro-
gramme vs. swimming
programme Cox 2008
Australia community Cox 2008
Parenting Adults referred for par-
enting mean age 29
years. Parent-child inter-
active therapy vs. stan-
dard didactic parenting
condition Chaffin 2009
USA community Chaffin 2009
Weight management Adults with BMI > 25
aged>18years. Internet-
based tailored
weightmanagement ma-
terials vs. Internet-based
non-tailored user nav-
igated weight manage-
ment materials Rothert
2006
USA community Couper 2007
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Effect of antibiotics on
neonatal outcomes
Women < 37 weeks’ ges-
tation in ORACLE 1
+ 2 trial: 2 x 2 facto-
rial: co-amoxiclav + ery-
thromycin vs. co-amoxi-
clav vs. erythromycin vs.
placebo; 4 times daily x
10 days or until birth
Kenyon 2005
UK secondary care/com-
munity
Kenyon 2005
Health promotion People aged 16-20 years
in the sex unzipped pi-
lot feasibility trial: inter-
active intervention web-
site vs. information only
website (main trial un-
published)
UK on line Bailey 1*
Health promotion People aged 16-20 years
in the sex unzipped pi-
lot feasibility trial: inter-
active intervention web-
site vs. information only
website (main trial un-
published)
UK on line Bailey 2*
* unpublished; ‡ unpublished abstract; † report; published abstract; appendix
AUDIT: Alcohol UseDisorders Identification Test; AVID: Antiarrhythmics Versus Implantable Defibrillators; BMI: body mass index;
CARET: Carotene and Retinol Efficacy Trial; COGENT: COlorectal cancer GENeTics; CRASH: Clinical Randomisation of an
Antifibrinolytic in Significant Haemorrhage; IU: international unit; OMENS: ; ORACLE: ; PLCO: Prostate, Lung, Colorectal,
Ovarian; PSA: prostate-specific antigen; RECORD: Randomised Evaluation of Calcium Or vitamin D; SANAD: Standard And New
Antiepileptic Drugs; SWEAT: Sedentary Women Exercise Adherence Trial; TOMBOLA: Trial Of Management of Borderline and
Other Low-grade Abnormal smears
C O N T R I B U T I O N S O F A U T H O R S
VB wrote the protocol for the review with comments from JT, GR, SS, SM, SH and IN. JT and VB designed the searches with
comments from SH. VB conducted the searches and screened all abstracts and full papers of potentially eligible trials. VB and GR
screened potentially eligible trial papers. SS acted as a third reviewer. Data extraction was conducted by VB and checked by JT. JT
designed the analysis plan with VB. VB conducted the analysis with advice on interpretation of results from JT, SS, IN and GR. VB
wrote the first draft of the review with comments from all authors.
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D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• None, Not specified.
External sources
• None, Not specified.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We grouped trials according to: the type of strategy used, whether the strategy was compared with usual follow-up or other strategies.
The diversity of trials and interventions identified in the review were not anticipated. Therefore, the prespecified analyses were not
appropriate. Instead, new subgroups were defined prior to analyses. We had planned to include trials that were targeted at treatment or
follow-up compliance. We have only included trials that targeted follow-up compliance as the strategies used are transferable to other
trials. We had planned to assess whether retention was immediate or longer term (e.g. if a response to a questionnaire was expected
immediately or at time points in the future). Time points were poorly reported, where these were reported we used data for this analysis
for the primary outcome time point, there was insufficient reporting of this variable to group other time points for further analysis. We
had also planned to group participant or management-focused strategies. Only one unpublished trial (Land) evaluated a management-
focused strategy to reduce attrition.
As treatment compliance was not a focus of this review, search strategies with the terms ’compliance’ were removed for the 2009 to
2012 updates. Most untruncated ’response’ search terms were removed because hits relating to ’response’ were captured by the search
term ’response*’. To avoid references to treatment response, the search term ’questionnaire’ was added to ’response’ in all remaining
search terms with ’response’ or ’response*’ to make the search specific to questionnaire response. Search updates (2009 to 2012) for
EMBASE,MEDLINE and PsycINFO were de duplicated in Ovid. MEDLINE and EMBASE records were excluded for search updates
in CENTRAL. C2 Spectre and ERIC searches were not updated from 1 May 2009, as C2-SPECTR geb9101.gse.upenn.edu/: was not
accessible and the search platform for ERIC changed from Datastarweb to Proquest in December 2011. The latter limits searches to
10 lines of text.
I N D E X T E R M S
Medical Subject Headings (MeSH)
CaseManagement;Correspondence asTopic; PatientCompliance [psychology; ∗ statistics&numerical data]; PatientDropouts [statistics
& numerical data]; Questionnaires; Randomized Controlled Trials as Topic [∗statistics & numerical data]; Reward
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MeSH check words
Humans
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